<SEC-DOCUMENT>0001047469-20-003155.txt : 20200520
<SEC-HEADER>0001047469-20-003155.hdr.sgml : 20200520
<ACCEPTANCE-DATETIME>20200520172345
ACCESSION NUMBER:		0001047469-20-003155
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20200520
DATE AS OF CHANGE:		20200520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238526
		FILM NUMBER:		20899063

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>a2241681z424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg13305_table_of_contents">  TABLE OF CONTENTS</A> <BR>
<A HREF="#bg13301a_main_toc"> TABLE OF CONTENTS 2</A><BR></font>
</P>

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>Filed Pursuant to Rule&nbsp;424(b)(5)<BR>
Registration No.&nbsp;333-238526</B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#EF505F" SIZE=2><B>The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has become
effective under the Securities Act of 1933, as amended. We are not using this preliminary prospectus supplement or the accompanying prospectus to sell these securities or to solicit offers to buy
these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#EF505F" SIZE=1><B>SUBJECT TO COMPLETION, DATED MAY 20, 2020</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=1><B> PRELIMINARY PROSPECTUS SUPPLEMENT<BR>
(To Prospectus dated May&nbsp;20, 2020)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>
<IMG SRC="g814919.jpg" ALT="LOGO" WIDTH="252" HEIGHT="111">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>7,500,000 Shares<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% Mandatory Convertible Preferred Stock, Series&nbsp;A  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are offering 7,500,000 shares of our&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% Series&nbsp;A Mandatory Convertible Preferred Stock, par value $0.01 per share (the
"Mandatory Convertible Preferred Stock"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends
on the Mandatory Convertible Preferred Stock will be payable on a cumulative basis when, as and if declared by our board of directors, or an authorized committee thereof, at
an annual rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the liquidation preference of $100.00 per share. We may pay declared dividends in cash or, subject to certain limitations, in shares of our common stock, par value
$0.01 per share, or in any combination of cash and shares of our common stock on March&nbsp;1, June&nbsp;1, September&nbsp;1 and December&nbsp;1 of each year, commencing on September&nbsp;1,
2020, and ending on, and including, June&nbsp;1, 2023. Until we amend or terminate our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital
stock, or such restrictions are no longer effective under the terms of such credit agreements, we will pay the relevant dividend in shares of our common stock. There is no assurance that we will be
successful in amending or terminating our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock. See "Summary&#151;Recent Developments"
and "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our capital stock, including the
Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing credit agreements." </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
share of our Mandatory Convertible Preferred Stock has a liquidation preference of $100.00. Unless earlier converted, each share of the Mandatory Convertible Preferred Stock will
automatically and mandatorily convert on the second business day immediately following the last Trading Day (as defined herein) of the Settlement Period (as defined herein) into between
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, each subject to anti-dilution adjustments (respectively, the "Minimum
Conversion Rate" and "Maximum Conversion Rate"). The number of
shares of our common stock issuable on conversion of the Mandatory Convertible Preferred Stock will be determined based on the Average VWAP (as defined herein) per share of our common stock over the
20 consecutive Trading Day period commencing on, and including, the 21st&nbsp;Scheduled Trading Day (as defined herein) immediately preceding June&nbsp;1, 2023. At any time prior to June&nbsp;1,
2023, holders may elect to convert each share of the Mandatory Convertible Preferred Stock into shares of common stock at the Minimum Conversion Rate. If you elect to convert any shares of the
Mandatory Convertible Preferred Stock during the Fundamental Change Conversion Period (as defined herein), such shares of the Mandatory Convertible Preferred Stock will be converted into shares of our
common stock at the Fundamental Change Conversion Rate (as defined herein), and you will also be entitled to receive a Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount
(each as defined herein). </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with this offering, we are also making a public offering (the "Concurrent Offering") of $750.0&nbsp;million of shares of our common stock (or up to $862.5&nbsp;million
of shares if the underwriters in the Concurrent Offering exercise in full their option to purchase additional shares). The completion of this offering is not contingent on the completion of the
Concurrent Offering, and the completion of the Concurrent Offering is not contingent on the completion of this offering. The Concurrent Offering is being made by means of a separate prospectus
supplement and accompanying prospectus, and nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy shares of our common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to this offering, there has been no public market for our Mandatory Convertible Preferred Stock. We intend to apply to list the Mandatory Convertible Preferred Stock on the New
York Stock Exchange ("NYSE") under the symbol "BSX PR A." Our common stock is listed on NYSE under the symbol "BSX." The last reported sale price of our common stock on NYSE on May&nbsp;19, 2020 was
$35.43 per share. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined that this prospectus supplement and the
accompanying prospectus are accurate or complete. Any representation to the contrary is a criminal offense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Investing in the Mandatory Convertible Preferred Stock involves risks. See "Information Concerning Forward-Looking
Statements" on page&nbsp;S-26 and the risks described under the heading "Risk Factors" beginning on page&nbsp;S-17 of this prospectus supplement and under the heading "Risk Factors" in our
periodic reports that we file with the Securities and Exchange Commission before investing in any of our securities.</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="65%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Per Share</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Total</B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1><B> </B></FONT><FONT SIZE=1>Public Offering Price</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Underwriting Discount</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Proceeds, before expenses, to us</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have granted the underwriters the option, exercisable within 30&nbsp;days from the date of this prospectus supplement, to purchase up to an additional 1,125,000 shares of Mandatory
Convertible Preferred Stock from us at the public offering price, less the underwriting discount, solely to cover over-allotments. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters expect to deliver the shares of the Mandatory Convertible Preferred Stock against payment therefor in New York, New York
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B><I>Joint Book-Running Managers  </I></B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=3><B>J.P. Morgan</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=3><B>BofA Securities</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=1>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=1>
The date of this prospectus supplement is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=810030,FOLIO='blank',FILE='DISK104:[20ZCM5.20ZCM13305]BC13305A.;15',USER='JTAYLORA',CD='20-MAY-2020;15:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_bg13305_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="BG13305A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg13305_table_of_contents"> </A>
<BR></FONT><FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg13305_prospectus_supplement"> </A></FONT> <FONT SIZE=2><B>  Prospectus Supplement    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG13305_TOC2"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="27pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#bi13305_about_this_prospectus_supplement"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#bi13305_about_this_prospectus_supplement"><FONT SIZE=2>S-ii</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#ca13305_summary"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SUMMARY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#ca13305_summary"><FONT SIZE=2>S-1</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#cc13305_the_offering"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>THE OFFERING</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#cc13305_the_offering"><FONT SIZE=2>S-3</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#ce13305_risk_factors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RISK FACTORS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#ce13305_risk_factors"><FONT SIZE=2>S-17</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#cg13305_information_concerning_forward-looking_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#cg13305_information_concerning_forward-looking_statements"><FONT SIZE=2>S-26</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#cg13305_use_of_proceeds"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>USE OF PROCEEDS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#cg13305_use_of_proceeds"><FONT SIZE=2>S-27</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#cg13305_capitalization"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CAPITALIZATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#cg13305_capitalization"><FONT SIZE=2>S-28</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#ci13305_description_of_mandatory_convertible_preferred_stock"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF MANDATORY CONVERTIBLE PREFERRED STOCK</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#ci13305_description_of_mandatory_convertible_preferred_stock"><FONT SIZE=2>S-30</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#co13305_material_u.s._federal_income_tax_considerations"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#co13305_material_u.s._federal_income_tax_considerations"><FONT SIZE=2>S-61</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#co13305_certain_erisa_considerations"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CERTAIN ERISA CONSIDERATIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#co13305_certain_erisa_considerations"><FONT SIZE=2>S-70</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#cq13305_underwriting_(conflicts_of_interest)"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>UNDERWRITING (CONFLICTS OF INTEREST)</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#cq13305_underwriting_(conflicts_of_interest)"><FONT SIZE=2>S-71</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#leg"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LEGAL MATTERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#leg"><FONT SIZE=2>S-79</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#exp"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPERTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#exp"><FONT SIZE=2>S-79</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#where"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#where"><FONT SIZE=2>S-80</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg13305_prospectus"> </A>
<BR></FONT><FONT SIZE=2><B>  Prospectus    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG13305_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_about_this_prospectus"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ABOUT THIS PROSPECTUS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_about_this_prospectus"><FONT SIZE=2>1</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_where_you_can_find_more_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_where_you_can_find_more_information"><FONT SIZE=2>2</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_forward-looking_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FORWARD-LOOKING STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_forward-looking_statements"><FONT SIZE=2>3</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_risk_factors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RISK FACTORS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_risk_factors"><FONT SIZE=2>4</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_boston_scientific_corporation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BOSTON SCIENTIFIC CORPORATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_boston_scientific_corporation"><FONT SIZE=2>5</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_use_of_proceeds"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>USE OF PROCEEDS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_use_of_proceeds"><FONT SIZE=2>5</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_description_of_capital_stock"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_description_of_capital_stock"><FONT SIZE=2>6</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_plan_of_distribution"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PLAN OF DISTRIBUTION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_plan_of_distribution"><FONT SIZE=2>10</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_legal_matters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LEGAL MATTERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_legal_matters"><FONT SIZE=2>12</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_experts"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPERTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_experts"><FONT SIZE=2>12</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-i</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=130886,FOLIO='S-i',FILE='DISK104:[20ZCM5.20ZCM13305]BG13305A.;7',USER='DSLOAN',CD='20-MAY-2020;13:17' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_bi13305_1_2"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bi13305_about_this_prospectus_supplement"> </A>
<A NAME="toc_bi13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  ABOUT THIS PROSPECTUS SUPPLEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of the Mandatory
Convertible Preferred Stock we are offering and other matters relating to us. The second part is the accompanying prospectus, which provides more general information about the securities we may offer
from time to time, some of which may not apply to this offering of Mandatory Convertible Preferred Stock. This prospectus supplement and the accompanying prospectus are part of a registration
statement that we filed with the Securities and Exchange Commission (the "SEC") using the SEC's shelf registration rules. You should read both this prospectus supplement and the accompanying
prospectus, together with the documents incorporated by reference and the additional information described under the heading "Where You Can Find More Information" in this prospectus supplement and the
accompanying prospectus before making an investment decision. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent there is a conflict between the information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus, on the
other hand, the information contained in this prospectus supplement shall control. If any statement in this prospectus supplement conflicts with any statement in a document that has been incorporated
herein by reference, then you should consider only the statement in the more recent document. You should assume that the information contained in this prospectus supplement, the accompanying
prospectus and the documents incorporated by reference is accurate only as of their respective dates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not, and the underwriters have not, authorized any person to provide you with any information or to make any representation other than as contained in this prospectus supplement
or in the accompanying prospectus and the information incorporated by reference herein and therein. We and the underwriters do not take any responsibility for, and can provide no assurance as to the
reliability of, any information that others may provide you. The information appearing or incorporated by reference in this prospectus supplement and the accompanying prospectus is accurate only as of
the date of this prospectus supplement or the date of the document in which incorporated information appears unless otherwise noted in such documents. Our business, financial condition, results of
operations and prospects may have changed since those dates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated or unless the context otherwise requires, all references in this prospectus supplement to "Boston Scientific," the "Company," "we," "us," and "our" refer to
Boston Scientific Corporation and its divisions and subsidiaries. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;References
to our "2019 Form&nbsp;10-K" refer to our <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">Annual Report on
Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2019, filed on February&nbsp;25, 2020</A>, and references to our "Q1 2020
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">Form&nbsp;10-Q" refer to our Quarterly Report on Form&nbsp;10-Q for the quarter ended
March&nbsp;31, 2020, filed on May&nbsp;6, 2020.</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
distribution of this prospectus supplement and the accompanying prospectus and the offering of the Mandatory Convertible Preferred Stock in certain jurisdictions may be restricted by
law. We are not, and the underwriters are not, making an offer of the Mandatory Convertible Preferred Stock in any jurisdiction where the offer is not permitted. Persons who come into possession of
this prospectus supplement and the accompanying prospectus should inform themselves about and observe any such restrictions. This prospectus supplement and the accompanying prospectus do not
constitute, and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer or solicitation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
prospectus supplement is for distribution only to and is directed only at (i)&nbsp;persons having professional experience in matters relating to investments falling within
Article&nbsp;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii)&nbsp;persons falling within
Article&nbsp;49(2)(a) to (d)&nbsp;("high net worth companies, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-ii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=325034,FOLIO='S-ii',FILE='DISK104:[20ZCM5.20ZCM13305]BI13305A.;5',USER='JTAYLORA',CD='20-MAY-2020;10:38' -->
<A NAME="page_bi13305_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>unincorporated
associations etc.") of the Financial Promotion Order, (iii)&nbsp;persons outside of the United Kingdom, or (iv)&nbsp;persons to whom an invitation or inducement to engage in
investment activity (within the meaning of section&nbsp;21 of the Financial Services and Markets Act 2000 (as amended, the "FSMA")) in connection with the issue or sale of any securities may
otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). This prospectus supplement is directed only at relevant persons and
must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this prospectus supplement relates is available only to relevant persons and
will be engaged in only with relevant persons. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-iii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=4,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=908107,FOLIO='S-iii',FILE='DISK104:[20ZCM5.20ZCM13305]BI13305A.;5',USER='JTAYLORA',CD='20-MAY-2020;10:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ca13305_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ca13305_summary"> </A>
<A NAME="toc_ca13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SUMMARY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The information below is a summary of the more detailed information included elsewhere or incorporated by reference in
this prospectus supplement and the accompanying prospectus. You should read carefully the following summary together with the more detailed information contained in this prospectus supplement,
including the "Risk Factors" section beginning on page&nbsp;S-17 of this prospectus supplement, the accompanying prospectus and the information incorporated by reference herein and therein. This
summary is not complete and does not contain all of the information you should consider before purchasing the Mandatory Convertible Preferred Stock.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Boston Scientific Corporation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of
interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for
nearly 40&nbsp;years, we advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
history began in the late 1960s when our co-founder, John Abele, acquired an equity interest in Medi-tech,&nbsp;Inc., a research and development company focused on developing
alternatives to surgery. In 1969, Medi-tech introduced a family of steerable catheters used in some of the world's first less-invasive procedures. In 1979, John Abele joined with Pete Nicholas to form
Boston Scientific Corporation, which indirectly acquired Medi-tech. This acquisition began a period of active and focused new product development, innovation, market development and organizational
growth. Since then, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions,
and improve patients' quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
net sales have increased substantially since our formation. Our growth has been fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth
opportunities in the medical device industry and to build depth of portfolio within our core businesses. These strategic acquisitions have helped us to add promising new technologies to our pipeline
and to offer one of the broadest product portfolios in the world for use in less-invasive procedures in our core areas of Medical Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular. We believe
that the depth and breadth of our product portfolio has also enabled us to compete more effectively in the current healthcare environment that seeks to improve outcomes and lower costs. Our strategy
of category leadership also enables us to compete in a changing healthcare landscape and position our products
with providers and payers, while also expanding internationally and managing the complexities of the global healthcare market. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
principal executive offices are located at 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234. Our telephone number is (508)&nbsp;683-4000. Our website is located at
www.bostonscientific.com. We have included our website address as an inactive textual reference only. Information contained on, or accessible through, our website is not incorporated in this
prospectus supplement, the accompanying prospectus or any document incorporated by reference herein or therein. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Developments  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Refinancing and Credit Agreement Amendments  </I></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April&nbsp;21, 2020, as part of our COVID-19 response efforts and mitigation plan, we entered into a new $1.25&nbsp;billion 364-day Term
Loan maturing on April&nbsp;20, 2021 (the "April 2021 Term Loan") to </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=5,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=158802,FOLIO='S-1',FILE='DISK104:[20ZCM5.20ZCM13305]CA13305A.;9',USER='JFUSS',CD='20-MAY-2020;14:01' -->
<A NAME="page_ca13305_1_2"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;"><FONT SIZE=2>refinance
borrowings under our $2.75&nbsp;billion revolving credit facility (the "Revolving Credit Facility"), increase available backup liquidity and modify the leverage covenant in our credit
agreements for
additional financial flexibility. The April 2021 Term Loan contains covenants which, among other things, restrict us from paying cash dividends and other cash distributions on our capital stock.
Borrowings from the April 2021 Term Loan, combined with $60.0&nbsp;million of cash on hand, were used to refinance $910.0&nbsp;million of borrowings under the Revolving Credit Facility, and repay
in full the $400.0&nbsp;million of outstanding amounts under our $700.0&nbsp;million term loan maturing in December 2020 ("December 2020 Term Loan"), after which such Term Loan was terminated. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Also
on April&nbsp;21, 2020, the Company amended its $1.0&nbsp;billion 364-day Term Loan maturing on February&nbsp;26, 2021 (the "February 2021 Term Loan") and the Revolving Credit
Facility to, among other things, make the same modification of the leverage covenant and include the same covenant restricting the company from paying cash dividends and other cash distributions on
its capital stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;18, 2020, the Company completed a public offering of $1.7&nbsp;billion aggregate principal amount of its senior notes (the "May 2020 Senior Notes Offering"). The public
offering consisted of $500.0&nbsp;million of 1.900% Senior Notes due 2025 and $1.2&nbsp;billion of 2.650% Senior Notes due 2030. The Company used the net proceeds from the May 2020 Senior Notes
Offering towards (i)&nbsp;repaying the remaining $450.0&nbsp;million of borrowings under the Revolving Credit Facility, $750.0&nbsp;million under its February 2021 Term Loan and
$500.0&nbsp;million under its April 2021 Term Loan and (ii)&nbsp;paying related fees, expenses and premiums. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
intend to use a portion of the combined net proceeds from this offering and the Concurrent Offering to repay in full the remaining $750.0&nbsp;million outstanding under the April
2021 Term Loan and to pay related fees, expenses and premiums, after which it will be terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or
repayment of other outstanding indebtedness and funding potential future acquisitions and investments. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this prospectus supplement, we have no outstanding borrowings under the Revolving Credit Facility. Following consummation of the this offering, we intend to seek
amendments to the Revolving Credit Facility and the February 2021 Term Loan to permit us to pay cash dividends and other distributions on the Mandatory Convertible Preferred Stock. There can be no
assurance that we will be successful in securing any such amendment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Concurrent Offering  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently with this offering of the Mandatory Convertible Preferred Stock, we are offering, by means of a separate prospectus supplement and
accompanying prospectus, $750.0&nbsp;million of our common stock (or up to $862.5&nbsp;million of our common stock if the underwriters in the Concurrent Offering exercise in full their option to
purchase additional shares). We estimate that the net proceeds to us from the Concurrent Offering, after deducting the underwriting discount and
commissions and estimated offering expenses, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the underwriters
in the Concurrent Offering exercise in full their option to
purchase additional shares of common stock). The completion of this offering is not contingent on the completion of the Concurrent Offering, and the completion of the Concurrent Offering is not
contingent on the completion of this offering. There can be no assurance that the Concurrent Offering will be completed on the terms described herein or at all. The Concurrent Offering is being made
by means of a separate prospectus supplement and accompanying prospectus, and nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy shares of our common
stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
refer to (i)&nbsp;the entry into the April 2021 Term Loan, (ii)&nbsp;the repayment of the December 2020 Term Loan, (iii)&nbsp;the consummation of the May 2020 Senior Notes
Offering, (iv)&nbsp;this offering, (v)&nbsp;the Concurrent Offering and (vi)&nbsp;the application of the net proceeds from any of the foregoing, collectively, as the "Transactions." </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=6,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=611449,FOLIO='S-2',FILE='DISK104:[20ZCM5.20ZCM13305]CA13305A.;9',USER='JFUSS',CD='20-MAY-2020;14:01' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cc13305_1_3"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cc13305_the_offering"> </A>
<A NAME="toc_cc13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  THE OFFERING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The following summary contains basic information about the terms of this offering and is not intended to be complete. It
does not contain all of the information that may be important to you. For a more detailed description of the terms of the Mandatory Convertible Preferred Stock, please refer to the section entitled
"Description of Mandatory Convertible Preferred Stock" in this prospectus supplement and any free writing prospectus w e may provide you in connection with this offering.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>As used in this section, the terms the "Company," "us," "we" or "our" refer to Boston Scientific Corporation and not any of its
subsidiaries.</I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Issuer</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>Boston Scientific Corporation, a Delaware corporation.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Securities Offered</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>7,500,000 shares of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% Series&nbsp;A Mandatory Convertible Preferred
Stock, par value $0.01 per share (the "Mandatory Convertible Preferred Stock").</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Underwriters' Option</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>We have granted the underwriters an option, exercisable within 30&nbsp;days from the date of this prospectus supplement, to purchase up to
1,125,000 additional shares of Mandatory Convertible Preferred Stock at the public offering price, less the underwriting discount, solely to cover over-allotments.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Public Offering Price</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>$100.00 per share of Mandatory Convertible Preferred Stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Liquidation Preference</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>$100.00 per share of Mandatory Convertible Preferred Stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Dividend Payment Dates</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>March&nbsp;1, June&nbsp;1, September&nbsp;1 and December&nbsp;1 of each year, commencing on September&nbsp;1, 2020 and ending on, and
including, June&nbsp;1, 2023.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Dividends</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the liquidation preference of $100.00 per share of the Mandatory
Convertible Preferred Stock per year.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=7,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=960043,FOLIO='S-3',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Dividends shall accumulate from the most recent date as to which dividends shall have been paid or, if no dividends have been paid, from, and including, the
first original issue date of shares of the Mandatory Convertible Preferred Stock (the "Initial Issue Date"), and, to the extent our board of directors, or an authorized committee thereof, declares (out of funds legally available for payment, in the
case of dividends paid in cash, and shares of common stock legally permitted to be issued, in the case of dividends paid in common stock) a dividend payable with respect to the Mandatory Convertible Preferred Stock, we will pay such dividend in cash,
by delivery of shares of our common stock or through any combination of cash and shares of our common stock, as determined by us in our sole discretion (subject to certain limitations, including restrictions on dividends under our existing credit
agreements); </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that any unpaid dividends on the Mandatory Convertible Preferred Stock will continue to accumulate, except as described
below. For the avoidance of doubt, we will pay the relevant dividend in shares of our common stock until we amend or terminate our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock, or
such restrictions are no longer effective under the terms of such credit agreements. There is no assurance that we will be successful in amending or terminating our existing credit agreements that contain a restriction on our ability to pay cash
dividends on our capital stock. See "Summary&#151;Recent Developments" and "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our capital stock,
including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing credit agreements."</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=8,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=176164,FOLIO='S-4',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If declared, dividends will be payable on the dividend payment dates to holders of record of the Mandatory Convertible Preferred Stock at the close of
business on the February&nbsp;15, May&nbsp;15, August&nbsp;15 and November&nbsp;15, as the case may be, immediately preceding the relevant dividend payment date (each a "regular record date"), whether or not such holders early convert their shares of
Mandatory Convertible Preferred Stock, or such shares of Mandatory Convertible Preferred Stock are automatically converted, after a regular record date and on or prior to the immediately succeeding dividend payment date. The expected dividend payable
on the first dividend payment date is approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of the Mandatory Convertible Preferred Stock. Each subsequent dividend is expected to be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of the Mandatory Convertible Preferred Stock. Accumulated dividends on shares of the Mandatory Convertible Preferred Stock will not bear interest, nor shall additional
dividends be payable thereon, if they are paid subsequent to the applicable dividend payment date. See "Description of Mandatory Convertible Preferred Stock&#151;Dividends."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>We will make each payment of a declared dividend on the Mandatory Convertible Preferred Stock in cash, except to the extent we elect to make
all or any portion of such payment in shares of our common stock. If we elect to make any payment of a declared dividend, or any portion thereof, in shares of our common stock, such shares shall be valued for such purpose at the Average VWAP (as
defined under "Description of Mandatory Convertible Preferred Stock&#151;Mandatory Conversion&#151;Certain Definitions") per share of our common stock over the five consecutive Trading Day period commencing on, and including, the seventh Scheduled
Trading Day immediately preceding the applicable dividend payment date (such average, the "Average Price"), </FONT><FONT SIZE=2><I>multiplied by</I></FONT><FONT SIZE=2> 97%. Until we amend or terminate our existing credit agreements that contain a
restriction on our ability to pay cash dividends on our capital stock, or such restrictions are no longer effective under the terms of such credit agreements, we will pay the relevant dividend in shares of our common stock. There is no assurance that
we will be successful in amending or terminating our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock. See "Summary&#151;Recent Developments" and "Risk Factors&#151;Risks Relating to the
Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our capital stock, including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing credit
agreements."</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=9,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=360301,FOLIO='S-5',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Notwithstanding the foregoing, in no event will the number of shares of our common stock to be delivered in connection with any declared dividend, including
any declared dividend payable in connection with a conversion, exceed a number equal to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the declared dividend
divided by</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT
SIZE=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which amount represents approximately 35% of the Initial Price (as defined below) (subject to adjustment in a manner inversely proportional to any anti-dilution
adjustment to each Fixed Conversion Rate as described below) (such dollar amount, the "Floor Price").</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>To the extent that the amount of any declared dividend exceeds the product of (x)&nbsp;the number of shares of our common stock delivered in
connection with such declared dividend and (y)&nbsp;97% of the Average Price, we will, to the extent we are legally able to do so, and to the extent permitted under the terms of the documents governing our indebtedness, notwithstanding any notice by
us to the contrary, pay such excess amount in cash (rounded to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments, and is not permitted under our existing credit agreements. See "Summary&#151;Recent
Developments" and "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our capital stock, including the Mandatory Convertible Preferred Stock, may be
limited and is prohibited by the terms of our existing credit agreements." To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such
amount in cash or deliver additional shares of our common stock in respect of such amount, and such amount will not form&nbsp;a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred
Stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The "Initial Price" is calculated by dividing $100.00 by the Maximum Conversion Rate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, which initially equals $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is the public offering price per share of our
common stock in the Concurrent Offering.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Redemption</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The Mandatory Convertible Preferred Stock is not redeemable by us.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Mandatory Conversion Date</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The second business day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be
June&nbsp;1, 2023.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=10,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=64575,FOLIO='S-6',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Mandatory Conversion</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>On the Mandatory Conversion Date, each outstanding share of the Mandatory Convertible Preferred Stock, unless previously converted, will automatically
convert into a number of shares of our common stock equal to the conversion rate described below.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If we declare a dividend on the Mandatory Convertible Preferred Stock for the dividend period ending on, but excluding, June&nbsp;1, 2023, we
will pay such dividend to the holders of record on the immediately preceding regular record date.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If, on or prior to June&nbsp;1, 2023, we have not declared all or any portion of the accumulated and unpaid dividends on the Mandatory
Convertible Preferred Stock, the conversion rate will be adjusted so that holders receive an additional number of shares of our common stock equal to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the amount of such
undeclared, accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock (such amount, the "Mandatory Conversion Additional Conversion Amount"), </FONT><FONT SIZE=2><I>divided by</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the greater of
(A)&nbsp;the Floor Price and (B)&nbsp;97% of the Average Price (calculated using June&nbsp;1, 2023 as the applicable dividend payment date).</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>To the extent that the Mandatory Conversion Additional Conversion Amount exceeds the product of such number of additional shares and 97% of
the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, declare and pay such excess amount in cash (rounded to the nearest cent) pro rata per share to the holders of the Mandatory
Convertible Preferred Stock. Any such payment in cash may not be permitted by our then existing debt instruments, and is not permitted under our existing credit agreements. See "Summary&#151;Recent Developments" and "Risk Factors&#151;Risks Relating
to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our capital stock, including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing
credit agreements." To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our
common stock in respect of such amount, and such amount will not form&nbsp;a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=11,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=717692,FOLIO='S-7',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Conversion Rate</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Upon conversion on the Mandatory Conversion Date, the conversion rate for each share of Mandatory Convertible Preferred Stock will not be more
than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (the "Maximum Conversion Rate") and not less than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
(the "Minimum Conversion Rate"), depending on the Applicable Market Value of our common stock, as described below, and subject to certain anti-dilution adjustments.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The "Applicable Market Value" of our common stock is the Average VWAP per share of our common stock over the 20&nbsp;consecutive Trading Day
period commencing on, and including, the 21st&nbsp;Scheduled Trading Day immediately preceding June&nbsp;1, 2023 (the "Settlement Period"). The conversion rate will be calculated as described under "Description of Mandatory Convertible Preferred
Stock&#151;Mandatory Conversion," and the following table illustrates hypothetical conversion rates per share of the Mandatory Convertible Preferred Stock (assuming no anti-dilution adjustments and assuming that dividends are declared and paid in
case and subject to the provisions described herein with respect to any fractional share of common stock).</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=1><B>Assumed Applicable Market Value of<BR>
our common stock</B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=1><B>Conversion rate (number of shares<BR>
of our common stock issuable upon<BR>
conversion of each share of the<BR>
Mandatory Convertible Preferred<BR>
Stock)</B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Greater than the Threshold Appreciation Price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equal to or less than the Threshold Appreciation Price but greater than or equal to the Initial Price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT
SIZE=2>Between&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, determined by dividing $100.00 by the Applicable Market
Value</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less than the Initial Price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The "Threshold Appreciation Price" is calculated by dividing $100.00 by the Minimum Conversion Rate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, which is equal to approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and represents an
approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% appreciation over the Initial Price.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=12,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=788139,FOLIO='S-8',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Early Conversion at the Option of the Holder</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Other than during a Fundamental Change Conversion Period (as defined herein), at any time prior to June&nbsp;1, 2023, holders of the Mandatory Convertible
Preferred Stock have the right to elect to convert their shares of Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory Convertible Preferred Stock), into shares of common stock at the Minimum
Conversion Rate, as described under "Description of Mandatory Convertible Preferred Stock&#151;Early Conversion at the Option of the Holder".</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If, as of the conversion date of any early conversion (the "Early Conversion Date"), we have not declared all or any portion of the
accumulated and unpaid dividends for all full dividend periods ending on or before the dividend payment date prior to such Early Conversion Date, the conversion rate for such early conversion will be adjusted so that holders converting their
Mandatory Convertible Preferred Stock at such time receive an additional number of shares of our common stock equal to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>such amount of undeclared,
accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock for such prior full dividend periods (such amount, the "Early Conversion Additional Conversion Amount"), </FONT><FONT SIZE=2><I>divided by</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the greater of
(i)&nbsp;the Floor Price and (ii)&nbsp;the Average VWAP per share of our common stock over the 20 consecutive Trading Day period commencing on, and including, the 21st&nbsp;Scheduled Trading Day immediately preceding the Early Conversion Date (such
Average VWAP, the "Early Conversion Average Price").</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>To the extent that the Early Conversion Additional Conversion Amount exceeds the product of such number of additional shares and the Early
Conversion Average Price, we will not have any obligation to pay the shortfall in cash or to deliver shares of our common stock in respect of such shortfall.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=13,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1046594,FOLIO='S-9',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Conversion at the option of the holder upon a fundamental change; fundamental change dividend make-whole amount</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If a "Fundamental Change" (as defined under "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon
Fundamental Change; Fundamental Change Dividend Make-Whole Amount") occurs on or prior to June&nbsp;1, 2023, holders of the Mandatory Convertible Preferred Stock will have the right, during the Fundamental Change Conversion Period (as defined under
"Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount"), to convert their shares of Mandatory Convertible Preferred Stock, in whole or
in part (but in no event less than one share of the Mandatory Convertible Preferred Stock), into shares of our common stock (or units of exchange property as described in "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the
Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount") at the "Fundamental Change Conversion Rate". The Fundamental Change Conversion Rate will be determined based on the effective date of the Fundamental Change
(the "Fundamental Change Effective Date") and the price paid or deemed paid per share of our common stock in such Fundamental Change (the "Fundamental Change Stock Price").</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=14,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=247082,FOLIO='S-10',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Holders who convert their Mandatory Convertible Preferred Stock during the Fundamental Change Conversion Period will also receive a "Fundamental Change
Dividend Make-Whole Amount" equal to the present value (calculated using a discount rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% per annum) of all dividend payments on their shares of Mandatory Convertible
Preferred Stock (excluding any Accumulated Dividend Amount (as defined under "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole
Amount&#151;Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount")) for (i)&nbsp;the partial dividend period, if any, from, and including, the Fundamental Change Effective Date to, but excluding, the next dividend payment
date and (ii)&nbsp;all remaining full dividend periods from, and including, the dividend payment date following the Fundamental Change Effective Date to, but excluding, June&nbsp;1, 2023. If we elect to pay the Fundamental Change Dividend Make-Whole
Amount in shares of our common stock in lieu of cash, the number of shares of our common stock that we will deliver will equal (x)&nbsp;the Fundamental Change Dividend Make-Whole Amount </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2>
(y)&nbsp;the greater of the Floor Price and 97% of the Fundamental Change Stock Price.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>However, to the extent that the Accumulated Dividend Amount exists as of the Fundamental Change Effective Date, holders who convert their
Mandatory Convertible Preferred Stock within the Fundamental Change Conversion Period will be entitled to receive, upon conversion, such Accumulated Dividend Amount in cash (to the extent we are able to do so under applicable law and in compliance
with our indebtedness) or shares of our common stock (or units of exchange property as described in this prospectus supplement) or any combination thereof, at our election. For the avoidance of doubt, our existing credit agreements contain a
restriction on our ability to pay such amounts in cash. See "Summary&#151;Recent Developments" and "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on
our capital stock, including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing credit agreements."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>If we elect to pay the Accumulated Dividend Amount in shares of our common stock (or units of exchange property) in lieu of cash, the number
of shares of our common stock (or units of exchange property) that we will deliver will equal (x)&nbsp;the Accumulated Dividend Amount </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> (y)&nbsp;the greater of the Floor Price and 97% of the
Fundamental Change Stock Price.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=15,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=558232,FOLIO='S-11',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>To the extent that the sum of the Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount or the dollar amount of any portion thereof
paid in shares of our common stock (or units of exchange property) exceeds the product of (x)&nbsp;the number of additional shares we deliver in respect thereof and (y)&nbsp;97% of the Fundamental Change Stock Price, we will, if we are legally able
to do so, and to the extent permitted under the terms of the documents governing our indebtedness, pay such excess amount in cash (rounded to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments, and
is not permitted under our existing credit agreements. See "Summary&#151;Recent Developments" and "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our Common Stock&#151;Our ability to declare and pay dividends on our
capital stock, including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our existing credit agreements." To the extent that we are not able to pay such excess amount in cash under applicable law and in
compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>However, if we are prohibited from paying or delivering, as the case may be, the Fundamental Change Dividend Make-Whole Amount (whether in
cash or in shares of our common stock), in whole or in part, due to limitations of applicable Delaware law, the Fundamental Change Conversion Rate will instead be increased by a number of shares of common stock equal to the cash amount of the
aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount, </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;97% of the Fundamental Change Stock Price. To the extent
that the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount exceeds the product of such number of additional shares and 97% of the Fundamental Change Stock Price, we will not have any obligation to pay
the shortfall in cash or to deliver shares of our common stock in respect of such shortfall.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>See "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental
Change Dividend Make-Whole Amount&#151;Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Voting Rights</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Except as specifically required by Delaware law or by our Third Restated Certificate of Incorporation, the holders of Mandatory Convertible
Preferred Stock will have no voting rights.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=16,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=805463,FOLIO='S-12',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Whenever dividends on any shares of Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods
(including, for the avoidance of doubt, the dividend period commencing on, and including, the Initial Issue Date and ending on, but excluding, September&nbsp;1, 2020), whether or not for consecutive dividend periods, the holders of the Mandatory
Convertible Preferred Stock, voting together as a single class with holders of any and all other series of preferred stock ranking equally with the Mandatory Convertible Preferred Stock and having similar voting rights, will be entitled, at our next
annual meeting of stockholders or at a special meeting of stockholders, to vote for the election of a total of two additional members of our board of directors, subject to certain limitations described herein.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>So long as any shares of Mandatory Convertible Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of
the holders of at least two-thirds in voting power of the outstanding shares of Mandatory Convertible Preferred Stock and all other series of preferred stock ranking equally with the Mandatory Convertible Preferred Stock at the time outstanding and
having similar voting rights, voting together as a single class:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>amend or alter the
provisions of our Third Restated Certificate of Incorporation so as to authorize or create, or increase the authorized number of, any specific class or series of stock ranking senior to the Mandatory Convertible Preferred Stock;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>amend, alter or repeal any
provisions of our Third Restated Certificate of Incorporation or the certificate of designations with respect to the Mandatory Convertible Preferred Stock so as to adversely affect the special rights, preferences, privileges or voting powers of the
Mandatory Convertible Preferred Stock; or</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=17,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=790087,FOLIO='S-13',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> consummate a binding
share exchange or reclassification involving the shares of the Mandatory Convertible Preferred Stock or a merger or consolidation of us with another entity, unless in each case: (i)&nbsp;the shares of the Mandatory Convertible Preferred Stock remain
outstanding following the consummation of such binding share exchange, reclassification, merger or consolidation or, in the case of any such merger or consolidation with respect to which we are not the surviving or resulting entity, are converted
into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent; and (ii)&nbsp;the shares of the Mandatory Convertible Preferred Stock that remain outstanding or such shares of preference securities, as the
case may be, have such rights, preferences, privileges and voting powers that, taken as a whole, are not materially less favorable to holders thereof than the rights, preferences, privileges and voting powers of the Mandatory Convertible Preferred
Stock immediately prior to the consummation of such transaction, in each case, subject to certain exceptions.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>See "Description of Mandatory Convertible Preferred Stock&#151;Voting Rights."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Ranking</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The Mandatory Convertible Preferred Stock, with respect to dividend rights and/or distribution rights upon our liquidation, winding-up or
dissolution, as applicable, will rank:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>senior to (i)&nbsp;our
common stock and (ii)&nbsp;each other class or series of our capital stock established after the Initial Issue Date, the terms of which do not expressly provide that such class or series ranks either (x)&nbsp;senior to the Mandatory Convertible
Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution or (y)&nbsp;on parity with the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation,
winding-up or dissolution;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>on parity with any class
or series of our capital stock established after the Initial Issue Date, the terms of which expressly provide that such class or series will rank on parity with the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights
upon our liquidation, winding-up or dissolution;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>junior to each class or
series of our capital stock established after the Initial Issue Date, the terms of which expressly provide that such class or series will rank senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our
liquidation, winding-up or dissolution; and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>junior to our existing and
future indebtedness and other liabilities.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=18,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=959904,FOLIO='S-14',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>In addition, with respect to dividend rights or distribution rights upon our liquidation, winding-up or dissolution, the Mandatory Convertible Preferred
Stock will be structurally subordinated to any existing and future indebtedness and other obligations of each of our subsidiaries.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>As of March&nbsp;31, 2020 and after giving effect to the Transactions we had outstanding approximately $9.275&nbsp;billion of indebtedness,
and no outstanding shares of preferred stock other than the Mandatory Convertible Preferred Stock. In addition, certain of our subsidiaries had approximately $11.000&nbsp;million of outstanding indebtedness at March&nbsp;31, 2020.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Use of Proceeds</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>We intend to use a portion of the combined net proceeds from this offering and the Concurrent Offering to repay in full the remaining
$750.0&nbsp;million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it will be terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or
repayment of other outstanding indebtedness and funding potential future acquisitions and investments. Certain affiliates of certain underwriters will receive at least 5% of the net proceeds from this offering and the Concurrent Offering in
connection with the repayment of outstanding amounts under the April 2021 Term Loan. See "Underwriting (Conflicts of Interest)&#151;Conflicts of Interest" and "Use of Proceeds" in this prospectus supplement.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Material U.S. Federal Income Tax Considerations</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The material U.S. federal income tax considerations of owning and disposing of the Mandatory Convertible Preferred Stock and any common stock
received upon conversion thereof are described in "Material U.S. Federal Income Tax Considerations."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Listing</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>We intend to apply to list the Mandatory Convertible Preferred Stock on the New York Stock Exchange under the symbol "BSX PR A." Our common
stock is listed on the New York Stock Exchange under the symbol "BSX."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Concurrent Offering</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Concurrently with this offering, we are offering, by means of a separate prospectus supplement and accompanying prospectus,
$750.0&nbsp;million of shares of our common stock (or up to $862.5&nbsp;million of shares if the underwriters in the Concurrent Offering exercise in full their option to purchase additional shares). We estimate that the net proceeds to us from the
sale of shares of our common stock in the Concurrent Offering, after deducting the underwriting discount and estimated offering expenses payable by us, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(or
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the underwriters exercise in full their option to purchase additional shares of our common stock).</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=19,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1041491,FOLIO='S-15',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<A NAME="page_cc13305_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>The completion of this offering is not contingent on the completion of the Concurrent Offering, and the completion of the Concurrent Offering is not
contingent on the completion of this offering. There can be no assurance that the Concurrent Offering will be completed on the terms described herein or at all.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Transfer Agent, Registrar and Conversion and Dividend Disbursing Agent</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Computershare Inc. is the transfer agent, registrar, conversion agent and dividend disbursement agent for the Mandatory Convertible Preferred
Stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Risk Factors</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Investing in our Mandatory Convertible Preferred Stock involves risks. See "Risk Factors" beginning on page&nbsp;S-17 of this prospectus
supplement and other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of factors you should carefully consider before deciding to invest in the Mandatory Convertible
Preferred Stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Conflicts of Interest</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2>  </FONT><FONT SIZE=2>Affiliates of certain underwriters will receive at least 5% of the net proceeds of this offering in connection with the repayment of
borrowings under our April 2021 Term Loan. See "Use of Proceeds." Accordingly, this offering is being made in compliance with the requirements of Rule&nbsp;5121 of the Financial Industry Regulatory Authority,&nbsp;Inc. ("FINRA"). Because such
underwriters are not primarily responsible for managing this offering, pursuant to FINRA Rule&nbsp;5121, the appointment of a qualified independent underwriter is not necessary. Any underwriter with a conflict of interest, as defined under FINRA
Rule&nbsp;5121, will not confirm sales of the Mandatory Convertible Preferred Stock to any account over which they exercise discretionary authority without the prior written approval of the customer.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated or the context otherwise requires, all information in this prospectus supplement reflects and assumes the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> no exercise by the underwriters in this offering of their over-allotment option to purchase additional shares of Mandatory Convertible
Preferred Stock; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the completion of the Concurrent Offering and assuming no exercise by the underwriters of the Concurrent Offering of their option to purchase
additional shares of common stock. </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=14,SEQ=20,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=428602,FOLIO='S-16',FILE='DISK104:[20ZCM5.20ZCM13305]CC13305A.;28',USER='JFUSS',CD='20-MAY-2020;14:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ce13305_1_17"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ce13305_risk_factors"> </A>
<A NAME="toc_ce13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>Investing in our Mandatory Convertible Preferred Stock involves risks. You should consider carefully the risks described
below and the other information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus before making an investment decision, including the risks and
uncertainties set forth in Part&nbsp;I, Item&nbsp;1A. under the heading "Risk Factors" in our 2019 Form&nbsp;10-K, and in Part&nbsp;II, Item&nbsp;1A. under the heading "Risk Factors" in our
Q1 2020 Form&nbsp;10-Q, as well as any other document we may file with the SEC that is incorporated by reference herein. The risks and uncertainties described in this prospectus supplement as well
as the documents incorporated by reference herein are not the only ones facing us. Additional risks and uncertainties that we do not currently know about or that we currently believe are not material
may also adversely affect our business. If any of the risks and uncertainties described in this prospectus supplement or the documents incorporated by reference herein or other unknown or currently
immaterial risks or uncertainties actually occur, our business, financial condition, results of operations and prospects could be adversely affected in a material way. The occurrence of any of these
risks may cause you to lose all or part of your investment in the Mandatory Convertible Preferred Stock.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>This prospectus supplement also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those
anticipated in these forward-looking statements as a result of certain factors, including the risks faced by us described below and elsewhere in this prospectus supplement. See "Information Concerning
Forward-Looking Statements" in this prospectus supplement.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks
described below and in the documents incorporated by reference herein. For a discussion of the recent COVID-19 pandemic and its impact on our business, see Part&nbsp;I, Item&nbsp;2 under the
heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Q1 2020 Form&nbsp;10-Q and Part&nbsp;II, Item&nbsp;1A under the heading "Risk Factors" in
our Q1 2020 Form&nbsp;10-Q.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Relating to the Mandatory Convertible Preferred Stock and our Common Stock  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You will bear the risk of a decline in the market price of our common stock between the pricing date for the
Mandatory Convertible Preferred Stock and the Mandatory Conversion Date.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of shares of our common stock that you will receive upon mandatory conversion of the Mandatory Convertible Preferred Stock is not
fixed but instead will depend on the Applicable Market Value of our common stock, which is the Average VWAP per share of our common stock over the Settlement Period, which is the 20 consecutive
Trading Day period commencing on, and including, the 21st&nbsp;Scheduled Trading Day immediately preceding June&nbsp;1, 2023. The aggregate market value of shares of our common stock that you
would receive upon mandatory conversion may be less than the aggregate liquidation preference of the Mandatory Convertible Preferred Stock. Specifically, if the Applicable Market Value of our common
stock is less than the Initial Price, the market value of our common stock that you would receive upon mandatory conversion of each share of the Mandatory Convertible Preferred Stock will be less than
the $100.00 liquidation preference per share of Mandatory Convertible Preferred Stock, and an investment in the Mandatory Convertible Preferred Stock would result in a loss, without taking into
consideration the payment of dividends. Accordingly, you will bear the risk of a decline in the market price of our common stock. Any such decline could be substantial. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, because the number of shares delivered to you upon mandatory conversion will be based upon the Applicable Market Value, the shares of common stock you receive upon mandatory
conversion may be worth less than the shares of common stock you would have received had the
Applicable Market Value been equal to the VWAP per share of our common stock on the Mandatory Conversion Date or the average VWAP of our common stock over a different period of days. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=21,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=18242,FOLIO='S-17',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Purchasers of the Mandatory Convertible Preferred Stock may not realize any or all of the benefit of an
increase in the market price of shares of our common stock. The opportunity for equity appreciation provided by your investment in the Mandatory Convertible Preferred Stock is less than that provided
by a direct investment in our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market value of each share of our common stock that you will receive upon mandatory conversion of each share of the Mandatory Convertible
Preferred Stock on the Mandatory Conversion Date (assuming that dividends on shares of Mandatory Convertible Preferred Stock will be declared and paid in cash) will only exceed the liquidation
preference of $100.00 per share of the Mandatory Convertible Preferred Stock if the Applicable Market Value of our common stock exceeds the Threshold Appreciation Price. The Threshold Appreciation
Price represents an appreciation of approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% over the Initial Price. If the Applicable Market Value of our common stock is greater than the Threshold Appreciation Price, you will
receive on the Mandatory Conversion Date approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% (which percentage is equal to the Initial Price </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> the Threshold
Appreciation Price) of the value of our common stock that you would have received if you had made a direct investment in shares of our common stock on the date of this prospectus supplement. This
means that the opportunity for equity appreciation provided by an investment in the Mandatory Convertible Preferred Stock is less than that provided by a direct investment in shares of our common
stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, if the market value of our common stock appreciates and the Applicable Market Value of our common stock is equal to or greater than the Initial Price but less than or equal
to the Threshold Appreciation Price, the aggregate market value of our common stock that you would receive upon mandatory conversion (assuming that dividends on shares of Mandatory Convertible
Preferred Stock will be declared and paid in cash) will only be equal to the aggregate Liquidation Preference of the Mandatory Convertible Preferred Stock, and you will realize no equity appreciation
on our common stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The market price of our common stock has been and could remain volatile and will directly affect the market
price for our Mandatory Convertible Preferred Stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We expect that, generally, the market price of our common stock will affect the market price of our Mandatory Convertible Preferred Stock more
than any other single factor. This may result in greater volatility in the market price of our Mandatory Convertible Preferred Stock than would be expected for nonconvertible preferred stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, we expect that the market price of our Mandatory Convertible Preferred Stock will be influenced by yield and interest rates in the capital markets, the time remaining to the
Mandatory Conversion Date, our creditworthiness and the occurrence of certain events affecting us that do not require an adjustment to the Fixed Conversion Rates. Fluctuations in yield rates in
particular may give rise to arbitrage opportunities based upon changes in the relative values of our Mandatory Convertible Preferred Stock and our common stock. Any such arbitrage could, in turn,
affect the market prices of our common stock and our Mandatory Convertible Preferred Stock. The market price of our common stock could also be affected by possible sales of our common stock by
investors who view our Mandatory Convertible Preferred Stock as a more attractive means of equity participation in us and by hedging or arbitrage trading activity that we expect to develop involving
our common stock. This trading activity could, in turn, affect the market price of our Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The Concurrent Offering and future sales of substantial amounts of our common stock could affect the market
price of our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently with this offering, we are offering, by means of a separate prospectus supplement and accompanying prospectus,
$750.0&nbsp;million of shares of our common stock (and up to $112.5&nbsp;million of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=22,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=259046,FOLIO='S-18',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>additional
shares of our common stock that the underwriters in the Concurrent Offering have the option, exercisable within 30&nbsp;days from the date of the prospectus supplement for the Concurrent
Offering, to purchase from us). The completion of this offering is not conditioned on the completion of the Concurrent Offering, and the completion of the Concurrent Offering is not conditioned on the
completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Concurrent Offering and future sales of substantial amounts of our common stock or other securities convertible or exchangeable into shares of our common stock into the public market
whether by us or any of our security holders, including shares of common stock issued and delivered pursuant to the terms of the Mandatory Convertible Preferred Stock or issued upon exercise of
options or warrants, or the vesting of restricted stock units, or in connection with other potential acquisitions or business combinations, or perceptions that those sales and/or conversions or
exchanges could occur, could adversely affect the prevailing market price of our common stock and our ability to raise capital in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of these events may dilute your ownership interest in us and any of these events or the perception that these sales and/or conversions or exchanges could occur may have an adverse
impact on the price of our common stock. Furthermore, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market
price of our common stock. This could also impair our ability to raise additional capital through the sale of our securities. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The adjustment to the conversion rate and the payment of the Fundamental Change Dividend Make-Whole Amount
upon the occurrence of certain Fundamental Changes may not adequately compensate you for the lost option value and lost dividends as a result of early conversion upon a Fundamental Change.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a Fundamental Change (as defined in "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder
upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount") occurs on or prior to June&nbsp;1, 2023, holders will be entitled to convert their Mandatory Convertible Preferred Stock
during the Fundamental Change Conversion Period at the Fundamental Change Conversion Rate (in each case as defined in "Description of Mandatory Convertible Preferred Stock&#151;Conversion at
the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount"). The Fundamental Change Conversion Rate will be determined as described in "Description of Mandatory
Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount." In addition, with respect to those shares of
Mandatory Convertible Preferred Stock converted, you will also receive, among other consideration, a Fundamental Change Dividend Make-Whole Amount in cash (subject to our right to deliver shares of
common stock in lieu of all or part of such amount in cash), subject to the limitations described in Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the
Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount." If these limitations to the delivery in shares in payment of the Fundamental Change Dividend Make-Whole Amount are
reached, we will pay the shortfall in cash to the extent we are permitted to do so under applicable law and in compliance with our indebtedness. To the extent we are not permitted to pay in cash or
deliver shares in respect of the Fundamental Change Dividend Make-Whole Amount, in whole or in part, due to limitations of applicable Delaware law, we will make an adjustment to the conversion rate
subject to certain limitations; provided that, we will not have an obligation to pay shortfall in cash if these limitations to the adjustment of the conversion rate are reached, nor shall we have any
obligation to deliver shares of our common stock in respect of such shortfall if these limitations to the adjustment of the conversion rate are reached. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
this adjustment to the conversion rate and the payment of the Fundamental Change Dividend Make-Whole Amount are generally designed to compensate you for the lost option value of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=23,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=733534,FOLIO='S-19',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>the
Mandatory Convertible Preferred Stock and lost dividends that you will suffer as a result of converting your Mandatory Convertible Preferred Stock upon a Fundamental Change, the Fundamental Change
Conversion Rate and Fundamental Change Dividend Make-Whole Amount are only an approximation of such lost option value and lost dividends and may not adequately compensate you for your actual loss. In
addition, if the price of our common stock is less than $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share or more than $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the feature of
the Fundamental Change Conversion Rate will not compensate
you for any loss suffered in connection with a Fundamental Change. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the agreements governing any of our and our subsidiaries' existing or future indebtedness may limit our ability to pay cash or deliver shares of our common stock, as the
case may be, to converting holders upon a Fundamental Change unless we can repay or refinance the amounts outstanding under such agreements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
our obligation to adjust the conversion rate in connection with a Fundamental Change and pay the Fundamental Change Dividend Make-Whole Amount (whether paid or delivered, as
the case may be, in cash or shares of our common stock) could be considered a penalty under state law, in which case the enforceability thereof would be subject to general principles of reasonableness
and equitable remedies and therefore may not be enforceable in whole or in part. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The Fixed Conversion Rates of the Mandatory Convertible Preferred Stock may not be adjusted for all dilutive
events that may adversely affect the market price of the Mandatory Convertible Preferred Stock or the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Fixed Conversion Rates of the Mandatory Convertible Preferred Stock are subject to adjustment only for the issuance of certain stock
dividends on our common stock, subdivisions or combinations of our common stock, the issuance of certain rights, options or warrants to holders of our common stock, distributions of capital stock,
indebtedness, or assets to holders of our common stock, spin-offs, cash dividends and certain issuer tender or exchange offers as described under "Description of Mandatory Convertible Preferred
Stock&#151;Anti-Dilution Adjustments." However, other events, such as employee stock option grants, offerings of our common stock or securities convertible into common stock for cash or in
connection with acquisitions, or third-party tender or exchange offers, which may adversely affect the market price of our common stock, may not
result in any adjustment, even though these other events may adversely affect the market price of our common stock and, therefore, the market price of the Mandatory Convertible Preferred Stock. In
addition, the terms of our Mandatory Convertible Preferred Stock do not restrict our ability to offer common stock or securities convertible into common stock in the future or to engage in other
transactions that could dilute our common stock. We have no obligation to consider the specific interests of the holders of our Mandatory Convertible Preferred Stock in engaging in any such offering
or transaction. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Recent regulatory actions may adversely affect the trading price and liquidity of the Mandatory Convertible
Preferred Stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investors in, and potential purchasers of, the Mandatory Convertible Preferred Stock who employ, or seek to employ, a convertible arbitrage
strategy with respect to the Mandatory Convertible Preferred Stock may be adversely impacted by regulatory developments that may limit or restrict such a strategy. The SEC and other regulatory and
self-regulatory authorities have implemented various rules and may adopt additional rules in the future that restrict and otherwise regulate short selling and over-the-counter swaps and security-based
swaps, which restrictions and regulations may adversely affect the ability of investors in, or potential purchasers of, the Mandatory Convertible Preferred Stock to conduct a convertible arbitrage
strategy with respect to the Mandatory Convertible Preferred Stock. This could, in turn, adversely affect the trading price and liquidity of the Mandatory Convertible Preferred Stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=24,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=51402,FOLIO='S-20',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Purchasers of the Mandatory Convertible Preferred Stock may be adversely affected upon the issuance of a new
series of preferred stock ranking senior to or equally with the Mandatory Convertible Preferred Stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Third Restated Certificate of Incorporation authorizes our board of directors, without the approval of our stockholders, to issue 50,000,000
shares of our preferred stock (including the shares of Mandatory Convertible Preferred Stock), subject to limitations prescribed by applicable law, rules and regulations and the provisions of our
Third Restated Certificate of Incorporation, as shares of preferred stock in series, to establish from time to time the number of shares to be included in each such series and to fix the designation,
powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. The powers, preferences and rights of these additional series of preferred
stock may be senior to or on parity with the Mandatory Convertible Preferred Stock, which may reduce its value. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms of the Mandatory Convertible Preferred Stock will not restrict our ability to offer a new series of preferred stock that ranks senior to or equally with the Mandatory
Convertible Preferred Stock as to dividend payments or liquidation preference in the future. We have no obligation to consider the specific interests of the holders of the Mandatory Convertible
Preferred Stock in engaging in any such offering or transaction. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You will have no rights with respect to our common stock until the Mandatory Convertible Preferred Stock is
converted, but you may be adversely affected by certain changes made with respect to our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You will have no rights, powers or preferences with respect to our common stock, including voting rights, rights to respond to common stock
tender offers, if any, and rights to receive dividends or other distributions on shares of our common stock, if any (other than through a conversion rate adjustment), prior to the conversion date with
respect to a conversion of the Mandatory Convertible Preferred Stock, but your investment in the Mandatory Convertible Preferred Stock may be negatively affected by these events. Upon conversion, you
will be entitled to exercise the rights of a holder of shares of our common stock only as to matters for which the record date occurs on or after the conversion date. For example, in the event that an
amendment is proposed to our Third Restated Certificate of Incorporation or bylaws requiring stockholder approval and the record date for determining the stockholders of record entitled to vote on the
amendment occurs prior to the conversion date, you will not be entitled to vote on the amendment (subject to certain limited exceptions, unless it would adversely affect the special rights,
preferences, privileges and voting powers of the Mandatory Convertible Preferred Stock), although you will nevertheless be subject to any changes in the powers, preferences or special rights of our
common stock, even if your Mandatory Convertible Preferred Stock has been converted into shares of our common stock prior to the effective date of such change. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You will have no voting rights with respect to the Mandatory Convertible Preferred Stock except under limited
circumstances.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You will have no voting rights with respect to the Mandatory Convertible Preferred Stock, except with respect to certain amendments to the terms
of the Mandatory Convertible Preferred Stock, in the case of certain dividend arrearages, in certain other limited circumstances and except as specifically required by Delaware law or by our Third
Restated Certificate of Incorporation. You will have no right to vote for any members of our board of directors except in the case of certain dividend arrearages. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
dividends on any Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods (including, for the avoidance of doubt, the
dividend period commencing on, and including, the initial issue date of the Mandatory Convertible Preferred Stock and
ending on, but excluding, September&nbsp;1, 2020), whether or not for consecutive dividend periods, the holders of such Mandatory Convertible Preferred Stock, voting together as a single class with
holders of all other series of preferred stock ranking equally with the Mandatory Convertible </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=25,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=586774,FOLIO='S-21',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_22"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Preferred
Stock and having similar voting rights, will be entitled at our next special or annual meeting of stockholders to vote for the election of a total of two additional members of our board of
directors, subject to certain limitations described in "Description of Mandatory Convertible Preferred Stock&#151;Voting Rights." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The Mandatory Convertible Preferred Stock will rank junior to all of our and our subsidiaries' consolidated
liabilities.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of a bankruptcy, liquidation, dissolution or winding-up, our assets will be available to pay obligations on the Mandatory
Convertible Preferred Stock only after all of our consolidated liabilities have been paid. In addition, the Mandatory Convertible Preferred Stock will rank structurally junior to all existing and
future indebtedness and other liabilities of our subsidiaries. Your rights to participate in the assets of our subsidiaries upon any bankruptcy, liquidation, dissolution or winding up of any
subsidiary will rank junior to the prior claims of that subsidiary's creditors. In the event of a bankruptcy, liquidation, dissolution or winding-up, there may not be sufficient assets remaining,
after paying our and our subsidiaries' indebtedness and other liabilities, to pay amounts due on any or all of the Mandatory Convertible Preferred Stock then outstanding. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
March&nbsp;31, 2020 and after giving effect to the Transactions, we had outstanding approximately $9.275&nbsp;billion of indebtedness, and no outstanding shares of preferred
stock. In addition, certain of our subsidiaries had approximately $11.000&nbsp;million of outstanding indebtedness at March&nbsp;31, 2020. In addition, we have the ability to, and may incur,
additional indebtedness in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Third Restated Certificate of Incorporation authorizes our board of directors to issue one or more additional series of preferred stock and set the terms of the preferred stock
without seeking any further approval from our stockholders. Any preferred stock that is issued will rank ahead of our common stock in terms of dividends and liquidation rights. If we issue additional
preferred stock, it may adversely affect the market price of our common stock. Our board of directors also has the power, without stockholder approval, subject to applicable law, to set the terms of
any such series of preferred stock that may be issued, including voting rights, dividend rights and preferences over our common stock with respect to dividends or upon our dissolution, winding-up and
liquidation and other terms. If we issue additional preferred stock in the future that has a preference over our common stock with
respect to the payment of dividends or upon our liquidation, dissolution, or winding up, or if we issue additional preferred stock with voting rights that dilute the voting power of our common stock,
the rights of holders of shares of the Mandatory Convertible Preferred Stock and our common stock or the market price of the Mandatory Convertible Preferred Stock and our common stock could be
adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our ability to declare and pay dividends on our capital stock, including the Mandatory Convertible Preferred
Stock, may be limited and is prohibited by the terms of our existing credit agreements.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any future payments of cash dividends, and the amount of any cash dividends we pay, on our capital stock, including on the shares of Mandatory
Convertible Preferred Stock will be determined by our board of directors (or an authorized committee thereof) in its sole discretion and will depend on, among other things, our financial condition,
earnings, growth prospects, other uses of cash, funding requirements, applicable law and other factors our board of directors deems relevant. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms of our existing credit agreements contain a restriction on our ability to pay cash dividends on our capital stock, including the Mandatory Convertible Preferred Stock. As such,
we will pay any dividends on the Mandatory Convertible Preferred Stock in shares of our common stock until we amend or terminate our existing credit agreements that contain a restriction on our
ability to pay cash dividends on our capital stock, or such restrictions are no longer effective under the terms of such credit agreements. There is no assurance that we will be successful in amending
or terminating our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=26,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=527753,FOLIO='S-22',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>existing
credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock. In addition, the agreements governing any of our and our subsidiaries' future
indebtedness may also limit our ability to declare and pay cash dividends on the shares of our capital stock, including the shares of Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, under applicable Delaware law, our board of directors (or an authorized committee thereof) may only declare and pay dividends on shares of our capital stock out of our
statutory "surplus" (which is defined as the amount equal to total assets minus total liabilities, in each case at fair market value, minus statutory capital), or if there is no such surplus, out of
our net profits for the then current and/or immediately preceding fiscal year. Further, even if we are permitted under our contractual obligations and Delaware law to declare and pay cash dividends on
the shares of our capital stock, including the Mandatory Convertible Preferred Stock, we may not have sufficient cash to declare and pay dividends in cash on the shares of our capital stock including
the Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
upon mandatory conversion we have not declared all or any portion of the accumulated and unpaid dividends payable on the Mandatory Convertible Preferred Stock, the applicable
conversion rate will be adjusted so that holders receive an additional number of shares of common stock having a market value generally equal to the amount of such accumulated and unpaid dividends,
subject to the limitations described under "Description of the Mandatory Convertible Preferred Stock&#151;Mandatory Conversion". As a result of such limitations, the market value of such
additional number of shares of common stock may be less than the amount of such accumulated and unpaid dividends. To the extent that the amount of such accumulated and unpaid dividends exceeds the
product of such number of additional shares and 97% of the Average Price (as defined herein), we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness,
declare and pay such excess amount in cash pro rata to the holders of the Mandatory Convertible Preferred Stock; however, to the extent we are not permitted to do so under applicable law or in
compliance with our indebtedness, you will not receive such dividends or any other consideration in respect thereof. The terms of our existing credit agreements do not permit such payment in cash. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
upon an early conversion at the option of a holder (other than during a Fundamental Change), we have not declared and paid all or any portion of the accumulated dividends payable on
the Mandatory Convertible Preferred Stock for all full dividend periods ending on or before the dividend payment date prior to the related Early Conversion Date, the applicable conversion rate will be
adjusted so that converting holders receive an additional number of shares of our common stock having a market value generally equal to the amount of such accumulated and unpaid dividends, subject to
the limitations described under "Description of Mandatory Convertible Preferred Stock&#151;Early Conversion at the Option of the Holder". As a result of such limitations, the market value of
such additional number of shares of common stock may be less than the amount of such accumulated and unpaid dividends. To the extent that the amount of such accumulated and unpaid dividends exceeds
the product of such number of additional shares and the Early Conversion Average Price, we will not have any obligation to pay the shortfall in cash or to deliver shares of our common stock in respect
of such shortfall. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
upon an early conversion during the Fundamental Change Conversion Period we have not declared all or any portion of the accumulated and unpaid dividends payable on the Mandatory
Convertible Preferred Stock for specified periods, we will pay the amount of such accumulated and unpaid dividends in cash, shares of our common stock (or units of exchange property) or any
combination thereof, in our sole discretion, subject to the limitations described under "Description of Mandatory Convertible Preferred Stock&#151;Conversion at the Option of the Holder upon
Fundamental Change; Fundamental Change Dividend Make-Whole Amount." If these limitations to the delivery in shares in payment of accumulated and unpaid dividends are reached, we will pay the shortfall
in cash if we are permitted to do so under applicable law and in compliance with our indebtedness; however, to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=27,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=45155,FOLIO='S-23',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>the
extent we are not permitted to do so under applicable law or in compliance with our indebtedness, you will not receive such dividends or any other consideration in respect thereof. The terms of
our existing credit agreements do not permit such payment in cash. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We depend on our subsidiaries for cash to fund our operations and expenses, including future dividend
payments with respect to the Mandatory Convertible Preferred Stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A significant portion of our operations is conducted through our subsidiaries and our ability to generate cash to meet our debt service
obligations or to make future dividend payments with respect to the Mandatory Convertible Preferred Stock is highly dependent on the earnings and the receipt of funds from our subsidiaries. Our
subsidiaries are separate legal entities that have no obligation to make any funds available to us, whether by dividends, loans or other payments. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You may be subject to tax upon an adjustment to the conversion rate of the Mandatory Convertible Preferred
Stock or upon a distribution paid in shares of common stock even though you do not receive a corresponding cash distribution.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The conversion rate of the Mandatory Convertible Preferred Stock is subject to adjustment in certain circumstances. Refer to "Description of
Mandatory Convertible Preferred Stock&#151;Anti-Dilution Adjustments." If, as a result of an adjustment (or failure to make an adjustment), your proportionate interest in our assets or earnings
and profits is increased, you may be deemed to have received for U.S. federal income tax purposes a taxable dividend without the receipt of any cash or property. In addition, we may make distributions
to holders of the Mandatory Convertible Preferred Stock that are paid in shares of our common stock and, although there is some uncertainty, we believe that any such distribution will be taxable to
the same extent as a cash distribution of the same amount. In these circumstances and possibly others, a holder of Mandatory Convertible Preferred Stock may be subject to tax even though it has
received no cash with which to pay that tax, thus giving rise to an out-of-pocket expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are a Non-U.S. Holder (as defined under "Material U.S. Federal Income Tax Considerations"), any of these deemed dividends generally will be subject to U.S. federal withholding tax
(currently at a 30% rate, or such lower rate as may be specified by an applicable treaty), which may be withheld from subsequent payments on the Mandatory Convertible Preferred Stock, any common stock
you receive or other amounts held or received on your behalf by the applicable withholding agent. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See
"Material U.S. Federal Income Tax Considerations" for a further discussion of the U.S. federal tax implications for U.S. Holders (as defined therein) and Non-U.S. Holders of the
ownership of the Mandatory Convertible Preferred Stock and any common stock received in exchange therefor. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Certain rights of the holders of the Mandatory Convertible Preferred Stock or our outstanding debt securities
could delay or prevent an otherwise beneficial takeover or takeover attempt of us and, therefore, the ability of holders of Mandatory Convertible Preferred Stock to exercise their rights associated
with a potential Fundamental Change.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain rights of the holders of the Mandatory Convertible Preferred Stock could make it more difficult or more expensive for a third party to
acquire us. For example, if a Fundamental Change were to occur on or prior to June&nbsp;1, 2023, holders of the Mandatory Convertible Preferred Stock may have the right to convert their Mandatory
Convertible Preferred Stock, in whole or in part, at an increased conversion rate and will also be entitled to receive a Fundamental Change Dividend Make-Whole Amount equal to the present value of all
remaining dividend payments on their Mandatory Convertible Preferred Stock from the Fundamental Change Effective Date to, but excluding, June&nbsp;1, 2023. See "Description of Mandatory Convertible
Preferred Stock&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount." These features of the Mandatory Convertible Preferred Stock
could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=28,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=443729,FOLIO='S-24',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<A NAME="page_ce13305_1_25"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the change of control repurchase event feature contained in certain of our outstanding debt securities may in certain circumstances make more difficult or discourage a sale
or takeover of us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions
of Delaware law and our Third Restated Certificate of Incorporation and bylaws could also make it more difficult for a third party to acquire control of us or have the effect
of discouraging a third party from attempting to acquire control of us. See "Description of Capital Stock" in the accompanying prospectus. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


An active trading market for the Mandatory Convertible Preferred Stock does not exist and may not develop.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Mandatory Convertible Preferred Stock is a new issue of securities with no established trading market. The liquidity of the trading market
in the Mandatory Convertible Preferred Stock, and the market price quoted for the Mandatory Convertible Preferred Stock, may be adversely affected by changes in the overall market for this type of
security and by changes in our financial performance or prospects or in the prospects for companies in our industry generally. We intend to apply to list the Mandatory Convertible Preferred Stock on
NYSE under the symbol "BSX PR A." Even if the Mandatory Convertible Preferred Stock is approved for listing on NYSE, such listing does not guarantee that a trading market for the Mandatory Convertible
Preferred Stock will develop or, if a trading market for the Mandatory Convertible Preferred Stock does develop, the depth or liquidity of that market. If an active trading market does not develop or
is not maintained, the market price and liquidity of the Mandatory Convertible Preferred Stock may be adversely affected. In that case you may not be able to sell your Mandatory Convertible Preferred
Stock at a particular time or you may not be able to sell your Mandatory Convertible Preferred Stock at a favorable price. In addition, as shares of the Mandatory Convertible Preferred Stock are
converted, the liquidity of the Mandatory Convertible Preferred Stock that remains outstanding may decrease. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We do not intend to pay cash dividends on the common stock for the foreseeable future.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have not historically paid cash dividends to our stockholders and currently do not intend to pay cash dividends. Moreover, unless accumulated
dividends have been paid on all our Mandatory Convertible Preferred Stock then outstanding through the most recently completed dividend period, no dividends may be declared or paid on our common
stock. As a result, you may only receive a return on your investment in our common stock if the trading price of your shares increases. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The market price of our common stock has been and could remain volatile, and accordingly, the value of an
investment in our common stock may also fluctuate.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock markets in general and our common stock in particular have experienced significant price and trading volume volatility, including recently
as a result of the ongoing COVID-19 pandemic. The market price and trading volume of our common stock may continue to be subject to significant fluctuations due to various factors, as well as economic
and geopolitical conditions in general and to variability in the prevailing sentiment regarding our operations or business prospects, as well as, among other things, changing investment priorities of
our stockholders. Because the market price of our common stock fluctuates significantly, stockholders may not be able sell their shares at attractive prices. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Anti-takeover provisions could adversely affect our stockholders.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions of Delaware law and of our Third Restated Certificate of Incorporation and amended and restated by-laws could make it more difficult
for a third party to acquire control of us or have the effect of discouraging a third party from attempting to acquire control of us. For example, we are subject to Section&nbsp;203 of the Delaware
General Corporation Law, which would make it more difficult for another party to acquire us without the approval of our board of directors. For additional information concerning these provisions,
please refer to the description of our common stock contained the accompanying prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=29,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=789789,FOLIO='S-25',FILE='DISK104:[20ZCM5.20ZCM13305]CE13305A.;8',USER='MTITUSS',CD='20-MAY-2020;11:14' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cg13305_1_26"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cg13305_information_concerning_forward-looking_statements"> </A>
<A NAME="toc_cg13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein or therein contain or incorporate by
reference statements that may constitute "forward-looking statements" within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section&nbsp;21E
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate,"
"intend," "aiming" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be
guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the
expectations and projections expressed or implied by our forward-looking statements. As a result, investors are cautioned not to place undue reliance on any of our forward-looking statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
forward-looking statements below and elsewhere in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein or therein are based on
certain risks and uncertainties, including the risk factors described in Part&nbsp;I, Item&nbsp;1A. under the heading "Risk Factors" in our
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">2019 Form&nbsp;10-K</A> and in Part&nbsp;II, Item&nbsp;1A. under the heading
"Risk Factors" in our <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">Q1 2020 Form&nbsp;10-Q</A> and in connection with
forward-looking statements throughout our <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">2019 Form&nbsp;10-K</A> and
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">Q1 2020 Form&nbsp;10-Q</A>, as well as in any other document we may file with the
SEC that is incorporated by reference herein, and the specific risk factors discussed below which could cause actual results to vary materially from the expectations and projections expressed or
implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause
actual results to differ materially from those contemplated by the forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: future economic,
political, competitive, reimbursement and regulatory conditions, new product introductions and the market acceptance of those products, markets for our products, expected pricing environment, expected
procedural volumes, the closing and integration of acquisitions, clinical trial results, demographic trends, intellectual property rights, litigation, financial market conditions, the execution and
effect of our restructuring program, the execution and effect of our business strategy, including our cost-savings and growth initiatives and future business decisions made by us and our competitors.
New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19
pandemic. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. We caution investors to consider carefully these factors. We disclaim any
intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may
be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking
statements contained in this prospectus supplement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
further discussion of these risks and uncertainties and other risk factors, see Part&nbsp;I, Item&nbsp;1A. in our
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">2019 Form&nbsp;10-K</A>, under the heading "Risk Factors," Part&nbsp;II,
Item&nbsp;1A. under the heading "Risk Factors" in our <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">Q1 2020
Form&nbsp;10-Q</A> and under the heading "Risk Factors" herein and in any other document we may file with the SEC that is incorporated by reference herein. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=1,SEQ=30,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1034934,FOLIO='S-26',FILE='DISK104:[20ZCM5.20ZCM13305]CG13305A.;24',USER='JTAYLORA',CD='20-MAY-2020;16:10' -->
<A NAME="page_cg13305_1_27"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cg13305_use_of_proceeds"> </A>
<A NAME="toc_cg13305_2"> </A>
<BR></FONT><FONT SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We estimate the net proceeds from this offering, after deducting the underwriting discounts and commissions and estimated offering expenses
payable by us, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million (or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters
exercise their option to purchase additional shares of
Mandatory Convertible Preferred Stock in full). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
intend to use a portion of the combined net proceeds from this offering and the Concurrent Offering to repay in full the remaining $750.0&nbsp;million outstanding under the April
2021 Term Loan and to pay related fees, expenses and premiums, after which it will be terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or
repayment of other outstanding indebtedness and funding potential future acquisitions and investments. Our April 2021 Term Loan matures on April&nbsp;20, 2021, and based on our current credit
ratings, bear interest at an annual rate of LIBOR plus 1.875%. The proceeds from borrowings under the April&nbsp;2021 Term Loan was primarily used to pay off outstanding indebtedness. Certain
affiliates of certain underwriters will receive at least 5% of the net proceeds from this offering and the Concurrent Offering in connection with the repayment of outstanding amounts under the
April&nbsp;2021 Term Loan. See "Underwriting (Conflicts of Interest)&#151;Conflicts of Interest" in this prospectus supplement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=31,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1012547,FOLIO='S-27',FILE='DISK104:[20ZCM5.20ZCM13305]CG13305A.;24',USER='JTAYLORA',CD='20-MAY-2020;16:10' -->
<A NAME="page_cg13305_1_28"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cg13305_capitalization"> </A>
<A NAME="toc_cg13305_3"> </A>
<BR></FONT><FONT SIZE=2><B>  CAPITALIZATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth our cash and cash equivalents and capitalization as of March&nbsp;31,
2020:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on an actual basis; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on an as adjusted basis to give effect to the April 2021 Term Loan and the May 2020 Senior Notes Offering (including the application of the net
proceeds therefrom); and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on an as further adjusted basis to give effect to the Transactions (assuming no exercise of the underwriters' options with respect to either
this offering or the Concurrent Offering) including the application of the proceeds from this offering and the Concurrent Offering before deducting the underwriting discount and estimated offering
expenses. The completion of this offering is not contingent on the completion of the Concurrent Offering, and the completion of the Concurrent Offering is not contingent on the completion of this
offering. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
should read this table in conjunction with "Summary&#151;Recent Developments" and "Use of Proceeds" in this prospectus supplement and our consolidated financial statements and
related notes contained in our Exchange Act reports filed with the SEC and incorporated by reference in this prospectus supplement and the accompanying prospectus. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of March&nbsp;31, 2020 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(amounts in millions)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Further<BR>
Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>370</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>310</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1060 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Debt:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current debt obligations, including February 2021 Term Loan<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,004</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>254</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>254 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Long-term debt:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>December 2020 Term Loan<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>April 2021 Term Loan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>May 2022 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>October 2023 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>244</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>244</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>244</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revolving Credit Facility<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2024 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>May 2025 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>523</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>523</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>523</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>June 2025 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2026 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>December 2027 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>988</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>988</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>988</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2028 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2029 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>June 2030 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>November 2035 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2039 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>January 2040 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March 2049 Notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unamortized Debt Issuance Discount and Deferred Financing Costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unamortized Gain on Fair Value Hedges</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Finance Lease Obligation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total long-term debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,331</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,021</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,271 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,335</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,525</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=32,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=272208,FOLIO='S-28',FILE='DISK104:[20ZCM5.20ZCM13305]CG13305A.;24',USER='JTAYLORA',CD='20-MAY-2020;16:10' -->
<A NAME="page_cg13305_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of March&nbsp;31, 2020 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(amounts in millions)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Further<BR>
Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stockholders' equity:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock, $0.01 par value&#151;authorized 50,000,000 shares, 0 issued and outstanding on an actual and an as adjusted basis and 7,500,000 issued
and outstanding on an as further adjusted basis</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock, $0.01 par value&#151;authorized 2,000,000,000 shares&#151;issued 1,646,877,242 shares on an actual and an as adjusted basis and shares on
an as further adjusted basis<SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Treasury stock, at cost&#151;247,566,270 shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,589</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,589</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,252</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,252</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,252</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated other comprehensive income, net of tax:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>168</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>168</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>168 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,804</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,804</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total capitalization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>24,139</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>24,079</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >


<P style="font-family:times;"><FONT SIZE=1><B>Note:</B></FONT><FONT SIZE=1> The table above does not include unamortized amounts related to interest rate contracts designated as cash
flow hedges, and has not been updated since March&nbsp;31, 2020 for changes in the balance of unamortized debt issuance discounts and deferred financing costs, unamortized gains on fair value
hedges, or finance lease obligations entered into in the normal course of business. In addition, changes in the balance of cash and cash equivalents reflects only those cash inflows and outflows
associated with recent financing transactions. Amounts may not add due to rounding.  </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Includes
the February 2021 Term Loan on an actual basis. On an as adjusted basis, includes the borrowings under the February 2021 Term Loan that remained outstanding
following consummation of the May 2020 Senior Notes Offering and the use of proceeds thereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>We
have classified the $400&nbsp;million of term loan borrowings due in December 2020 as non-current, due to the repayment prior to the issuance of our unaudited
condensed consolidated financial statements for the period ending March&nbsp;31, 2020 using proceeds from our April 2021 Term Loan that does not require repayment within one year from the balance
sheet date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Available
borrowings under the Revolving Credit Facility on an as further adjusted basis are $2.75&nbsp;billion.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Excludes:</FONT><FONT
SIZE=2>
<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issuable upon conversion of, or as payment of dividends on, the Mandatory Convertible Preferred
Stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 25,215,000 shares of our common stock issuable upon exercise of outstanding options at a weighted average exercise price of $23 per share; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 10,377,000 shares of our common stock issuable upon vesting of outstanding restricted stock units; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 49,458,000 shares of our common stock reserved for future grants under our Long-Term Incentive Plans. </FONT></DD></DL>
</DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=33,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=18762,FOLIO='S-29',FILE='DISK104:[20ZCM5.20ZCM13305]CG13305A.;24',USER='JTAYLORA',CD='20-MAY-2020;16:10' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ci13305_1_30"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ci13305_description_of_mandatory_convertible_preferred_stock"> </A>
<A NAME="toc_ci13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  DESCRIPTION OF MANDATORY CONVERTIBLE PREFERRED STOCK    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following description is a summary of certain provisions of our&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% Series&nbsp;A Mandatory Convertible Preferred Stock, par
value $0.01 per share, or the "Mandatory Convertible Preferred Stock". The following summary supplements and, to the extent that it is inconsistent therewith, replaces the description of our preferred
stock in the accompanying prospectus. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
copy of the certificate of designations setting forth the terms of the Mandatory Convertible Preferred Stock, which we refer to as the "Certificate of Designations," as well as our
Third Restated Certificate of Incorporation, which we refer to as our "Charter," is available upon request from us at the address set forth in the section of this prospectus supplement entitled "Where
You Can Find More Information." This description of the terms of the Mandatory Convertible Preferred Stock is not complete and is subject to, and qualified in its entirety by reference to, the
provisions of our Charter and the Certificate of Designations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this description, references to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "the Company," "us," "we" or "our" refer to Boston Scientific Corporation and not any of its subsidiaries; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "Business Day" refer to any day other than a Saturday or Sunday or other day on which commercial banks in New York City are authorized or
required by law or executive order to close or be closed; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "close of business" refer to 5:00&nbsp;p.m., New York City time, and "open of business" refer to 9:00&nbsp;a.m., New York City time. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our Charter, our board of directors is authorized to provide, without further stockholder action, for the issuance of up to 50,000,000
shares of preferred stock, par value of $0.01 per share, and the designation of each series of preferred stock and, with respect to each such series, to fix the number of shares constituting such
series and fix the voting power, full or limited or no voting power, the powers, preferences and relative, participating, option or other special rights, if any, and any qualifications, limitations or
restrictions thereof, of the shares of each series. As of the date of this prospectus supplement, no shares of preferred stock are outstanding. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the closing of this offering, we will issue 7,500,000 shares of Mandatory Convertible Preferred Stock (or 8,625,000 shares of Mandatory Convertible Preferred Stock if the underwriters
exercise their option to purchase additional shares of mandatory Convertible Preferred Stock in full as described under "Underwriting"). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
issued, the Mandatory Convertible Preferred Stock and our common stock issued upon the conversion of the Mandatory Convertible Preferred Stock will be fully paid and nonassessable.
The
holders of the Mandatory Convertible Preferred Stock will have no preemptive or preferential rights to purchase or subscribe for any class of our stock, obligations, warrants or other securities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Ranking  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Mandatory Convertible Preferred Stock, with respect to dividend rights and/or distribution rights upon our liquidation, winding-up or
dissolution, as applicable, will rank:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> senior to (i)&nbsp;our common stock and (ii)&nbsp;each other class or series of our capital stock established after the first original
issue date of shares of the Mandatory Convertible Preferred Stock (which we refer to as the "Initial Issue Date"), the terms of which do not expressly provide that such class or series ranks either
(x)&nbsp;senior to the Mandatory Convertible Preferred Stock as to </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=34,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=370655,FOLIO='S-30',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>dividend
rights or distribution rights upon our liquidation, winding-up or dissolution or (y)&nbsp;on parity with the Mandatory Convertible Preferred Stock as to dividend rights or distribution
rights upon our liquidation, winding-up or dissolution (we refer to our common stock and all such other classes or series of capital stock, collectively, as "Junior Stock"); </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on parity with any class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such
class or series will rank on parity with the Mandatory Convertible Preferred Stock as to dividend rights and distribution rights upon our liquidation, winding-up or dissolution (which we refer to
collectively as "Parity Stock"); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> junior to each class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such
class or series will rank senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution (which we refer to
collectively as "Senior Stock"); and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> junior to our existing and future indebtedness and other liabilities. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, with respect to dividend rights and distribution rights upon our liquidation, winding-up or dissolution, the Mandatory Convertible Preferred Stock will be structurally
subordinated to any existing and future indebtedness and other obligations of each of our subsidiaries. See "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and
Our Common Stock&#151;The Mandatory Convertible Preferred Stock will rank junior to all of our and our subsidiaries' consolidated liabilities." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
March&nbsp;31, 2020 and after giving effect to the Transactions, we would have had outstanding approximately $9.275&nbsp;billion of indebtedness, and no outstanding shares of
preferred stock other than the Mandatory Convertible Preferred Stock. In addition, certain of our subsidiaries had approximately $11.000&nbsp;million of outstanding indebtedness at March&nbsp;31,
2020. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Listing  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We intend to apply to list the Mandatory Convertible Preferred Stock on The New York Stock Exchange ("NYSE"), under the symbol "BSX PR A" and,
if approved, we expect trading to commence within 30&nbsp;days of the Initial Issue Date. In addition, upon listing, we have agreed to use our commercially reasonable efforts to keep the Mandatory
Convertible Preferred Stock listed on NYSE. However, there can be no assurance that the Mandatory Convertible Preferred Stock will be listed, and if listed, that it will continue to be listed. Listing
the Mandatory Convertible Preferred Stock on NYSE does not guarantee that a trading market will develop or, if a trading market does develop, the depth or liquidity of that market or the ability of
holders to sell their Mandatory Convertible Preferred Stock easily. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividends  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the rights of holders of any class or series of any Senior Stock, holders of the Mandatory Convertible Preferred Stock will be
entitled to receive, when, as and if declared by our board of directors, or an authorized committee thereof, out of funds legally available for payment, in the case of dividends paid in cash, and
shares of common stock legally permitted to be issued, in the case of dividends paid in shares of common stock, cumulative dividends at the rate per annum of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the Liquidation
Preference of $100.00 per share of the Mandatory Convertible Preferred Stock (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per annum per share), payable in cash, by delivery of shares of our common stock or
through
any combination of cash and shares of our common stock, as determined by us in our sole discretion (subject to the limitations on our ability to pay cash dividends and other cash distributions on our
capital stock described below with respect to our credit facilities, see "&#151;Limitation on Cash Payments under our Credit Facilities"). See "&#151;Method of Payment of Dividends." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=35,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=939896,FOLIO='S-31',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_32"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
declared, dividends on the Mandatory Convertible Preferred Stock will be payable quarterly on March&nbsp;1, June&nbsp;1, September&nbsp;1 and December&nbsp;1 of each year to,
and including, June&nbsp;1, 2023 commencing on September&nbsp;1, 2020 (each, a "Dividend Payment Date"), at such annual rate, and dividends shall accumulate from the most recent date as to which
dividends shall have been paid or, if no dividends have been paid, from the Initial Issue Date of the Mandatory Convertible Preferred Stock, whether or not in any dividend period or periods there have
been funds legally available or shares of common stock legally permitted for the payment of such dividends. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
declared, dividends will be payable on the relevant Dividend Payment Date to holders of record of the Mandatory Convertible Preferred Stock as they appear on our stock register at the
close of business on the February&nbsp;15, May&nbsp;15, August&nbsp;15 and November&nbsp;15, as the case may be, immediately preceding the relevant Dividend Payment Date (each, a "Regular
Record Date"), whether or not such holders early convert their shares, or such shares are automatically converted, after a Regular Record Date and on or prior to the immediately succeeding Dividend
Payment Date. These Regular Record Dates will apply regardless of whether a particular Regular Record Date is a Business Day. If a Dividend Payment Date is not a Business Day, payment will be made on
the next succeeding Business Day, without any interest or other payment in lieu of interest accruing with respect to this delay. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
full dividend period is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial dividend period will commence
on, and include, the Initial Issue Date of the Mandatory Convertible Preferred Stock and will end on, and exclude, the September&nbsp;1, 2020 Dividend Payment Date. The amount of dividends payable
on each share of
Mandatory Convertible Preferred Stock for each full dividend period (subsequent to the initial dividend period) will be computed by dividing the annual dividend rate by four. Dividends payable on the
Mandatory Convertible Preferred Stock for the initial dividend period and any other partial dividend period will be computed based upon the actual number of days elapsed during such period over a
360-day year (consisting of twelve 30-day months). Accordingly, the dividend on the Mandatory Convertible Preferred Stock for the initial dividend period, assuming the Initial Issue Date is
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of
Mandatory Convertible Preferred Stock (based on the annual dividend rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% and a Liquidation Preference of $100.00 per
share) and will be payable, when, as and if declared, on September&nbsp;1, 2020 to the holders of record thereof on August&nbsp;15, 2020. The dividend on the Mandatory Convertible Preferred Stock
for each subsequent full dividend period, when, as and if declared, will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of Mandatory Convertible Preferred Stock (based on the annual dividend rate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%
and a Liquidation Preference of $100.00 per share). Accumulated dividends on shares of the Mandatory Convertible Preferred Stock will not bear interest, nor shall additional dividends be payable
thereon, if they are paid subsequent to the applicable Dividend Payment Date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
dividend will be paid unless and until our board of directors, or an authorized committee of our board of directors, declares a dividend payable with respect to the Mandatory
Convertible Preferred Stock. No dividend will be declared or paid upon, or any sum of cash or number of shares of our common stock set apart for the payment of dividends upon, any outstanding shares
of Mandatory Convertible Preferred Stock with respect to any dividend period unless all dividends for all preceding dividend periods have been declared and paid upon, or a sufficient sum of cash or
number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as described above, dividends on shares of Mandatory Convertible Preferred Stock converted to common stock will cease to accumulate, and all other rights of holders of Mandatory
Convertible Preferred Stock will terminate, from and after the Mandatory Conversion Date, the Early Conversion Date and the Fundamental Change Conversion Date (each, as defined below), as applicable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=36,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=985891,FOLIO='S-32',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitation on cash payments under our credit facilities  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to declare and pay cash dividends and to make other distributions with respect to our capital stock, including the Mandatory
Convertible Preferred Stock, is limited by the terms of our term loans and our Revolving Credit Facility. We intend to use a portion of the net proceeds from this offering and the Concurrent Offering
to repay in full remaining borrowings under, and terminate, the April 2021 Term Loan. In addition, following consummation of this offering, we
intend to seek amendments to our Revolving Credit Facility and the February 2021 Term Loan to permit us to pay cash dividends and other distributions on the Mandatory Convertible Preferred Stock. We
will, however, be required to pay the relevant dividend in shares of our common stock until we amend or terminate our Revolving Credit Facility and the February 2021 Term Loan or such restrictions are
no longer effective under the terms of such credit agreements. There is no assurance that we will be successful in amending or terminating our existing credit agreements that contain a restriction on
our ability to pay cash dividends on our capital stock. In addition, the terms of our future indebtedness and our subsidiaries' existing and any future indebtedness may contain similar restrictions.
In addition, our ability to declare and pay dividends may be limited by applicable Delaware law. See "Risk Factors&#151;Risks Relating to the Mandatory Convertible Preferred Stock and Our
Common Stock&#151;Our ability to declare and pay dividends on our capital stock, including the Mandatory Convertible Preferred Stock, may be limited and is prohibited by the terms of our
existing credit agreements." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Method of Payment of Dividends  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the limitations described below, we may pay any declared dividend (or any portion of any declared dividend) on the shares of
Mandatory Convertible Preferred Stock (whether or not for a current dividend period or any prior dividend period) determined in our sole discretion:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in cash; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by delivery of shares of our common stock; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> through any combination of cash and shares of our common stock. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will make each payment of a declared dividend on the shares of Mandatory Convertible Preferred Stock in cash, except to the extent we elect to make all or any portion of such payment
in shares of our common stock. We will give the holders of the Mandatory Convertible Preferred Stock notice of
any such election, and the portion of such payment that will be made in cash and the portion that will be made in shares of our common stock no later than 10 Scheduled Trading Days (as defined under
"&#151;Mandatory Conversion&#151;Certain Definitions") prior to the Dividend Payment Date for such dividend; </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT> <FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that if we do not provide
timely notice of this election, we will be deemed to have elected to pay the relevant dividend in cash; for the
avoidance of doubt, however, we will pay the relevant dividend in shares of our common stock until we amend or terminate our existing credit agreements that contain a restriction on our ability to pay
cash dividends on our capital stock, or such restrictions are no longer effective under the terms of such credit agreements. See "&#151;Dividends&#151;Limitation on Cash Payments under
our Credit Facilities." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
cash payments to which a holder of the Mandatory Convertible Preferred Stock is entitled in connection with a declared dividend on the shares of Mandatory Convertible Preferred Stock
will be rounded to the nearest cent. If we elect to make any such payment of a declared dividend, or any portion thereof, in shares of our common stock, such shares will be valued for such purpose, in
the case of any dividend payment or portion thereof, at 97% of the Average VWAP (as defined under "&#151;Mandatory Conversion&#151;Certain Definitions") per share of our common stock
over the five consecutive Trading Day (as defined under "&#151;Mandatory Conversion&#151;Certain Definitions") period commencing on, and including, the seventh Scheduled Trading Day (as
defined under "&#151;Mandatory Conversion&#151;Certain Definitions") prior to the applicable Dividend Payment Date (such average, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=37,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=726065,FOLIO='S-33',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>"Average
Price"). If the five Trading Day period to determine the Average Price ends on or after the relevant Dividend Payment Date (whether because a Scheduled Trading Day is not a Trading Day due to
the occurrence of a Market Disruption Event (as defined under "&#151;Mandatory Conversion&#151;Certain Definitions") or otherwise), then the Dividend Payment Date will be postponed until
the second Business Day after the final Trading Day of such five Trading Day period; provided that no interest or other amounts will accrue as a result of such postponement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
fractional shares of our common stock will be delivered to the holders of the Mandatory Convertible Preferred Stock in payment or partial payment of a dividend. We will instead, to
the extent we are legally permitted to do so (including under our credit agreements), pay a cash amount (computed to the nearest cent) to each holder that would otherwise be entitled to receive a
fraction of a share of our common stock based on the Average Price with respect to such dividend. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the
nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See
"&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent a shelf registration statement is required in our reasonable judgment in connection with the issuance of or for resales of shares of our common stock issued as payment of a
dividend on the shares of Mandatory Convertible Preferred Stock, including dividends paid in connection with a conversion, we will, to the extent such a shelf registration statement is not currently
filed and effective, use our commercially reasonable efforts to file and maintain the effectiveness of such a shelf registration statement until the earlier of such time as all such shares of common
stock have been resold thereunder and such time as all such shares are freely tradable without registration by holders thereof that are not, and have not been within the three months preceding,
"affiliates" of ours for purposes of the Securities Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent applicable, we will use our commercially reasonable efforts to have the shares of our common stock approved for listing on NYSE (or if our common stock is not listed on
NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is then listed), and qualified or registered under applicable state securities laws, if required; </FONT> <FONT SIZE=2><I>provided</I></FONT><FONT
SIZE=2> that we will not be required to qualify as a foreign corporation or to take any action that would subject us to general service of process in
any such jurisdiction where we are not presently qualified or where we are not presently subject to taxation as a foreign corporation and such qualification or action would subject us to such
taxation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, in no event will the number of shares of our common stock to be delivered in connection with any declared dividend, including any declared dividend payable
in connection with a conversion, exceed a number equal to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the declared dividend, </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which amount represents approximately 35% of the Initial Price (as defined under "&#151;Mandatory
Conversion&#151;Certain Definitions"), subject to adjustment in a manner inversely proportional to any anti-dilution adjustment to each Fixed Conversion Rate as set forth below in
"&#151;Anti-Dilution Adjustments" (such dollar amount, the "Floor Price"). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the amount of any declared dividend exceeds the product of (x)&nbsp;the number of shares of our common stock delivered in connection with such declared dividend and
(y)&nbsp;97% of the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, notwithstanding any notice by us to the contrary, pay
such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments, and is not permitted under our existing credit
agreements. See "&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." To the extent that we are not able to pay </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=38,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=868951,FOLIO='S-34',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>such
excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in
respect of such amount, and such amount will not form&nbsp;a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividend Stopper  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So long as any share of Mandatory Convertible Preferred Stock remains outstanding, no dividend or distribution shall be declared or paid on our
common stock or any other class or series of Junior Stock, and no common stock or any other class or series of Junior Stock or Parity Stock shall be, directly or indirectly, purchased, redeemed or
otherwise acquired for consideration by us or any of our subsidiaries unless all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid in full in cash, shares
of our common stock or a combination thereof, or a sufficient sum of cash or number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of
Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
foregoing limitation shall not apply to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any dividend or distribution payable in shares of common stock or other Junior Stock, together with cash in lieu of any fractional share; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> purchases, redemptions or other acquisitions of common stock, other Junior Stock or Parity Stock in connection with the administration of any
benefit or other incentive plan, including any employment contract, in the ordinary course of business (including purchases to offset the Share Dilution Amount pursuant to a publicly announced
repurchase plan, or acquisitions of shares of common stock surrendered, deemed surrendered or withheld in connection with the exercise of stock options or the vesting of restricted stock or restricted
stock units); provided that the number of shares purchased to offset the Share Dilution Amount shall in no event exceed the Share Dilution Amount; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> purchases of common stock or other Junior Stock pursuant to a contractually binding agreement to buy such securities that existed prior to the
date of this prospectus supplement; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any dividends or distributions of rights in connection with a stockholders' rights plan or any redemption or repurchase of rights pursuant to
any stockholders' rights plan; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock (with the same or
lesser aggregate liquidation preference) or Junior Stock and, in each case, the payment of cash solely in lieu of fractional shares; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the deemed purchase or acquisition of fractional interests in shares of our common stock, other Junior Stock or Parity Stock pursuant to the
conversion or exchange provisions of such shares or the security being converted or exchanged. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
phrase "Share Dilution Amount" means the increase in the number of diluted shares of our common stock outstanding (determined in accordance with accounting principles generally
accepted in the United States of America, and as measured from the Initial Issue Date) resulting from the grant, vesting or exercise of equity-based compensation to directors, employees and agents and
equitably adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar transaction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
dividends on shares of the Mandatory Convertible Preferred Stock (i)&nbsp;have not been declared and paid in full on any Dividend Payment Date (or, in the case of Parity Stock
having dividend payment dates different from such Dividend Payment Dates, on a dividend payment date falling within a regular dividend period related to such Dividend Payment Date), or
(ii)&nbsp;have been declared but a sum of cash or number of shares of our common stock sufficient for payment thereof has not been set aside for the benefit of the holders thereof on the applicable
Regular Record Date, no </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=39,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=924280,FOLIO='S-35',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>dividends
may be declared or paid on any shares of Parity Stock unless dividends are declared on the shares of Mandatory Convertible Preferred Stock such that the respective amounts of such dividends
declared on the shares of Mandatory Convertible Preferred Stock and such shares of Parity Stock shall be allocated pro rata among the holders of the shares of Mandatory Convertible Preferred Stock and
the holders of any shares of Parity Stock then outstanding. For purposes of calculating the pro rata allocation of partial dividend payments, the Company shall allocate those payments so that the
respective amounts of those payments for the declared dividend bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of Mandatory Convertible Preferred
Stock and all declared and unpaid dividends per share on such shares of Parity Stock bear to each other (subject to their having been declared by our board of directors, or an authorized committee
thereof, out of legally available funds); </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that any unpaid dividends on the Mandatory
Convertible Preferred Stock will continue to accumulate except as described herein. For purposes of this calculation, with respect to non-cumulative Parity Stock, we will use the full amount of
dividends that would be payable for the most recent dividend period if dividends were declared in full on such non-cumulative Parity Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the foregoing, and not otherwise, such dividends as may be determined by our board of directors, or an authorized committee thereof, may be declared and paid (payable in cash
or other property or securities) on any securities, including our common stock and other Junior Stock, from time to time out of any funds legally available for such payment, and holders of the
Mandatory Convertible Preferred Stock shall not be entitled to participate in any such dividends. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Redemption  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Mandatory Convertible Preferred Stock will not be redeemable. However, at our option, we may purchase or exchange the Mandatory Convertible
Preferred Stock from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidation Preference  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of our voluntary or involuntary liquidation, winding-up or dissolution, each holder of the Mandatory Convertible Preferred Stock
will be entitled to receive a Liquidation Preference in the amount of $100.00 per share of the Mandatory Convertible Preferred Stock (the "Liquidation Preference"), </FONT> <FONT SIZE=2><I>plus</I></FONT><FONT SIZE=2> an amount (the "Liquidation
Dividend Amount") equal to accumulated and unpaid dividends on such shares, whether or not declared, to, but excluding,
the date fixed for liquidation, winding-up or dissolution to be paid out of our assets legally available for distribution to our stockholders, after satisfaction of debt and other liabilities owed to
our creditors and holders of shares of any Senior Stock and before any payment or distribution is made to holders of Junior Stock (including our common stock). If, upon our voluntary or involuntary
liquidation, winding-up or dissolution, the amounts payable with respect to (1)&nbsp;the Liquidation Preference plus the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred
Stock and (2)&nbsp;the liquidation preference of, and the amount of accumulated and unpaid dividends (to, but excluding, the date fixed for liquidation, winding-up or dissolution) on, all Parity
Stock are not paid in full, the holders of the Mandatory Convertible Preferred Stock and all holders of any such Parity Stock will share equally and ratably in any distribution of our assets in
proportion to their respective liquidation preferences and amounts equal to accumulated and unpaid dividends to which they are entitled. After payment of the full amount of the Liquidation Preference
and the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred Stock, the holders of the Mandatory Convertible Preferred Stock will have no right or claim to any of our remaining
assets. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the sale, lease nor exchange of all or substantially all of our assets or business (other than in connection with our liquidation, winding-up or dissolution), nor our merger or
consolidation into or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=40,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=651535,FOLIO='S-36',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_37"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>with
any other person, will be deemed to be our voluntary or involuntary liquidation, winding-up or dissolution. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Charter, including the Certificate of Designations for the Mandatory Convertible Preferred Stock, will not contain any provision requiring funds to be set aside to protect the
Liquidation Preference of the Mandatory Convertible Preferred Stock even though it is substantially in excess of the par value thereof. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Rights  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The holders of the Mandatory Convertible Preferred Stock will not have voting rights other than those described below, except as specifically
required by Delaware law or by our Charter from time to time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever
dividends on any shares of the Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods (including, for the
avoidance of doubt, the dividend period commencing on, and including, the Initial Issue Date and ending on, but excluding, September&nbsp;1, 2020), whether or not for consecutive dividend periods (a
"Nonpayment"), the authorized number of directors on our board of directors will, at the next annual meeting of stockholders or at a special meeting of stockholders as provided below, automatically be
increased by two and the holders of such shares of the Mandatory Convertible Preferred Stock, voting together as a single class with holders of any and all other series of Voting Preferred Stock (as
defined below) then outstanding, will be entitled, at our next annual meeting of stockholders or at a special meeting of stockholders as provided below, to vote for the election of a total of two
additional members of our board of directors (the "Preferred Stock Directors"); </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that
the election of any such Preferred Stock Directors will not cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our
securities may be listed or quoted) that requires listed or quoted companies to have a majority of independent directors; and </FONT><FONT SIZE=2><I>provided further</I></FONT><FONT SIZE=2> that our
board of directors shall, at no time, include more than two Preferred Stock Directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event of a Nonpayment, the holders of at least 25% of the shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock may request that a
special meeting of stockholders be called to elect such Preferred Stock Directors (</FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>,
that if our next annual or a special meeting of stockholders is scheduled to be held within 90&nbsp;days of the receipt of such request, the election of such Preferred Stock Directors will be
included in the agenda for, and will be held at, such scheduled annual or special meeting of stockholders). The Preferred Stock Directors will stand for reelection annually, at each subsequent annual
meeting of the stockholders, so long as the holders of the Mandatory Convertible Preferred Stock continue to have such voting rights. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
any meeting at which the holders of the Mandatory Convertible Preferred Stock are entitled to elect Preferred Stock Directors, the holders of a majority of the then outstanding shares
of the Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock, present in person or represented by proxy, will constitute a quorum and the vote of the holders of a
majority of such shares of the Mandatory Convertible Preferred Stock and other Voting Preferred Stock so present or represented by proxy at any such meeting at which there shall be a quorum shall be
sufficient to elect the Preferred Stock Directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this prospectus supplement, "Voting Preferred Stock" means any other class or series of our preferred stock, ranking equally with the Mandatory Convertible Preferred Stock as
to dividends and to the distribution of assets upon liquidation, dissolution or winding-up and upon which like voting rights for the election of directors have been conferred and are exercisable.
Whether a plurality, majority or other portion in voting power of the Mandatory Convertible Preferred Stock and any other Voting Preferred Stock have been voted in favor of any matter shall be
determined by reference to the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=41,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=457692,FOLIO='S-37',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>respective
liquidation preference amounts of the Mandatory Convertible Preferred Stock and such other Voting Preferred Stock voted. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
and when all accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock have been paid in full, or declared and a sum or number of shares of our common stock
sufficient for such payment shall have been set aside for the benefit of the holders thereof (a "Nonpayment Remedy"), the holders of the Mandatory Convertible Preferred Stock shall immediately and,
without any further action by us, be divested of the foregoing voting rights, subject to the revesting of such rights in the event of each subsequent Nonpayment. If such voting rights for the holders
of the Mandatory Convertible Preferred Stock and all other holders of Voting Preferred Stock have terminated, the term of office of each Preferred Stock Director so elected will terminate at such time
and the authorized number of directors on our board of directors shall automatically decrease by two. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Preferred Stock Director may be removed at any time, with or without cause, by the holders of record of a majority in voting power of the outstanding shares of the Mandatory
Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above. In the event that a
Nonpayment shall have occurred and there shall not have been a Nonpayment Remedy, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election of Preferred Stock
Directors after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, except in the event that such vacancy is created as a result of such Preferred
Stock Director being removed or if no Preferred Stock Director remains in office, such vacancy may be filled by a vote of the holders of record of a majority in voting power of the outstanding shares
of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above; </FONT> <FONT SIZE=2><I>provided</I></FONT><FONT
SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that the election of any such Preferred Stock Directors to fill such vacancy will not
cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires listed or quoted
companies to have a majority of independent directors. The Preferred Stock Directors will each be entitled to one vote per director on any matter that comes before our board of directors for a vote. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as any shares of Mandatory Convertible Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds in voting
power of the
outstanding shares of Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class,
given in person or by proxy, either in writing or at an annual or special meeting of such stockholders:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> amend or alter the provisions of our Charter so as to authorize or create, or increase the authorized number of, any class or series of Senior
Stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> amend, alter or repeal any provision of our Charter or the Certificate of Designations so as to adversely affect the special rights,
preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> consummate a binding share exchange or reclassification involving the shares of the Mandatory Convertible Preferred Stock or a merger or
consolidation of us with another entity, unless in each case: (i)&nbsp;the shares of Mandatory Convertible Preferred Stock remain outstanding and are not amended in any respect or, in the case of
any such merger or consolidation with respect to which we are not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or
its ultimate parent; and (ii)&nbsp;the shares of the Mandatory Convertible Preferred Stock that remain outstanding or such shares of preference securities, as the case may be, have such rights,
preferences, privileges and voting powers that, taken as a whole, are not materially less favorable to the holders thereof than the </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=42,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=394050,FOLIO='S-38',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<A NAME="page_ci13305_1_39"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>rights,
preferences, privileges and voting powers of the Mandatory Convertible Preferred Stock immediately prior to the consummation of such transaction; </FONT></P>

</UL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that in the event that a transaction would trigger voting rights under both the
second and the third bullet point above, the third bullet point will govern; </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>further</I></FONT><FONT SIZE=2>, </FONT> <FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>,
that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any increase in the number of our authorized but unissued shares of preferred stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any increase in the number of authorized or issued shares of Mandatory Convertible Preferred Stock; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the creation and issuance, or an increase in the authorized or issued number, of any class or series of Parity Stock or Junior Stock, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>will
be deemed not to adversely affect the rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock and shall not require the affirmative vote or consent of
holders of the Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Charter and Delaware law permit us, without the approval of any of our stockholders (including any holders of the Mandatory Convertible Preferred Stock), to establish and issue a new
series of preferred stock ranking equally with or junior to the Mandatory Convertible Preferred Stock, which may dilute the voting and other interests of holders of the Mandatory Convertible Preferred
Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any amendment, alteration, repeal, binding share exchange, reclassification, merger or consolidation described above would adversely affect the rights, preferences, privileges or
voting powers of one or more but not all series of Voting Preferred Stock (including the Mandatory Convertible Preferred Stock for this purpose), then only the series of Voting Preferred Stock the
rights, preferences, privileges or voting powers of which are adversely affected and entitled to vote, shall vote as a class in lieu of all other series of Voting Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
the consent of the holders of the Mandatory Convertible Preferred Stock, so long as such action does not adversely affect the special rights, preferences, privileges or voting
powers of the
Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock for the following
purposes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to cure any ambiguity, omission or mistake, or to correct or supplement any provision contained in the Certificate of Designations establishing
the terms of the Mandatory Convertible Preferred Stock that may be defective or inconsistent with any other provision contained in such Certificate of Designations; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to make any provision with respect to matters or questions relating to the Mandatory Convertible Preferred Stock that is not inconsistent with
the provisions of our Charter or the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, without the consent of the holders of the Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred
Stock in order to (i)&nbsp;conform the terms thereof to the description of the terms of the Mandatory Convertible Preferred Stock set forth under "Description of Mandatory Convertible Preferred
Stock" in the preliminary prospectus supplement for the Mandatory Convertible Preferred Stock, as supplemented and/or amended by any related pricing term sheet or (ii)&nbsp;file&nbsp;a certificate
of correction with respect to the Certificate of Designations to the extent permitted by Section&nbsp;103(f) of the Delaware General Corporation Law. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Mandatory Conversion  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each outstanding share of the Mandatory Convertible Preferred Stock, unless previously converted, will automatically convert on the Mandatory
Conversion Date (as defined under "&#151;Certain Definitions"), into a number of shares of our common stock equal to the conversion rate described below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=43,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=147244,FOLIO='S-39',FILE='DISK104:[20ZCM5.20ZCM13305]CI13305A.;12',USER='JFUSS',CD='20-MAY-2020;14:07' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ck13305_1_40"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The "conversion rate", which is the number of shares of our common stock issuable upon conversion of each share of the Mandatory Convertible Preferred Stock on
the Mandatory Conversion Date (excluding any shares of our common stock issued in respect of accrued and unpaid dividends, as described below), will be as
follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Applicable Market Value (as defined under "&#151;Certain Definitions") of our common stock is greater than the Threshold
Appreciation Price, which is approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, then the conversion rate will be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
per share of Mandatory Convertible Preferred Stock (the "Minimum
Conversion Rate"); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Applicable Market Value of our common stock is less than or equal to the Threshold Appreciation Price but equal to or greater than the
Initial Price, then the conversion rate will be equal to $100.00 </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> the Applicable Market Value of our common stock, rounded to the nearest
ten-thousandth of a share; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Applicable Market Value of our common stock is less than the Initial Price, then the conversion rate will be shares of our common stock
per share of Mandatory Convertible Preferred Stock (the "Maximum Conversion Rate"). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
refer to the Minimum Conversion Rate and the Maximum Conversion Rate collectively as the "Fixed Conversion Rates". The Fixed Conversion Rates are subject to adjustment as described in
"&#151;Anti-Dilution Adjustments" below. The "Threshold Appreciation Price" is calculated by dividing $100.00 by the Minimum Conversion Rate, and represents an approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%
appreciation over the Initial Price. The "Initial Price" is calculated by dividing $100.00 by the Maximum Conversion Rate and initially equals approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is the
public
offering price of our common stock in the Concurrent Offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we declare a dividend on the Mandatory Convertible Preferred Stock for the dividend period ending on, but excluding, June&nbsp;1, 2023, we will pay such dividend to the holders of
record as of the immediately preceding Regular Record Date, as described above under "&#151;Dividends." If on or prior to June&nbsp;1, 2023 we have not declared all or any portion of the
accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock, the conversion rate will be adjusted so that holders receive an additional number of shares of our common stock equal
to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the amount of such accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared (the
"Mandatory Conversion Additional Conversion Amount"), </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;97% of the Average Price (calculated using June&nbsp;1, 2023 as the applicable
Dividend Payment Date). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the Mandatory Conversion Additional Conversion Amount exceeds the product of such number of additional shares and 97% of the Average Price, we will, to the extent we
are able to do so under applicable law and in compliance with our indebtedness declare and pay such excess
amount in cash (computed to the nearest cent) pro rata per share to the holders of the Mandatory Convertible Preferred Stock. Any such payment in cash may not be permitted by our then existing debt
instruments, and is not permitted under our existing credit agreements. See "&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." To the extent that we are not
able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our
common stock in respect of such amount, and such amount will not form&nbsp;a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the avoidance of doubt, the conversion rate per share of the Mandatory Convertible Preferred Stock will in no event exceed the Maximum Conversion Rate, subject to adjustment as
described under </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=44,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=918326,FOLIO='S-40',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_41"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>"&#151;Anti-Dilution
Adjustments" below and exclusive of any amounts owing in respect of any Mandatory Conversion Additional Conversion Amount or any accrued and unpaid dividends paid at our
election in shares of common stock. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Hypothetical conversion values upon mandatory conversion  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For illustrative purposes only, the following table shows the number of shares of our common stock that a holder of the Mandatory Convertible
Preferred Stock would receive upon mandatory conversion of one share of Mandatory Convertible Preferred Stock at various Applicable Market Values for our common stock. The table assumes that there
will be no conversion adjustments as described above for any Mandatory Conversion Additional Conversion Amount or as described below in "&#151;Anti-Dilution Adjustments" and that dividends on
the Mandatory Convertible Preferred Stock will be declared and paid in cash (and not in additional shares of our common stock). The actual Applicable Market Value of our common stock may differ from
those set forth in the table below. Given an Initial Price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and a Threshold Appreciation Price of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, a holder of Mandatory Convertible Preferred Stock
would receive on the Mandatory Conversion Date the number of shares of our common stock per share of Mandatory Convertible Preferred Stock set forth below, subject to the provisions described below
with respect to any fractional share of our common stock: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="114pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="173pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Assumed Applicable<BR>
Market Value<BR>
of our common stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of shares of our<BR>
common stock to be<BR>
received upon<BR>
mandatory conversion </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Assumed conversion value (calculated<BR>
as Applicable Market Value<BR>
multiplied by the number of shares of<BR>
our common stock to be received<BR>
upon mandatory conversion) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accordingly,
assuming that the market price of our common stock on the Mandatory Conversion Date is the same as the Applicable Market Value of our common stock, the aggregate market
value of our common stock you receive upon mandatory conversion of a share of Mandatory Convertible Preferred Stock (excluding any shares of our common stock you receive in respect of accrued and
unpaid dividends) will be:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> greater than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is
greater than the Threshold Appreciation Price; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> equal to the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than
or equal to the Threshold Appreciation Price and greater than or equal to the Initial Price; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> less than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than
the Initial Price. </FONT></DD></DL>
</UL>
<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Certain Definitions  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Applicable Market Value" means the Average VWAP per share of our common stock over the Settlement Period. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Settlement
Period" means the 20 consecutive Trading Day period commencing on, and including, the 21st&nbsp;Scheduled Trading Day immediately preceding June&nbsp;1, 2023. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=45,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=297485,FOLIO='S-41',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Mandatory
Conversion Date" means the second Business Day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be
June&nbsp;1, 2023. If the Mandatory Conversion Date occurs after June&nbsp;1, 2023 (whether because a Scheduled Trading Day during the Settlement Period is not a Trading Day due to the occurrence
of a Market Disruption Event or otherwise), no interest or other amounts will accrue as a result of such postponement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
"Trading Day" means a day on which:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> there is no Market Disruption Event; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> trading in our common stock generally occurs on the Relevant Stock Exchange; </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, that if our common stock is not listed or admitted for trading, "Trading Day" means any Business Day. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
"Scheduled Trading Day" is any day that is scheduled to be a Trading Day. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Market
Disruption Event" means:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a failure by the Relevant Stock Exchange to open for trading during its regular trading session; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the occurrence or existence, prior to 1:00&nbsp;p.m., New York City time, on any Scheduled Trading Day for our common stock, for more than a
one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the Relevant Stock
Exchange or otherwise) in our common stock. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Relevant
Stock Exchange" means NYSE or, if our common stock is not then listed on NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is
then listed or, if our common stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which our common stock is then listed or admitted for
trading. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"VWAP"
per share of our common stock on any Trading Day means the per share volume-weighted average price as displayed on Bloomberg page "BSX &#60;EQUITY&gt; AQR" (or its
equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day
(or, if such volume-weighted average price is not available, the market value per share of our common stock on such Trading Day as determined, using a volume-weighted average method, by a nationally
recognized independent investment banking firm retained by us for this purpose, which may include any of the underwriters for this offering). The "Average VWAP" per share over a certain period means
the arithmetic average of the VWAP per share for each Trading Day in the relevant period. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Early Conversion at the Option of the Holder  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than during a Fundamental Change Conversion Period (as defined in "&#151;Conversion at the Option of the Holder upon Fundamental
Change; Fundamental Change Dividend Make-Whole Amount"), holders of Mandatory Convertible Preferred Stock will have the right to convert their Mandatory Convertible Preferred Stock, in whole or in
part (but in no event less than one share of Mandatory Convertible Preferred Stock), at any time prior to June&nbsp;1, 2023 (an "Early Conversion"), into shares of our common stock at the Minimum
Conversion Rate per share of Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
as of the conversion date (as defined under "&#151;Conversion Procedures&#151;Upon Early Conversion or Upon Early Fundamental Change Conversion") of any Early
Conversion (the "Early Conversion Date"), we have not declared all or any portion of the accumulated and unpaid dividends for all full dividend periods ending on or before a Dividend Payment Date
prior to such Early Conversion Date, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=46,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=679076,FOLIO='S-42',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_43"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>the
conversion rate for such Early Conversion will be adjusted so that holders converting their Mandatory Convertible Preferred Stock at such time receive an additional number of shares of our common
stock equal to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> such amount of accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared for such prior
full dividend periods (the "Early Conversion Additional Conversion Amount"), </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;the Average VWAP per share of our common stock over the 20 consecutive Trading Day
period (the "Early Conversion Settlement Period"), commencing on, and including, the 21st&nbsp;Scheduled Trading Day immediately preceding the Early Conversion Date (such average VWAP, the "Early
Conversion Average Price"). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the Early Conversion Additional Conversion Amount exceeds the product of such number of additional shares and the Early Conversion Average Price, we will not have any
obligation to pay the shortfall in cash or deliver shares of our common stock in respect of such shortfall. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as described above, upon any Early Conversion of any Mandatory Convertible Preferred Stock, we will make no payment or allowance for unpaid dividends on such shares of the
Mandatory Convertible Preferred Stock, unless such Early Conversion Date occurs after the Regular Record Date for a declared dividend and on or prior to the immediately succeeding Dividend Payment
Date, in which case such dividend will be paid on such Dividend Payment Date to the holder of record of the converted shares of the Mandatory Convertible Preferred Stock as of such Regular Record
Date, as described under "&#151;Dividends." </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole
Amount  </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a "Fundamental Change" (as defined below) occurs on or prior to June&nbsp;1, 2023, holders of Mandatory Convertible Preferred Stock will
have the right (the "Fundamental Change Conversion Right") during the Fundamental Change Conversion Period (as defined below) to: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>convert
their share of Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory Convertible Preferred Stock),
into a number of shares of our common stock (or Units of Exchange Property as described below) at the conversion rate specified in the table below (the "Fundamental Change Conversion Rate");
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(ii)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>with
respect to such converted shares, receive a Fundamental Change Dividend Make-Whole Amount (as defined below) payable in cash or shares of our common stock; and
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(iii)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>with
respect to such converted shares, receive the Accumulated Dividend Amount (as defined below) payable in cash or shares of our common stock, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>subject,
in the case of clauses&nbsp;(ii) and (iii), to certain limitations with respect to the number of shares of our common stock that we will be required to deliver, all as described below.
Notwithstanding clauses&nbsp;(ii) and (iii)&nbsp;above, if the Fundamental Change Effective Date (as defined below) or the Fundamental Change Conversion Date (as defined below) falls after the
Regular Record Date for a dividend period for which we have declared a dividend and prior to the next Dividend Payment Date, then we will pay such dividend on the relevant Dividend Payment Date to the
holders of record on such Regular Record Date, as described under "&#151;Dividends," and the Accumulated
Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of the payment of such dividend. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=47,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=564765,FOLIO='S-43',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
exercise the Fundamental Change Conversion Right, a holder must submit its shares of Mandatory Convertible Preferred Stock for conversion at any time during the period (the
"Fundamental Change Conversion Period") commencing on, and including, the Fundamental Change Effective Date and ending at the close of business on the date that is 20 calendar days after the
Fundamental Change Effective Date (or, if later, the date that is 20 calendar days after the date of notice of such Fundamental Change), but in no event later than June&nbsp;1, 2023. Holders of the
Mandatory Convertible Preferred Stock that submit the shares for conversion during the Fundamental Change Conversion Period shall be deemed to have exercised their Fundamental Change Conversion Right.
Holders of the Mandatory Convertible Preferred Stock who do not submit their shares for conversion during the Fundamental Change Conversion Period will not be entitled to convert their Mandatory
Convertible Preferred Stock at the relevant Fundamental Change Conversion Rate or to receive the relevant Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. A conversion
date occurring during such Fundamental Change Conversion Period is referred to herein as a "Fundamental Change Conversion Date." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will notify holders of the Fundamental Change Effective Date no later than the second Business Day immediately following such Fundamental Change Effective Date. If we notify holders
of a Fundamental Change later than the second Business Day following the Fundamental Change Effective Date, the Fundamental Change Conversion Period will be extended by a number of days equal to the
number of days from, and including, such Fundamental Change Effective Date to, but excluding, the date of the notice; provided, however, that the Fundamental Change Conversion Period will not be
extended beyond June&nbsp;1, 2023. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
"Fundamental Change" will be deemed to have occurred, at any time after the Initial Issue Date of the Mandatory Convertible Preferred Stock, if any of the following
occurs: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>any
"person" or "group" (as such terms are used for purposes of Sections&nbsp;13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, and the rules and
regulations thereunder (the "Exchange Act"), whether or not applicable), other than us, any of our wholly-owned subsidiaries or any of our or our wholly-owned subsidiaries' employee benefit plans,
filing a Schedule&nbsp;TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the "beneficial owner" (as defined in Rule&nbsp;13d-3 under the
Exchange Act), directly or indirectly, of more than 50% of the total voting power in the aggregate of all classes of capital stock then outstanding entitled to vote generally in elections of our
directors;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(ii)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the
consummation of (A)&nbsp;any recapitalization, reclassification or change of our common stock (other than changes resulting from a subdivision or combination
or change in par value) as a result of which our common stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or a combination thereof);
(B)&nbsp;any consolidation, merger or other combination of us or binding share exchange pursuant to which our common stock will be converted into, or exchanged for, stock, other securities or other
property or assets (including cash or a combination thereof); or (C)&nbsp;any sale, lease or other transfer or disposition in one transaction or a series of transactions of all or substantially all
of the consolidated assets of ours and our subsidiaries taken as a whole, to any person other than one or more of our wholly-owned subsidiaries; or
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(iii)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our
common stock (or other Exchange Property (as defined below)) ceases to be listed or quoted for trading on any of NYSE, the NASDAQ Global Select Market or the
NASDAQ Global Market (or another U.S. national securities exchange or any of their respective successors). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;However,
a transaction or transactions described in clause&nbsp;(i) or clause&nbsp;(ii) above will not constitute a Fundamental Change if at least 90% of the consideration received
or to be received by our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=48,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=873364,FOLIO='S-44',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_45"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>common
stockholders, excluding cash payments for fractional shares or pursuant to statutory appraisal rights, in connection with such transaction or transactions consists of shares of common stock
that are listed or quoted on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted when issued or exchanged in
connection with such transaction or transactions and as a result of such transaction or transactions such consideration (excluding cash payments for fractional shares or pursuant to statutory
appraisal rights) becomes the Exchange Property. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fundamental Change Conversion Rate  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Fundamental Change Conversion Rate will be determined by reference to the table below and is based on the effective date of such Fundamental
Change (the "Fundamental Change Effective Date"), and the price (the "Fundamental Change Share Price") paid or deemed paid per
share of our common stock in such Fundamental Change. If the holders of our common stock receive only cash in such Fundamental Change, the Fundamental Change Share Price shall be the cash amount paid
per share of common stock. Otherwise, the Fundamental Change Share Price shall be the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including,
the Trading Day immediately preceding the Fundamental Change Effective Date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Fundamental Change Share Prices set forth in the first row of the table below (i.e.,&nbsp;the column headers) will be adjusted as of any date on which the Fixed Conversion Rates of
the Mandatory Convertible Preferred Stock are adjusted. The adjusted Fundamental Change Share Prices will equal (i)&nbsp;the Fundamental Change Share Prices applicable immediately prior to such
adjustment, </FONT><FONT SIZE=2><I>multiplied by</I></FONT><FONT SIZE=2> (ii)&nbsp;a fraction, the numerator of which is the Minimum Conversion Rate immediately prior to the adjustment giving rise
to the Fundamental Change Share Price adjustment and the denominator of which is the Minimum Conversion Rate as so adjusted. Each of the Fundamental Change Conversion Rates in the table below will be
subject to adjustment in the same manner and at the same time as each Fixed Conversion Rate as set forth in "&#151;Anti-Dilution Adjustments". </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table sets forth the Fundamental Change Conversion Rate per share of Mandatory Convertible Preferred Stock for each Fundamental Change Share Price and Fundamental Change
Effective Date set forth below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=38 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fundamental Change Share Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Fundamental Change<BR>
Effective Date

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>$ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>June&nbsp;1, 2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>June&nbsp;1, 2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>June&nbsp;1, 2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exact Fundamental Change Share Price and Fundamental Change Effective Date may not be set forth in the table, in which case:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Fundamental Change Share Price is between two Fundamental Change Share Price amounts in the table or the Fundamental Change Effective
Date is between two Fundamental Change Effective Dates in the table, the Fundamental Change Conversion Rate will be determined by a straight-line interpolation between the Fundamental Change
Conversion Rates set forth for the higher and lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based on a 365- or 366-day year,
as applicable; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Fundamental Change Share Price is in excess of $ per share (subject to adjustment in the same manner as the Fundamental Change Share
Prices set forth in the first row of the table </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=49,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=536371,FOLIO='S-45',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_46"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>above),
then the Fundamental Change Conversion Rate will be the Minimum Conversion Rate; and </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if the Fundamental Change Share Price is less than $ per share (subject to adjustment in the same manner as the Fundamental Change Share Prices
set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Maximum Conversion Rate. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For any shares of Mandatory Convertible Preferred Stock that are converted during the Fundamental Change Conversion Period, in addition to the
common stock issued upon conversion at the Fundamental Change Conversion Rate, we will, at our option (subject to satisfaction of the requirements described below): </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>pay
in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness, an amount equal to the
present value, calculated using a discount rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% per annum, of all dividend payments (excluding any Accumulated Dividend Amount) on the Mandatory Convertible Preferred Stock for
(i)&nbsp;the partial dividend period, if any, from, and including, the Fundamental Change Effective Date to, but excluding, the next Dividend Payment Date and (ii)&nbsp;all remaining full dividend
periods from, and including, the Dividend Payment Date following the Fundamental Change Effective Date to, but excluding, the Mandatory Conversion Date (the "Fundamental Change Dividend Make-Whole
Amount");
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>increase
the number of shares of our common stock (or Units of Exchange Property as described below) to be issued upon conversion by a number equal to (x)&nbsp;the
Fundamental Change Dividend Make-Whole Amount </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> (y)&nbsp;the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;97% of the Fundamental
Change Share Price; or
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>pay
the Fundamental Change Dividend Make-Whole Amount through any combination of cash and shares of our common stock (or Units of Exchange Property as described
below) in accordance with the provisions of clauses&nbsp;(a) and (b)&nbsp;above. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used herein, the term "Accumulated Dividend Amount" means, with respect to any Fundamental Change, the aggregate amount of accumulated and unpaid dividends, if any, that have not been
declared for dividend periods prior to the relevant Fundamental Change Effective Date, including (but subject to the second sentence under "&#151;General" above) for the partial dividend
period,
if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective Date to, but excluding, such Fundamental Change Effective Date. For the avoidance of
doubt, if the Regular Record Date for a dividend period for which we have, as of the Fundamental Change Effective Date, declared a dividend occurs before or during the related Fundamental Change
Conversion Period, then we will pay such dividend on the relevant Dividend Payment Date to the holders of record at the Close of Business on such Regular Record Date, as described under
"&#151;Dividends," and the Accumulated Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of
such dividend. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Accumulated Dividend Amount will be payable at our option (subject to satisfaction of the requirements described below):</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=50,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=666491,FOLIO='S-46',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_47"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in an additional number of shares of our common stock (or Units of Exchange Property as described below) equal to (x)&nbsp;the Accumulated
Dividend Amount </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> (y)&nbsp;the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;97% of the Fundamental Change Share Price; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> through any combination of cash and shares of our common stock (or Units of Exchange Property) in accordance with the provisions of the
preceding two bullets. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will pay the Fundamental Change Dividend Make-Whole Amount and the Accumulated Dividend Amount in cash, except to the extent we elect on or prior to the second Business Day following
the Fundamental Change Effective Date to make all or any portion of such payments in shares of our common stock (or Units of Exchange Property). For the avoidance of doubt, however, our existing
credit agreements currently contain a restriction on our ability to pay such amounts in cash. See "&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we elect to deliver common stock (or Units of Exchange Property) in respect of all or any portion of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend
Amount, to the extent that the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount or the dollar amount of any portion thereof paid in common stock (or Units of Exchange
Property) exceeds the product of (x)&nbsp;the number of additional shares we deliver in respect thereof and (y)&nbsp;97% of the Fundamental Change Share Price, we will, to the extent we are able
to do so under applicable law and in compliance with our indebtedness, pay such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing
debt instruments, and is not permitted under our existing credit agreements. See "&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." To the extent that we are
not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our
common stock in respect of such amount. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;However,
if we are prohibited from paying or delivering, as the case may be, the Fundamental Change Dividend Make-Whole Amount (whether in cash or in shares of our common stock), in
whole or in part, due to limitations of applicable law, then the Fundamental Change Conversion Rate will instead be increased by a number of shares of common stock equal to the cash amount of the
aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount, </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> the greater of (i)&nbsp;the Floor Price and (ii)&nbsp;97%
of the Fundamental Change Share Price. To the extent that the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount exceeds the product of such number of
additional shares and 97% of the Fundamental Change Share Price, we will not have any obligation to pay the shortfall in cash or deliver additional shares of our common stock in respect of such
amount. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
fractional shares of our common stock (or to the extent applicable, Units of Exchange Property) will be delivered to converting holders of the Mandatory Convertible Preferred Stock in
respect of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. We will instead, to the extent we are able to do so under applicable law and in compliance with our
indebtedness, pay a cash amount (computed to the nearest cent) to each converting holder that would otherwise be entitled to receive a fraction of a share of our common stock (or to the extent
applicable, Units of Exchange Property) based on the Average VWAP per share of our common stock (or to the extent applicable, Units of Exchange Property) over the five consecutive Trading Day period
commencing on, and including, the seventh Scheduled Trading Day immediately preceding the Fundamental Change Conversion Date. In the event that we cannot pay cash in lieu of a fractional share, we
will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=51,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=614992,FOLIO='S-47',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_48"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>"&#151;Dividends&#151;Limitation
on Cash Payments under our Credit Facilities." Not later than the second Business Day following the Fundamental Change Effective Date, we will notify
holders of:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Fundamental Change Conversion Rate (if we provide notice to holders prior to the anticipated Fundamental Change Effective Date, specifying
how the Fundamental Change Conversion Rate will be determined); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Fundamental Change Dividend Make-Whole Amount and whether we will pay such amount in cash, shares of our common stock (or to the extent
applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Accumulated Dividend Amount as of the Fundamental Change Effective Date and whether we will pay such amount in cash, shares of our common
stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
obligation to deliver shares at the Fundamental Change Conversion Rate in connection with a Fundamental Change and pay the Fundamental Change Dividend Make-Whole Amount (whether in
cash, our common stock or any combination thereof) could be considered a penalty under state law, in which case the enforceability thereof would be subject to general principles of reasonableness of
economic remedies and therefore may not be enforceable in whole or in part. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conversion Procedures  </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Upon Mandatory Conversion  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any outstanding shares of Mandatory Convertible Preferred Stock will mandatorily and automatically convert into shares of common stock on the
Mandatory Conversion Date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but you will be required to pay any tax
or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than your own. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock issuable upon conversion will be delivered to the
converting holder through the facilities of DTC, in each case together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable
taxes and duties, if any, payable by you have been paid in full, and such shares and cash will be delivered on the later of (i)&nbsp;the Mandatory Conversion Date and (ii)&nbsp;the Business Day
after you have paid in full all applicable taxes and duties, if any. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person or persons entitled to receive the shares of our common stock issuable upon mandatory conversion of the Mandatory Convertible Preferred Stock will be treated as the record
holder(s) of such shares as of the close of business on the Mandatory Conversion Date. Prior to the close of business on the Mandatory Conversion Date, the common stock issuable upon conversion of the
Mandatory Convertible Preferred Stock on the Mandatory Conversion Date will not be deemed to be outstanding for any purpose and you will have no rights, powers or preferences with respect to such
common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the Mandatory Convertible
Preferred Stock. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Upon Early Conversion or Upon Early Fundamental Change Conversion  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a holder elects to convert the Mandatory Convertible Preferred Stock prior to the Mandatory Conversion Date, in the manner described in
"&#151;Early Conversion at the Option of the Holder" or "&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=52,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=224958,FOLIO='S-48',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_ck13305_1_49"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Make-Whole
Amount" (an "Early Fundamental Change Conversion"), you must observe the following conversion procedures:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if such holder holds a beneficial interest in a global share of Mandatory Convertible Preferred Stock, such holder must deliver to DTC the
appropriate instruction form for conversion pursuant to DTC's conversion program; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if such holder holds shares of the Mandatory Convertible Preferred Stock in certificated form, such holder must comply with certain procedures
set forth in the Certificate of Designations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
either case, if required, you must pay all transfer or similar taxes or duties, if any. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
"conversion date" will be the date on which you have satisfied the foregoing requirements with respect to an Early Conversion or an Early Fundamental Change Conversion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but you will be required to pay any tax
or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than your own. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock will be issued and delivered to the converting holder
through the facilities of DTC, together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable taxes and duties, if any, payable
by you have been paid in full, and such shares and cash will be delivered on the latest of (i)&nbsp;the second Business Day immediately succeeding the conversion date, (ii)&nbsp;the second
Business Day immediately succeeding the last day of the Early Conversion Settlement Period, if applicable, and (iii)&nbsp;the Business Day after you have paid in full all applicable taxes and
duties, if any. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person or persons entitled to receive the common stock issuable upon early conversion of the Mandatory Convertible Preferred Stock will be treated as the record holder(s) of such
shares as of the close of business on the applicable Early Conversion Date or Fundamental Change Conversion Date. Prior to the close of business on the applicable Early Conversion Date or Fundamental
Change Conversion Date, the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock will not be deemed to be outstanding for any purpose, and you will have no rights, powers
or preferences with respect to such common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue
of holding the Mandatory Convertible Preferred Stock. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fractional Shares  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No fractional shares of our common stock will be issued to holders of the Mandatory Convertible Preferred Stock upon conversion. In lieu of any
fractional shares of our common stock otherwise issuable in respect of the aggregate number of shares of the Mandatory Convertible Preferred Stock of any holder that are converted, that holder will be
entitled to receive an amount in cash (computed to the nearest cent) equal to the product of: (i)&nbsp;that same fraction; and (ii)&nbsp;the Average VWAP of our common stock over the five
consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the relevant conversion date. In the event that we cannot pay cash in lieu of a
fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional
share. See "&#151;Dividends&#151;Limitation on Cash Payments under our Credit Facilities." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to any applicable rules and procedures of DTC, if more than one share of the Mandatory Convertible Preferred Stock is surrendered for conversion at one time by or for the same
holder, the number of shares of full shares of our common stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Mandatory Convertible Preferred
Stock so surrendered. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=53,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=800314,FOLIO='S-49',FILE='DISK104:[20ZCM5.20ZCM13305]CK13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cm13305_1_50"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Anti-Dilution Adjustments  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Fixed Conversion Rate will be adjusted as described below, except that we will not make any adjustments to the Fixed Conversion Rates if
holders of the Mandatory Convertible Preferred Stock participate (other than in the case of a share split or share combination), at the same time and upon the same terms as holders of our common stock
and solely as a result of holding the Mandatory Convertible Preferred Stock, in any of the transactions described below without having to convert their Mandatory Convertible Preferred Stock as if they
held a number of shares of common stock equal to (i)&nbsp;the Maximum Conversion Rate as of the record date for such transaction, </FONT><FONT SIZE=2><I>multiplied by</I></FONT><FONT SIZE=2>
(ii)&nbsp;the number of shares of Mandatory Convertible Preferred Stock held by such holder.  </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>If
we exclusively issue shares of our common stock as a dividend or distribution on shares of our common stock, or if we effect a share split or share combination,
each Fixed Conversion Rate will be adjusted based on the following formula: </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g208995.jpg" ALT="GRAPHIC" WIDTH="256" HEIGHT="37">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>where,
</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the close of business on the record date (as defined below) of such dividend or distribution, or immediately prior to the open of
business on the effective date of such share split or share combination, as applicable; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the close of business on such record date or immediately after the open of business on such effective date, as applicable; </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>OS0&nbsp;=
the number of shares of our common stock outstanding immediately prior to the close of business on such record date or immediately prior to the open of business on such effective date, as
applicable, before giving effect to such dividend, distribution, share split or share combination; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>OS1&nbsp;=
the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
adjustment made under this clause&nbsp;(1) shall become effective immediately after the close of business on the record date for such dividend or distribution, or immediately after
the open of business on the effective date for such share split or share combination, as applicable. If any dividend or
distribution of the type described in this clause&nbsp;(1) is declared but not so paid or made, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of
directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared.
For the purposes of this clause&nbsp;(1), the number of shares of our common stock outstanding immediately prior to the close of business on the record date and the number of shares of our common
stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination shall, in each case, not include shares that we hold in treasury. We will not pay any
dividend or make any distribution on shares of our common stock that we hold in treasury. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"effective
date" as used in this clause&nbsp;(1) means the first date on which the shares of our common stock trade on the Relevant Stock Exchange, regular way, reflecting the relevant
share split or share combination, as applicable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"record
date" means, with respect to any dividend, distribution or other transaction or event in which the holders of our common stock (or other applicable security) have the right to
receive any cash, securities or other property or in which our common stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the date
fixed for determination of holders of our common stock (or such other security) entitled to receive such cash, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=54,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=794845,FOLIO='S-50',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>securities
or other property (whether such date is fixed by our board of directors or a duly authorized committee thereof, statute, contract or otherwise).  </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>If
we issue to all or substantially all holders of our common stock any rights, options or warrants entitling them, for a period of not more than 60 calendar days
after the announcement date of such issuance, to subscribe for or purchase shares of our common stock at a price per share that is less than the Average VWAP per share of our common stock for the 10
consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, each Fixed Conversion Rate will be increased based on the
following formula: </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g353076.jpg" ALT="GRAPHIC" WIDTH="258" HEIGHT="37">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>where, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such issuance; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the close of business on such record date; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>OS0&nbsp;=
the number of shares of our common stock outstanding immediately prior to the close of business on such record date; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>X&nbsp;=
the total number of shares of our common stock issuable pursuant to such rights, options or warrants; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Y&nbsp;=
the number of shares of our common stock equal to (i)&nbsp;the aggregate price payable to exercise such rights, options or warrants, </FONT><FONT SIZE=2><I>divided
by</I></FONT><FONT SIZE=2> (ii)&nbsp;the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
date of announcement of the issuance of such rights, options or warrants. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
increase made under this clause&nbsp;(2) will be made successively whenever any such rights, options or warrants are issued and shall become effective immediately after the close
of business on the record date for such issuance. To the extent that such rights, options or warrants are not exercised prior to their expiration or shares of common stock are not delivered after the
exercise of such rights, options or warrants, each Fixed Conversion Rate shall be decreased to such Fixed Conversion Rate that would then be in effect had the increase with respect to the issuance of
such rights, options or warrants been made on the basis of delivery of only the number of shares of common stock actually delivered, if any. If such rights, options or warrants are not so issued, each
Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed
Conversion Rate that would then be in effect if such record date for such issuance had not occurred. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purpose of this clause&nbsp;(2), in determining whether any rights, options or warrants entitle the holders of our common stock to subscribe for or purchase shares of our
common stock at less than such Average VWAP per share for the 10 consecutive trading day period ending on, and including, the Trading Day immediately preceding the date of announcement of such
issuance, and in determining the aggregate offering price of such shares of our common stock, there shall be taken into account any consideration received by us for such rights, options or warrants
and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by our board of directors or a committee thereof. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=55,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=756108,FOLIO='S-51',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_52"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)(A)
If we distribute shares of our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other
securities, to all or substantially all holders of our common stock, excluding:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> dividends, distributions or issuances as to which the provisions set forth in in clause&nbsp;(1) or (2)&nbsp;shall apply; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> dividends or distributions paid exclusively in cash as to which the provisions set forth in clause&nbsp;(4) below shall apply; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any dividends and distributions upon conversion of, or in exchange for, our common stock in connection with a recapitalization,
reclassification, change, consolidation, merger or other combination, share exchange, or sale, lease or other transfer or disposition resulting in the change in the conversion consideration as
described below under "&#151;Recapitalizations, Reclassifications and Changes of Our Common Stock"; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> except as otherwise described below, rights issued pursuant to a shareholder rights plan adopted by us; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> spin-offs as to which the provisions set forth below in clause&nbsp;(3)(B) shall apply; then each Fixed Conversion Rate will be increased
based on the following formula: </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g920114.jpg" ALT="GRAPHIC" WIDTH="201" HEIGHT="33">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>where,
</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such distribution; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the close of business on such record date; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>SP0&nbsp;=
the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the ex-date (as defined below)
for such distribution; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>FMV&nbsp;=
the fair market value (as determined by our board of directors or a committee thereof) of the shares of capital stock, evidences of indebtedness, assets, property, rights, options or
warrants so distributed, expressed as an amount per share of our common stock on the ex-date for such distribution. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"ex-date"
means the first date on which the shares of our common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the
issuance, dividend or distribution in question, from us or, if applicable, from the seller of our common stock on such exchange or market (in the form of due bills or otherwise) as determined by such
exchange or market. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
increase made under this clause&nbsp;(3)(A) above will become effective immediately after the close of business on the record date for such distribution. If such distribution is
not so paid or made, each fixed conversion rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or
distribution, to be such fixed conversion rate that would then be in effect if such distribution had not been declared. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, if "FMV" (as defined above) is equal to or greater than "SP0" (as defined above), or if the difference is less than $1.00, in lieu of the foregoing
increase, each holder shall receive, in respect of each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of our common stock, the amount and kind of
our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities that such holder would have received
if such holder owned a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=56,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1039685,FOLIO='S-52',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_53"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>number
of shares of common stock equal to the Maximum Conversion Rate in effect on the record date for the distribution. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we issue rights, options or warrants that are only exercisable upon the occurrence of certain triggering events, then:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we will not adjust the Fixed Conversion Rates pursuant to the foregoing in this clause&nbsp;(3) until the earliest of these triggering events
occurs; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we will readjust the Fixed Conversion Rates to the extent any of these rights, options or warrants are not exercised before they expire; </FONT> <FONT
SIZE=2><I>provided</I></FONT><FONT SIZE=2> that the rights, options or warrants trade together with our common stock and will be issued in respect of future issuances of the shares of
our common stock. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>(3)(B)
With respect to an adjustment pursuant to this clause&nbsp;(3) where there has been a payment of a dividend or other distribution on our common stock of shares of capital stock of any class
or series, or similar equity interest, of or relating to a subsidiary or other business unit, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange,
which we refer to as a "spin-off," each Fixed Conversion Rate will be increased based on the following formula: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g330364.jpg" ALT="GRAPHIC" WIDTH="189" HEIGHT="42">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>where, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the open of business on the ex-date for the spin-off; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the open of business on the ex-date for the spin-off; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>FMV0&nbsp;=
the Average VWAP per share of the capital stock or similar equity interest distributed to holders of our common stock applicable to one share of our common stock over the 10 consecutive
Trading Day period commencing on, and including, the ex-date for the spin-off, or the "valuation period"; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>MP0&nbsp;=
the Average VWAP per share of our common stock over the valuation period. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase to each Fixed Conversion Rate under the preceding paragraph will be calculated as of the close of business on the last Trading Day of the valuation period but will be given
effect as of immediately after the open of business on the ex-date of the spin-off. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the
settlement of any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the valuation period
until the second Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. If such dividend or distribution
is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or distribution, to be
such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=57,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=648615,FOLIO='S-53',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_54"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>If
any cash dividend or distribution is made to all or substantially all holders of our common stock, each Fixed Conversion Rate will be adjusted based on the
following formula: </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g95360.jpg" ALT="GRAPHIC" WIDTH="156" HEIGHT="43">
  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>where, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such dividend or distribution; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the close of business on the record date for such dividend or distribution; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>SP0&nbsp;=
the last reported sale price of our common stock on the Trading Day immediately preceding the ex-date for such dividend or distribution; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>C&nbsp;=
the amount in cash per share we distribute to all or substantially all holders of our common stock. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
increase made under this clause&nbsp;(4) shall become effective immediately after the close of business on the record date for such dividend or distribution. If such dividend or
distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or
distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
"last reported sale price" of our common stock on any date means:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either
case, the average of the average bid and the average ask prices) on such date as reported in composite transactions for the relevant stock exchange (as defined below); </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if our common stock is not listed for trading on a relevant stock exchange on such date, the last quoted bid price for our common stock in the
over-the-counter market on such date as reported by OTC Markets Group&nbsp;Inc. or a similar organization; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if our common stock is not so quoted, the average of the mid-point of the last bid and ask prices for our common stock on such date from each
of at least three nationally recognized independent investment banking firms selected by us for this purpose. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, if "C" (as defined above) is equal to or greater than "SP0" (as defined above), or if the difference is less than $1.00, in lieu of the foregoing increase,
each holder shall receive, for each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of shares of our common stock, the amount of cash that such
holder would have received if such holder owned a number of shares of our common stock equal to the Maximum Conversion Rate on the record date for such cash dividend or distribution. </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>If
we or any of our subsidiaries make a payment in respect of a tender or exchange offer for our common stock, to the extent that the cash and value of any other
consideration included in the payment per share of common stock exceeds the Average VWAP per share of our common stock over the 10 consecutive Trading Day period commencing on, and including, the
Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=58,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=827990,FOLIO='S-54',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>exchange
offer (the "expiration date"), each Fixed Conversion Rate will be increased based on the following formula: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g125798.jpg" ALT="GRAPHIC" WIDTH="207" HEIGHT="37">
  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>where, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR0&nbsp;=
such Fixed Conversion Rate in effect immediately prior to the close of business on the expiration date; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>CR1&nbsp;=
such Fixed Conversion Rate in effect immediately after the close of business on the expiration date; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>AC&nbsp;=
the aggregate value of all cash and any other consideration (as determined by our board of directors or a committee thereof) paid or payable for shares purchased in such tender or exchange
offer; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>OS0&nbsp;=
the number of shares of our common stock outstanding immediately prior to the expiration date (prior to giving effect to the purchase of all shares accepted for purchase or exchange in
such tender or exchange offer); </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>OS1&nbsp;=
the number of shares of our common stock outstanding immediately after the expiration date (after giving effect to the purchase of all shares accepted for purchase or exchange in such
tender or exchange offer); and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>SP1&nbsp;=
the Average VWAP of our common stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the expiration date (the "averaging period"). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase to each Fixed Conversion Rate under the preceding paragraph will be calculated at the close of business on the last Trading Day of the averaging period but will be given
effect as of immediately after the close of business on the expiration date. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the settlement of
any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the averaging period until the second
Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. For the avoidance of doubt, no adjustment under
this clause&nbsp;(5) will be made if such adjustment would result in a decrease in any Fixed Conversion Rate. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that we or one of our subsidiaries is obligated to purchase shares of common stock pursuant to any such tender offer or exchange offer, but we or such subsidiary is
permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded,
then each Fixed Conversion Rate shall again be adjusted to be such Fixed Conversion Rate that would then be in effect if such tender offer or exchange offer had not been made. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the avoidance of doubt, for purposes of this subsection&nbsp;(5), the term "tender offer" is used as such term is used in the Exchange Act and the term "exchange offer" means an
exchange offer that constitutes a tender offer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may, to the extent permitted by law and the rules of NYSE or any other securities exchange on which our common stock or the Mandatory Convertible Preferred Stock is then listed,
increase each Fixed Conversion Rate by any amount for a period of at least 20 Business Days if such increase is irrevocable during such 20 Business Days and our board of directors (or a committee
thereof) determines that such increase would be in our best interest. In addition, we may make such increases in each Fixed Conversion Rate as we deem advisable in order to avoid or diminish any
income tax to holders of our common stock resulting from any dividend or distribution of shares of our common stock (or issuance of rights or warrants to acquire shares of our common stock) or from
any event treated as such for income tax purposes or for any other reason. We may only make such a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=59,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=832820,FOLIO='S-55',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_56"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>discretionary
adjustment if we make the same proportionate adjustment to each Fixed Conversion Rate. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of the Mandatory Convertible Preferred Stock may, in certain circumstances, including a distribution of cash dividends to holders of our shares of common stock, be deemed to have
received a distribution subject to U.S. Federal income tax as a dividend as a result of an adjustment or the nonoccurrence of an adjustment to the Fixed Conversion Rates. See "Material U.S. Federal
Income Tax Considerations." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we have a rights plan in effect upon conversion of the Mandatory Convertible Preferred Stock into common stock, you will receive, in addition to any shares of common stock received in
connection with such conversion, the rights under the rights plan. However, if, prior to any conversion, the rights have separated from the shares of common stock in accordance with the provisions of
the applicable rights plan, each Fixed Conversion Rate will be adjusted at the time of separation as if we distributed to all or substantially all holders of our common stock, shares of our capital
stock, evidences of indebtedness, assets, property, rights, options or warrants as described in clause&nbsp;(3)(A) above, subject to readjustment in the event of the expiration, termination or
redemption of such rights. We do not currently have a stockholder rights plan in effect. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments
to the Fixed Conversion Rates will be calculated to the nearest 1/10,000th&nbsp;of a share of our common stock. No adjustment to any Fixed Conversion Rate will be required
unless the adjustment would require an increase or decrease of at least 1% of the Fixed Conversion Rate; </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT> <FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that if an adjustment is not
made because the adjustment does not change the Fixed Conversion Rates by at least 1%, then such adjustment will
be carried forward and taken into account in any future adjustment. Notwithstanding the foregoing, on each date for determining the number of shares of our common stock issuable to a holder upon any
conversion of the Mandatory Convertible Preferred Stock we will give effect to all adjustments that we have otherwise deferred pursuant to this sentence, and those adjustments will no longer be
carried forward and taken into account in any future adjustment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Fixed Conversion Rates will not be adjusted:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> upon the issuance of any shares of our common stock pursuant to any present or future plan providing for the reinvestment of dividends or
interest payable on our securities and the investment of additional optional amounts in common stock under any plan; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> upon the issuance of any shares of our common stock or rights or warrants to purchase those shares pursuant to any present or future benefit or
other incentive plan or program of or assumed by us or any of our subsidiaries; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> upon the issuance of any shares of our common stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security
not described in the preceding bullet and outstanding as of the Initial Issue Date; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> for a change in the par value of our common stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> for stock repurchases that are not tender offers referred to in clause&nbsp;(5) of the adjustments above, including structured or derivative
transactions or pursuant to a stock repurchase program approved by our board of directors; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> for accumulated dividends on the Mandatory Convertible Preferred Stock, except as described above under "&#151;Mandatory Conversion,"
"&#151;Early Conversion at the Option of the Holder" and "&#151;Conversion at the Option of the Holder upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount." </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=60,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=301959,FOLIO='S-56',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_57"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise provided above, we will be responsible for making all calculations called for under the Mandatory Convertible Preferred Stock. These calculations include, but are not
limited to, determinations of the Fundamental Change Share Price, the VWAPs, the Average VWAPs, the last reported sale price and the Fixed Conversion Rates of the Mandatory Convertible Preferred
Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will be required, within 10 Business Days after the Fixed Conversion Rates are adjusted, to provide or cause to be provided written notice of the adjustment to the holders of the
Mandatory Convertible Preferred Stock. We will also be required to deliver a statement setting forth in reasonable detail the method by which the adjustment to each Fixed Conversion Rate was
determined and setting forth each adjusted Fixed Conversion Rate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the avoidance of doubt, if an adjustment is made to the Fixed Conversion Rates, no separate inversely proportionate adjustment will be made to the Initial Price or the Threshold
Appreciation Price because the Initial Price is equal to $100.00 </FONT><FONT SIZE=2><I>divided by</I></FONT><FONT SIZE=2> the Maximum Conversion Rate (as adjusted in the manner described herein) and
the Threshold Appreciation Price is equal to $100.00 divided by the Minimum Conversion Rate (as adjusted in the manner described herein). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever
the terms of the Mandatory Convertible Preferred Stock require us to calculate the VWAP per share of our common stock over a span of multiple days, our board of directors or an
authorized committee thereof will make appropriate adjustments (including, without limitation, to the Applicable Market Value, the Early Conversion Average Price, the Fundamental Change Share Price
and the Average Price (as the case may be)) to account for any adjustments to the Fixed Conversion Rates (as the case may be) that become effective, or any event that would require such an adjustment
if the ex-date, effective date, record date or expiration date (as the case may be) of such event occurs, during the relevant period used to calculate such prices or values (as the case may be). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the record date for a dividend or distribution on shares of our common stock occurs after the end of the 20 consecutive Trading Day period used
for calculating the Applicable Market Value and before the Mandatory Conversion Date; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> that dividend or distribution would have resulted in an adjustment of the number of shares issuable to the holders of the Mandatory Convertible
Preferred Stock had such record date occurred on or before the last Trading Day of such 20-Trading Day period, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>then
we will deem the holders of the Mandatory Convertible Preferred Stock to be holders of record of our common stock for purposes of that dividend or distribution. In this case, the holders of the
Mandatory </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible
Preferred Stock would receive the dividend or distribution on our common stock together with the number of shares of our common stock issuable upon mandatory conversion of
the Mandatory Convertible Preferred Stock. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recapitalizations, Reclassifications and Changes of Our Common Stock  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any consolidation or merger of us with or into another person (other than a merger or consolidation in which we are the surviving corporation
and in which the shares of our common stock outstanding immediately prior to the merger or consolidation are not exchanged for cash, securities or other property of us or another person); </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any sale, transfer, lease or conveyance to another person of all or substantially all of our property and assets; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=61,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=988551,FOLIO='S-57',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_58"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any reclassification of our common stock into securities, including securities other than our common stock; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any statutory exchange of our securities with another person (other than in connection with a merger or acquisition), </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>in
each case, as a result of which our common stock would be converted into, or exchanged for, stock, other securities or other property or assets (including cash or any combination thereof) (each, a
"Reorganization Event"), each share of the Mandatory Convertible Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of the holders of the Mandatory
Convertible Preferred Stock, become convertible into the kind of stock, other securities or other property or assets (including cash or any combination thereof) that such holder would have been
entitled to receive if such holder had converted its Mandatory Convertible Preferred Stock into common stock immediately prior to such Reorganization Event (such stock, other securities or other
property or assets (including cash or any combination thereof), the "Exchange Property", with each "Unit of Exchange Property" meaning the kind and amount of Exchange Property that a holder of one
share of common stock is entitled to receive). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the transaction causes our common stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form
of stockholder election), the Exchange Property into which the Mandatory Convertible Preferred Stock will be convertible will be deemed to be the weighted average of the types and amounts of
consideration actually received by the holders of our common stock. We will notify holders of the Mandatory Convertible Preferred Stock of the weighted average as soon as practicable after such
determination is made. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of Units of Exchange Property we will deliver for each share of the Mandatory Convertible Preferred Stock converted following the effective date of such Reorganization Event
will be determined as if references to our common stock in the description of the conversion rate applicable upon mandatory conversion, Early Conversion and Early Fundamental Change Conversion were to
Units of Exchange Property (without interest thereon and without any right to dividends or
distributions thereon which have a record date prior to the date such Mandatory Convertible Preferred Stock is actually converted). For the purpose of determining which bullet of the definition of
conversion rate in the second paragraph under "&#151;Mandatory Conversion" will apply upon mandatory conversion, and for the purpose of calculating the conversion rate if the second bullet is
applicable, the value of a Unit of Exchange Property will be determined in good faith by our board of directors or an authorized committee thereof (which determination will be final), except that if a
Unit of Exchange Property includes common stock or American Depositary Receipts, or "ADRs", that are traded on a U.S. national securities exchange, the value of such common stock or ADRs will be the
average over the 20 consecutive Trading Day period used for calculating the Applicable Market Value of the volume-weighted average prices for such common stock or ADRs, as displayed on the applicable
Bloomberg screen (as determined in good faith by our board of directors or an authorized committee thereof (which determination will be final)); or, if such price is not available, the average market
value per share of such common stock or ADRs over such period as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for
this purpose. The provisions of this paragraph will apply to successive Reorganization Events, and the provisions summarized under "&#151;Anti-Dilution Adjustments" will apply to any shares of
capital stock or ADRs of us or any successor received by the holders of shares of our common stock in any such Reorganization Event. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
(or any successor to us) will, as soon as reasonably practicable (but in any event within 20 calendar days) after the occurrence of any Reorganization Event provide written notice to
the holders of the Mandatory Convertible Preferred Stock of such occurrence and of the kind and amount of cash, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=62,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=766822,FOLIO='S-58',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_59"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>securities
or other property that constitute the Exchange Property. Failure to deliver such notice will not affect the operation of the provisions described in this section. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reservation of Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will at all times reserve and keep available out of the authorized and unissued shares of common stock, solely for issuance upon conversion
of the Mandatory Convertible Preferred Stock, the maximum number of shares of our common stock as shall be issuable from time to time upon the conversion of all the shares of the Mandatory Convertible
Preferred Stock then outstanding. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent, Registrar and Conversion and Dividend Disbursing Agent  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Computershare Inc. is the transfer agent and registrar of our common stock and will serve as transfer agent, registrar, conversion and dividend
disbursing agent for the Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Book-Entry, Delivery and Form  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Mandatory Convertible Preferred Stock will be issued in global form. DTC or its nominee will be the sole registered holder of the Mandatory
Convertible Preferred Stock. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be limited to persons who have accounts with DTC, or "participants", or
persons who hold interests through such participants. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be shown on, and the transfer of that ownership
will be effected only through, records maintained by DTC or its nominee (with respect to interests of participants) and the records of participants (with respect to interests of persons other than
participants). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as DTC, or its nominee, is the registered owner or holder of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, DTC or such nominee, as
the case may be, will be considered the sole holder of the shares of the Mandatory Convertible Preferred Stock represented by such global certificate for all purposes under the Certificate of
Designations establishing the terms of the Mandatory Convertible Preferred Stock. No beneficial owner of an interest in the shares of the Mandatory Convertible Preferred Stock in global form will be
able to transfer that interest except in accordance with the applicable procedures of DTC in addition to those provided for under the Certificate of Designations establishing the terms of the
Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
of dividends on the global certificate representing the shares of the Mandatory Convertible Preferred Stock will be made to DTC or its nominee, as the case may be, as the
registered holder thereof. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility or liability for any aspect of the records relating to or
payments made on account of beneficial ownership interests in a global certificate representing the shares of the Mandatory Convertible Preferred Stock or for maintaining, supervising or reviewing any
records relating to such beneficial ownership interests. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect that DTC or its nominee, upon receipt of any payment of dividends in respect of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, will
credit participants' accounts with payments in amounts proportionate to their respective beneficial ownership interests in the aggregate Liquidation Preference of such global certificate representing
the shares of the Mandatory Convertible Preferred Stock as shown on the records of DTC or its nominee, as the case may be. We also expect that payments by participants to owners of beneficial
interests in such global certificate representing the shares of the Mandatory Convertible Preferred Stock held through such participants will be governed by standing instructions and customary
practices, as is now the case </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=63,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=187022,FOLIO='S-59',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<A NAME="page_cm13305_1_60"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>with
securities held for the accounts of customers registered in the names of nominees for such customers. Such payments will be the responsibility of such participants. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfers
between participants in DTC will be effected in the ordinary way in accordance with DTC rules and will be settled in same-day funds. We understand that DTC
is:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a limited purpose trust company organized under the laws of the State of New York; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a "banking organization" within the meaning of New York Banking Law; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a member of the Federal Reserve System; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a "clearing corporation" within the meaning of the Uniform Commercial Code; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a "Clearing Agency" registered pursuant to the provisions of Section&nbsp;17A of the Exchange Act. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DTC
was created to hold securities for its participants and facilitate the clearance and settlement of securities transactions between participants through electronic book-entry changes
in accounts of its participants, thereby eliminating the need for physical movement of certificates. Participants include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> securities brokers and dealers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> banks and trust companies; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> clearing corporations and certain other organizations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indirect
access to the DTC system is available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant,
either directly or indirectly (indirect participants). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
DTC is expected to follow the foregoing procedures in order to facilitate transfers of interests in a global security among its participants, it is under no obligation to
perform or continue to perform such </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;procedures,
and such procedures may be discontinued at any time. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility for the
performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
DTC is at any time unwilling or unable to continue as a depositary for the shares of the Mandatory Convertible Preferred Stock in global form or DTC ceases to be registered as a
clearing agency under the Exchange Act, and in either case a successor depositary is not appointed by us within 90&nbsp;days, we will issue certificated shares in exchange for the global securities.
Holders of an interest in the Mandatory Convertible Preferred Stock in global form may receive certificated shares, at our option, in accordance with the rules and procedures of DTC in addition to
those provided for under the Certificate of Designations. Beneficial interests in Mandatory Convertible Preferred Stock in global form held by any direct or indirect participant may also be exchanged
for certificated shares upon request to DTC by such direct participant (for itself or on behalf of an indirect participant), to the transfer agent in accordance with their respective customary
procedures. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
information in this section concerning DTC and its book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy
thereof. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=64,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=310810,FOLIO='S-60',FILE='DISK104:[20ZCM5.20ZCM13305]CM13305A.;14',USER='DSLOAN',CD='20-MAY-2020;12:31' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_co13305_1_61"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="co13305_material_u.s._federal_income_tax_considerations"> </A>
<A NAME="toc_co13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following discussion is a general summary of the material U.S. federal income tax consequences of the purchase, ownership, disposition and
conversion of the Mandatory Convertible Preferred Stock and any common stock received in respect of the Mandatory Convertible Preferred Stock. This summary does not purport to be a comprehensive
description of all the potential tax considerations that may be relevant to a holder's decision to purchase Mandatory Convertible Preferred Stock, including tax consequences that arise from rules of
general application to all taxpayers or certain classes of taxpayers. This summary is based upon the provisions of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), U.S. Treasury
regulations (including proposed Treasury regulations) promulgated thereunder, administrative rulings and judicial decisions, each as of the date hereof. These authorities may be changed, perhaps
retroactively, so as to result in U.S. federal income tax consequences different from those set forth below. We have not sought any ruling from the U.S. Internal Revenue Service (the "IRS") with
respect to the matters discussed below, and there can be no assurance that the IRS or a court will not take a contrary position regarding the tax consequences of the ownership, disposition or
conversion of the Mandatory Convertible Preferred Stock or common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
summary assumes that the Mandatory Convertible Preferred Stock and shares of our common stock will be held as "capital assets" within the meaning of Section&nbsp;1221 of the Code
(generally, property held for investment). This discussion does not address all aspects of U.S. federal income taxes that may be relevant to holders in light of their particular circumstances, does
not discuss the potential application of the Medicare surtax on net investment income and the alternative minimum tax and does not deal with state or local taxes, U.S. federal gift and estate tax laws
or any non-U.S. tax consequences. In addition, this discussion does not address all tax considerations that may be applicable to a holder's particular circumstances or to holders that may be subject
to special tax rules, including, without limitation:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> banks, insurance companies or other financial institutions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> tax-exempt organizations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> regulated investment companies or real estate investment trusts; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> controlled foreign corporations and passive foreign investment companies </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> dealers or traders in securities that elect to use a mark-to-market method of accounting for their securities holdings; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> S corporations, partnerships or other pass-through entities or arrangements (or investors therein); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> certain former citizens or long-term residents of the United States; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> U.S. Holders (as defined below) whose "functional currency" is not the U.S. dollar; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons who hold or receive our Mandatory Convertible Preferred Stock or our common stock pursuant to the exercise of any employee stock option
or otherwise as compensation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons that hold our Mandatory Convertible Preferred Stock as a position in a hedging transaction, "straddle," "conversion transaction" or
other risk reduction transaction; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons that own, actually or constructively, more than 5% of the Mandatory Convertible Preferred Stock or common stock. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=65,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1001037,FOLIO='S-61',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_62"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this discussion, a "U.S. Holder" is a beneficial owner of the Mandatory Convertible Preferred Stock that is, for U.S. federal income tax
purposes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an individual who is a citizen or resident of the United States; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a corporation (including an entity treated as a corporation for such purposes) created or organized in or under the laws of the United States,
any State thereof or the District of Columbia; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an estate the income of which is subject to U.S. federal income taxation regardless of its source; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a trust (i)&nbsp;if a court within the United States is able to exercise primary supervision over the administration of the trust and one or
more United States persons (as defined under the Code) have the authority to control all substantial decisions, or (ii)&nbsp;the trust has a valid election in effect under the applicable U.S.
Treasury regulations to be treated as a United States person under the Code. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this discussion, a "Non-U.S. Holder" is a beneficial owner of the Mandatory Convertible Preferred Stock that is neither a U.S. Holder nor a partnership for U.S. federal
income tax purposes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a partnership (or other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds the Mandatory Convertible Preferred Stock, the U.S. federal income
tax treatment of a partner in the partnership generally will depend on the activities of the partnership and the status of the partner. Prospective investors that are partners in partnerships (or
entities or arrangements treated as partnerships for U.S. federal income tax purposes) should consult their tax advisors regarding the U.S. federal income tax consequences to them of the purchase,
ownership, disposition and conversion of the Mandatory Convertible Preferred Stock or common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S.
FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS, AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, CONVERSION (IN THE CASE OF OUR MANDATORY CONVERTIBLE PREFERRED STOCK), AND
DISPOSITION OF OUR MANDATORY CONVERTIBLE PREFERRED STOCK OR OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING
JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tax Considerations Applicable to U.S. Holders  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Distributions  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions paid on the Mandatory Convertible Preferred Stock or our common stock generally will constitute dividends for U.S. federal income
tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Subject to applicable limitations and restrictions,
dividends paid to non-corporate U.S. Holders will be treated as "qualified dividend income" (as defined in the Code) taxable at favorable rates applicable to long-term capital gains. Subject to
applicable limitations and restrictions, dividends paid to corporate U.S. Holders will be eligible for the dividends-received deduction. U.S. Holders should consult their tax advisors regarding the
application of reduced tax rates and the dividends-received deduction in their particular circumstances. If a distribution exceeds our current and accumulated earnings and profits, the excess will be
treated as a tax-free return of the U.S. Holder's investment, up to such holder's tax basis in the Mandatory Convertible Preferred Stock or common stock. Any remaining excess will be treated </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=66,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=389557,FOLIO='S-62',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_63"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>as
capital gain, subject to the tax treatment described below under the heading "&#151;Sale or Other Taxable Disposition." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we make a distribution on our Mandatory Convertible Preferred Stock in the form of our common stock, although there is some uncertainty, we believe that such distribution will be
taxable for U.S. federal income tax purposes in the same manner as distributions described above. The amount of such distribution and a U.S. Holder's tax basis in such common stock will equal the fair
market value of such common stock on the distribution date, and a U.S. Holder's holding period for such common stock will begin on the day following the distribution date. Because such distribution
would not give rise to any cash from which any applicable withholding tax could be satisfied, if we (or an applicable withholding agent) pay backup withholding on behalf of a U.S. Holder (because such
U.S. Holder failed to establish an exemption from backup withholding), we expect that the applicable withholding agent will withhold such taxes from shares of common stock or current or subsequent
payments of cash
to such U.S. Holder. U.S. Holders should consult with their tax advisors regarding the tax consequences of a common stock distribution on our Mandatory Convertible Preferred Stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Extraordinary Dividends  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends that exceed certain thresholds in relation to a U.S. Holder's tax basis in the Mandatory Convertible Preferred Stock or common stock
could be characterized as "extraordinary dividends" under the Code. A corporate U.S. Holder that has held our Mandatory Convertible Preferred Stock or common stock for two years or less before the
dividend announcement date and that receives an extraordinary dividend generally will be required to reduce its tax basis in the stock with respect to which such dividend was made by the nontaxed
portion of such dividend. If the amount of the reduction exceeds the U.S. Holder's tax basis in such stock, the excess is taxable as capital gain realized on the sale or other disposition of the
Mandatory Convertible Preferred Stock or common stock and will be treated as described under "&#151;Sale or Other Taxable Disposition" below. A non-corporate U.S. Holder that receives an
extraordinary dividend generally will be required to treat any loss on the sale of our Mandatory Convertible Preferred Stock or common stock as long-term capital loss to the extent of the
extraordinary dividends the U.S. Holder receives that qualify for taxation at the reduced rates discussed above under "&#151;Distributions." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Adjustments to Conversion Rate  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The conversion rate of our Mandatory Convertible Preferred Stock is subject to adjustment under specified circumstances. Treasury Regulations
promulgated under Section&nbsp;305 of the Code would treat a U.S. Holder of our Mandatory Convertible Preferred Stock as having received a deemed distribution includable in such U.S. Holder's income
in the manner described under "&#151;Distributions," above, if and to the extent that certain adjustments in the conversion rate increase the proportionate interest of the U.S. Holder in our
assets or earnings and profits. In addition, the failure to make certain adjustments on the Mandatory Convertible Preferred Stock may cause a U.S. Holder of our common stock to be deemed to have
received a constructive distribution from us, even though the U.S. Holder has not received any cash or property as a result of such adjustments. Adjustments to the conversion rate made pursuant to a
bona fide reasonable adjustment formula which has the effect of preventing the dilution of the interest of the holders of the Mandatory Convertible Preferred Stock generally will not be deemed to
result in a constructive distribution. Certain of the possible adjustments in the terms of the Mandatory Convertible Preferred Stock (including, without limitation, adjustments in respect of taxable
dividends to our common stockholders) may not qualify as being made pursuant to a bona fide reasonable adjustment formula. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an adjustment that does not qualify as being pursuant to a bona fide reasonable adjustment formula is made, a U.S. Holder of Mandatory Convertible Preferred Stock will be deemed to
have received a constructive distribution from us, even though such U.S. Holder has not received any cash or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-63</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=67,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=545202,FOLIO='S-63',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_64"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>property
as a result of such adjustment. The tax consequences of the receipt of a distribution from us are described above under "&#151;Distributions." Because constructive distributions deemed
received by a U.S. Holder would not give rise to any cash from which any applicable withholding could be satisfied, if we (or an applicable withholding agent) pay backup withholding on behalf of a
U.S. Holder (because the U.S. Holder failed to establish an exemption from backup withholding), we expect that the applicable withholding agent will withhold such taxes from payments of cash or shares
of common stock payable to the U.S. Holder. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
rules currently in effect, we are generally required to report the amount of any deemed distributions on our website or to the IRS and to holders of Mandatory Convertible Preferred
Stock not exempt from reporting. The IRS has proposed regulations addressing the amount and timing of constructive distributions as well as obligations of withholding agents and filing and notice
obligations of the issuers in respect of such constructive distributions. If adopted as proposed, the regulations would generally provide, among other things, that (i)&nbsp;the amount of a
constructive distribution is the excess of the fair market value of the right to acquire common stock immediately after the conversion rate adjustment over the fair market value of the right to
acquire common stock (determined immediately after the conversion rate adjustment) without the adjustment, and (ii)&nbsp;the constructive distribution occurs at the earlier of the date the
adjustment occurs under the terms of the Mandatory Convertible Preferred Stock and the date of the actual distribution of cash or property that results in the constructive distribution. The final
regulations will be effective for deemed distributions occurring on or after the date of adoption, but holders of Mandatory Convertible and withholding agents may rely on them prior to that date under
certain circumstances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sale or Other Taxable Disposition  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the sale or other taxable disposition of Mandatory Convertible Preferred Stock (other than pursuant to a conversion into common stock
described below) or common stock, a U.S. Holder generally will recognize taxable gain or loss equal to the difference between the amount realized on the sale or other taxable disposition and the
holder's adjusted tax basis in such shares. Gain or loss realized on the sale or other disposition generally will be capital gain or loss and will be long-term capital gain or loss if at the time of
the sale or other disposition the Mandatory Convertible Preferred Stock or the common stock has been held for more than one year. For non-corporate
taxpayers, long-term capital gains are generally eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conversion of Mandatory Convertible Preferred Stock into Common Stock  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A U.S. Holder generally will not recognize gain or loss upon the conversion of our Mandatory Convertible Preferred Stock into shares of our
common stock, except that any cash or common stock received in respect of accrued and unpaid dividends that have been declared will be taxable as described above under "&#151;Distributions,"
with any common stock received in respect of such dividends treated as if the U.S. Holder had received cash equal to the fair market value of any such common stock determined as of the date of
conversion. In addition, a U.S. Holder's receipt of cash in lieu of a fractional share of our common stock will result in capital gain or loss (measured by the difference between the cash received in
lieu of the fractional share of our common stock and the U.S. Holder's tax basis allocable to the fractional share). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
tax treatment of a U.S. Holder's receipt of any cash or common stock paid upon conversion in respect of accrued and unpaid dividends that have not been declared, or paid in respect
of any fundamental change dividend make-whole amount, is uncertain. Although not free from doubt, we believe the receipt of such cash or common stock should be treated as additional consideration
received by the U.S. Holder upon conversion of the Mandatory Convertible Preferred Stock into shares of our common stock. Accordingly, in the event we choose to pay solely common stock in respect of
such </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-64</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=68,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=67050,FOLIO='S-64',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_65"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>amount,
the receipt of such stock should be taxed as described in the preceding paragraph. In the event a U.S. Holder converts its Mandatory Convertible Preferred Stock and we pay such holder cash or
a combination of cash and common stock in respect of a portion of the then-current dividend period or the present value of future dividends, the conversion should be taxable to the extent of the
lesser of the cash received (other than cash received in respect of a fractional share of common stock) and any gain realized by the U.S. Holder. For this purpose, gain realized generally would equal
the excess, if any, of (i)&nbsp;the fair market value of our common stock received upon conversion (including any fractional shares of our common stock for which cash is received) and the cash or
cash and common stock received in respect of accrued and unpaid dividends that have not been declared, or paid in respect of the fundamental change dividend make-whole amount over (ii)&nbsp;the U.S.
Holder's tax basis in our Mandatory Convertible Preferred Stock immediately prior to conversion. The character of such gain recognized (which will be the lesser of such gain and such cash) is
uncertain. If the receipt of such cash is considered to have the effect of a dividend (which generally would be the case if the receipt of such cash did not result in a meaningful reduction in such
U.S. Holder's equity interest in us, as determined for U.S. federal income tax purposes), such gain (to the extent recognized) will be taxable as dividend
income, to the extent of the U.S. Holder's allocable share of our current and accumulated earnings and profits. Alternatively, such gain could be capital gain. To the extent the amount of cash
received in respect of accrued but unpaid dividends that have not been declared, or in respect of any fundamental change dividend make-whole amount, exceeds the gain realized by a U.S. Holder, the
excess amount will not be taxable to such U.S. Holder but will reduce its adjusted tax basis in our common stock. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S.
Holders should be aware that the tax treatment described above in respect of the payments of cash or common stock made in respect of accrued and unpaid dividends that have not been
declared and any fundamental change dividend make-whole amount is not certain and may be challenged by the IRS, including on grounds that the amount received attributable to the accrued and unpaid
dividends that have not been declared and any fundamental change dividend make-whole amount represents a taxable dividend to the extent we have earnings and profits at the time of conversion, as
described above under "&#151;Distributions." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
payments of common stock that are treated as dividends will not give rise to any cash from which any applicable withholding tax could be satisfied, if we (or an applicable
withholding agent) pay backup withholding on behalf of a U.S. Holder (because such U.S. Holder failed to establish an exemption from backup withholding), we expect that the applicable withholding
agent will withhold such taxes from shares of common stock or current or subsequent payments of cash to such U.S. Holder. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as discussed in the last sentence of this paragraph, a U.S. Holder's tax basis in shares of common stock received upon conversion of the Mandatory Convertible Preferred Stock (and
any fractional shares of our common stock treated as received and then exchanged for cash) will equal the adjusted tax basis of the converted shares of the Mandatory Convertible Preferred Stock,
increased by any gain recognized on the conversion and reduced by any cash received that was treated as additional consideration received in the conversion as discussed above, and the holding period
of such shares of common stock will include the holding period of the converted shares of Mandatory Convertible Preferred Stock. A U.S. Holder's tax basis in common stock received may be further
reduced under the rules described above under "&#151;Extraordinary Dividends." Common stock received in payment of accrued but unpaid dividends that have been declared and taxed as a dividend
upon receipt, if any, will have a tax basis equal to their fair market value on the date of conversion, and a new holding period which will commence on the day after the conversion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event a U.S. Holder's Mandatory Convertible Preferred Stock is converted pursuant to certain transactions (including our consolidation or merger into another person), the tax
treatment of such a conversion will depend upon the facts underlying the particular transaction triggering such a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-65</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=69,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=151165,FOLIO='S-65',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_66"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>conversion.
U.S. Holders should consult their tax advisors to determine the specific tax treatment of a conversion under such circumstances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, information reporting will apply to distributions (including constructive distributions) on our Mandatory Convertible Preferred Stock
or our common stock and the proceeds from a sale or other disposition of such stock, unless the U.S. Holder is an exempt recipient (such as a corporation). Backup withholding may apply to such
payments if a U.S. Holder fails to provide a correct taxpayer identification number or a certification of exempt status or fails to report in full dividend and interest income. Backup withholding is
not an additional tax. Any amount withheld under the backup withholding rules generally will be allowed as a refund or credit against a U.S. Holder's U.S. federal income tax liability; </FONT> <FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2> that the
required information is timely furnished to the IRS. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tax Considerations Applicable to Non-U.S. Holders  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Distributions  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the discussion below on effectively connected income, distributions or other payments that are treated as dividends (see
"&#151;Tax Considerations Applicable to U.S. Holders&#151;Distributions" and "&#151;Conversion of Mandatory Convertible Preferred Stock into Common Stock" above), including deemed
distributions described above under "&#151;Tax Considerations Applicable to U.S. Holders&#151;Adjustments to Conversion Rate," generally will be subject to withholding tax at a 30% rate
or such lower rate as may be specified by an applicable income tax treaty between the United States and such Non-U.S. Holder's country of residence. A Non-U.S. Holder who claims the benefit of an
applicable income tax treaty between the United States and such holder's country of residence generally will be required to provide a properly executed IRS Form&nbsp;W-8BEN or W-8BEN-E (or successor
form) and satisfy applicable
certification and other requirements. A Non-U.S. Holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may generally obtain a refund or credit of any excess
amounts withheld by timely filing an appropriate claim with the IRS. Non-U.S. Holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax
treaty. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends
that are treated as effectively connected with a trade or business conducted by a Non-U.S. Holder within the United States and, if an applicable income tax treaty so provides,
that are attributable to a permanent establishment or a fixed base maintained by the Non-U.S. Holder within the United States, are generally exempt from the 30% withholding tax if the Non-U.S. Holder
satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income is taxed on a net income basis at the same U.S. federal income tax rates applicable to
United States persons (as defined in the Code). Any U.S. effectively connected income received by a Non-U.S. Holder that is a corporation may also, under certain circumstances, be subject to an
additional "branch profits tax" at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder's country of residence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
constructive distributions or distributions made in common stock to a Non-U.S. Holder would not give rise to any cash from which any applicable withholding tax could be
satisfied, we (or an applicable withholding agent) will withhold such taxes from shares of common stock or current or subsequent payments of cash to such Non-U.S. Holder. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the amount of a distribution exceeds our current and accumulated earnings and profits, such excess first will be treated as a tax-free return of capital to the extent of a Non-U.S.
Holder's adjusted tax basis in its shares of Mandatory Convertible Preferred Stock or our common stock, and thereafter will be treated as capital gain. See "&#151;Gain on Sale or Other Taxable
Disposition" below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-66</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=70,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=766667,FOLIO='S-66',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_67"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Gain on Sale or Other Taxable Disposition  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the discussions above under "&#151;Distributions," and below under "&#151;Information Reporting and Backup
Withholding," a Non-U.S. Holder generally will not be subject to U.S. federal income tax on gain recognized on a disposition of our Mandatory Convertible Preferred Stock or our common stock
unless:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the gain is effectively connected with the Non-U.S. Holder's conduct of a trade or business in the United States and, if an applicable income
tax treaty so provides, the gain is attributable to a permanent establishment or fixed base maintained by the Non-U.S. Holder in the United States; in these cases, the Non-U.S. Holder will be taxed on
a net income basis at the same U.S. federal income tax rates applicable to United States persons (as defined in the Code), and if the Non-U.S. Holder is a foreign corporation, an additional branch
profits tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty, may also apply; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Non-U.S. Holder is a nonresident alien present in the United States for 183&nbsp;days or more in the taxable year of the disposition and
certain other requirements are met, in which case the Non-U.S. Holder will be subject to a 30% tax (or such lower rate as may be specified by an applicable income tax treaty) on the net gain derived
from the disposition, which may be offset by U.S.-source capital losses of the Non-U.S. Holder, if any; provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to
such losses; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we are, or have been at any time during the five-year period preceding such disposition (or the Non-U.S. Holder's holding period, if shorter),
a "United States real property holding corporation." We believe that we are not currently, and we do not anticipate becoming, a "United States real property holding corporation." </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conversion of Mandatory Convertible Preferred Stock into Common Stock  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Non-U.S. Holder generally will not recognize gain or loss upon the conversion of Mandatory Convertible Preferred Stock into our common stock,
except that (1)&nbsp;cash received upon conversion in lieu of a fractional share of common stock generally will be treated as a payment in a taxable exchange for such fractional share of common
stock and will be subject to the treatment described above under "&#151;Gain on Sale or Other Taxable Disposition," (2)&nbsp;cash or common stock received in respect of accrued and unpaid
dividends that have been declared should be treated in the manner described above under "&#151;Tax Considerations Applicable to U.S. Holders&#151;Conversion of Mandatory Convertible
Preferred Stock into Common Stock," and (3)&nbsp;cash or common stock received in respect of accrued and unpaid dividends that have not been declared or any fundamental change dividend make-whole
amount should be treated in the manner described above under "&#151;Tax Considerations Applicable to U.S. Holders&#151;Conversion of Mandatory Convertible Preferred Stock into Common
Stock." In
the case of payments described in (2), a Non-U.S. Holder should expect a withholding agent to withhold tax from such amounts, as described above under "&#151;Distributions." In the case of
payments described in (3), the tax treatment of such amounts is uncertain, and therefore a withholding agent may withhold 30% of such amount as described under "&#151;Distributions." Non-U.S.
Holders should consult their tax advisors to determine the specific tax consequences to them. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Adjustments to Conversion Rate  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described above under "&#151;Tax Considerations Applicable to U.S. Holders&#151;Adjustments to Conversion Rate," adjustments in
the conversion rate (or failures to adjust the conversion rate) of our Mandatory Convertible Preferred Stock that result in an increase in the proportionate interest of a Non-U.S. Holder in our assets
or earnings and profits could result in deemed distributions to the Non-U.S. Holder that are taxed as described under "&#151;Distributions." It is possible that any </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-67</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=71,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=662124,FOLIO='S-67',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_68"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>withholding
tax on such a deemed distribution could be withheld from cash dividends, shares of our common stock or sale proceeds subsequently paid or credited to such Non-U.S. Holder. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, distributions in respect of the Mandatory Convertible Preferred Stock or common stock to a Non-U.S. Holder and the amount of any tax
withheld from such payments must be reported annually to the IRS and to the Non-U.S. Holder. Copies of these information returns may be made available by the IRS to the tax authorities of the country
in which the Non-U.S. Holder is a resident under the provisions of an applicable income tax treaty. Under certain circumstances, backup withholding of U.S. federal income tax may apply to
distributions in respect of the Mandatory Convertible Preferred Stock or common stock to a Non-U.S. Holder if the Non-U.S. Holder fails to certify under penalties of perjury that it is not a United
States person. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
of the proceeds of the sale or other disposition of Mandatory Convertible Preferred Stock or common stock to or through a foreign office of a U.S. broker or of a foreign broker
with certain specified U.S. connections will be subject to information reporting requirements, but generally not backup withholding, unless (i)&nbsp;the broker has evidence in its records that the
payee is not a United States person, and the broker has no actual knowledge or reason to know to the contrary or (ii)&nbsp;the payee otherwise establishes an exemption. Payments of the proceeds of a
sale or other disposition of Mandatory Convertible Preferred Stock or common stock to or through the U.S. office of a broker will be subject to information reporting and backup withholding unless the
payee certifies under penalties of perjury that it is not a United States person (and the payor has no actual knowledge or reason to know to the contrary) or otherwise establishes an exemption. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Backup
withholding is not an additional tax. Any amount withheld under the backup withholding rules generally will be allowed as a refund or credit against a Non-U.S. Holder's U.S.
federal income tax liability (if any); </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2> that the required information is timely furnished to the IRS. Non-U.S. Holders should consult their tax
advisors about the filing of a U.S. federal income tax return in order to obtain a refund. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FATCA  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders should be aware that, under Sections&nbsp;1471 through 1474 of the Code ("FATCA"), a 30% withholding tax will be imposed on certain
payments (which could include distributions in respect of the Mandatory Convertible Preferred Stock or common stock) to a foreign entity if such entity fails to satisfy certain disclosure and
reporting rules that in general require that (i)&nbsp;in the case of a foreign financial entity, the entity or a relating entity register with the IRS and identify and provide information in respect
of financial accounts with such entity held (directly or indirectly) by United States persons and United States owned foreign entities, and (ii)&nbsp;in the case of a non-financial foreign entity,
the entity identify and provide information in respect of substantial United States owners of such entity. Foreign entities that hold Mandatory Convertible Preferred Stock or common stock generally
will be subject to this tax unless they certify on an applicable IRS Form&nbsp;W-8 (generally, IRS Form&nbsp;W-8BEN-E) that they comply with, or are deemed to comply with, or are exempted from the
application of, these rules. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Various
requirements and exceptions are provided under FATCA and additional requirements and exceptions may be provided in subsequent guidance. Further, the United States has entered
into many intergovernmental agreements ("IGAs") with foreign governments relating to the implementation of, and information sharing under, FATCA and such IGAs may alter one or more of the FATCA
information reporting rules. Holders should consult their tax advisors regarding the potential application and impact of these requirements based on their particular circumstances. Particularly,
Non-U.S. Holders should consult their tax advisors regarding the possible implications of FATCA on </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-68</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=72,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=381883,FOLIO='S-68',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_69"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>their
investment in the Mandatory Convertible Preferred Stock or common stock and the entities through which they hold the Mandatory Convertible Preferred Stock or common stock. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>The preceding discussion of material U.S. federal tax considerations is for prospective investors' information only. It is not tax advice. Prospective investors
should consult their own tax advisors regarding the particular U.S. federal, state, local, and non-U.S. tax consequences of the purchasing, converting, and disposing of the Mandatory Convertible
Preferred Stock or common stock, including the consequences of any proposed changes in applicable laws.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-69</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=73,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=6839,FOLIO='S-69',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<A NAME="page_co13305_1_70"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="co13305_certain_erisa_considerations"> </A>
<A NAME="toc_co13305_2"> </A>
<BR></FONT><FONT SIZE=2><B>  CERTAIN ERISA CONSIDERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of certain considerations associated with a purchase in this offering by (i)&nbsp;"employee benefit plans" within
the meaning of Section&nbsp;3(3) of the U.S. Employee Retirement Income Security Act of 1974, as amended ("ERISA") that are subject to Title I of ERISA, (ii)&nbsp;plans, individual retirement
accounts and other arrangements that are subject to Section&nbsp;4975 of the Code or provisions under any federal, state, local, non-U.S. or other laws or regulations that are similar to such
provisions of the Code or ERISA (collectively, "Similar Laws"), and (iii)&nbsp;entities whose underlying assets are considered to include the assets of any of the foregoing described in
clauses&nbsp;(i) and (ii)&nbsp;(each of the foregoing described in clauses&nbsp;(i), (ii)&nbsp;and (iii)&nbsp;referred to herein as a "Plan"). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General Fiduciary Matters  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ERISA and the Code impose certain duties on persons who are fiduciaries of a Plan subject to Title I of ERISA or Section&nbsp;4975 of the Code
(a "Covered Plan") and prohibit certain transactions involving the assets of a Covered Plan and its fiduciaries or other interested parties. Under
ERISA and the Code, any person who exercises any discretionary authority or control over the administration of such a Covered Plan or the management or disposition of the assets of such a Covered
Plan, or who renders investment advice for a fee or other compensation to such a Covered Plan, is generally considered to be a fiduciary of the Covered Plan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
considering an investment in this offering of a portion of the assets of any Plan, a fiduciary should determine whether the investment is in accordance with the documents and
instruments governing the Plan and the applicable provisions of ERISA, the Code or any Similar Law relating to a fiduciary's duties to the Plan including, without limitation, the prudence,
diversification, delegation of control and prohibited transaction provisions of ERISA, the Code and any other applicable Similar Laws. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Prohibited Transaction Issues  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;406 of ERISA and Section&nbsp;4975 of the Code prohibit Covered Plans from engaging in specified transactions involving plan
assets with persons or entities who are "parties in interest," within the meaning of ERISA, or "disqualified persons," within the meaning of Section&nbsp;4975 of the Code, unless an exemption is
available. A party in interest or disqualified person who engaged in a non-exempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code. In
addition, the fiduciary of the Covered Plan that engaged in such a non-exempt prohibited transaction may be subject to penalties and liabilities under ERISA and the Code. An acquisition in this
offering by a Covered Plan with respect to which the Company or an underwriter or any of their respective affiliates is considered a party in interest or a disqualified person may constitute or result
in a direct or indirect prohibited transaction under Section&nbsp;406 of ERISA and/or Section&nbsp;4975 of the Code, unless the investment is acquired in accordance with an applicable statutory,
class or individual prohibited transaction exemption. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plans
that are governmental plans, certain church plans and non-United States plans, while not subject to the fiduciary responsibility provisions of ERISA or the prohibited transaction
provisions of ERISA and Section&nbsp;4975 of the Code, may nevertheless be subject to Similar Laws. Fiduciaries of any such Plans should consult with their advisors before purchasing in this
offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
foregoing discussion is general in nature and is not intended to be all inclusive. Due to the complexity of these rules and the penalties that may be imposed upon persons involved in
non-exempt prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing in this offering on behalf of, or with the assets of, any Plan, consult with
their legal advisors regarding the potential applicability of ERISA, Section&nbsp;4975 of the Code and any Similar Laws to such investment and whether an exemption would be applicable to a purchase
in this offering. Neither the Company, the underwriters nor any of their respective representatives or affiliates make any representation as to whether an investment in this offering is appropriate
for Plans in general or for any particular Plan or arrangement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-70</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=74,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=731008,FOLIO='S-70',FILE='DISK104:[20ZCM5.20ZCM13305]CO13305A.;7',USER='DSLOAN',CD='20-MAY-2020;12:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cq13305_1_71"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cq13305_underwriting_(conflicts_of_interest)"> </A>
<A NAME="toc_cq13305_1"> </A>
<BR></FONT><FONT SIZE=2><B>  UNDERWRITING (CONFLICTS OF INTEREST)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are offering the shares of Mandatory Convertible Preferred Stock described in this prospectus through a number of underwriters. J.P. Morgan
Securities&nbsp;LLC and BofA Securities,&nbsp;Inc. are acting as joint book-running managers of the offering and as representatives of the underwriters. We have entered into an underwriting
agreement with the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase,
at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of shares of Mandatory Convertible Preferred Stock listed next
to its name in the following table: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>J.P. Morgan Securities&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BofA Securities,&nbsp;Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters are committed to purchase all the shares of Mandatory Convertible Preferred Stock offered by us if they purchase any shares. The underwriting agreement also provides
that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters propose to offer the shares of Mandatory Convertible Preferred Stock directly to the public at the initial public offering price set forth on the cover page of this
prospectus supplement and to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the initial offering of the shares to the public, if all of the
shares
of Mandatory Convertible Preferred Stock are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. Sales of any shares made outside
of the United States may be made by affiliates of the underwriters. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters have an option to buy up to 1,125,000 additional shares of Mandatory Convertible Preferred Stock from us to cover sales of shares by the underwriters which exceed the
number of
shares specified in the table above, solely to cover over-allotments. The underwriters have 30&nbsp;days from the date of this prospectus supplement to exercise this option to purchase additional
shares. If any shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any
additional shares of Mandatory Convertible Preferred Stock are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriting fee is equal to the public offering price per share less the amount paid by the underwriters to us per share. The underwriting fee is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. The
following table shows the per share and total underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters' option to purchase
additional shares. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Without<BR>
option to<BR>
purchase<BR>
additional<BR>
shares<BR>
exercise </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>With full<BR>
option to<BR>
purchase<BR>
additional<BR>
shares<BR>
exercise </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Per Share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-71</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=75,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=10617,FOLIO='S-71',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_72"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting
discounts and commissions, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The
underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the
representatives to underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have agreed that we will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Securities and Exchange Commission a registration statement under the
Securities Act relating to, any shares of our common stock or securities convertible into or exercisable or exchangeable for any shares of our common stock, or publicly disclose the intention to make
any offer, sale, pledge, loan, disposition or filing, or (ii)&nbsp;enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership
of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in
cash or otherwise), in each case without the prior written consent of
J.P. Morgan Securities&nbsp;LLC and BofA Securities,&nbsp;Inc. for a period of 90&nbsp;days after the date of this prospectus, other than the shares of Mandatory Convertible Preferred Stock to
be sold in this offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
restrictions on our actions, as described above, do not apply to certain transactions, including (i)&nbsp;the issuance of shares of common stock or securities convertible into or
exercisable for shares of our common stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the
settlement of restricted stock units ("RSUs") (including net settlement), in each case outstanding on the date of the underwriting agreement and described in this prospectus; (ii)&nbsp;grants of
stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable for shares of
our common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in
effect as of the closing of this offering and described in this prospectus, provided that such recipients enter into a lock-up agreement with the underwriters; (iii)&nbsp;the issuance of shares of
our common stock to be sold in the Concurrent Offering; (iv)&nbsp;the issuance of up to 2.5% of the outstanding shares of our common stock, or securities convertible into, exercisable for, or which
are otherwise exchangeable for, our common stock, immediately following the closing of this offering, in acquisitions or other similar strategic transactions, provided that such recipients enter into
a lock-up agreement with the underwriters; or (v)&nbsp;our filing of any registration statement on Form&nbsp;S-8 relating to securities granted or to be granted pursuant to any plan in effect on
the date of the underwriting agreement and described in this prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic transaction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
directors and executive officers (such persons, the "lock-up parties") have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant
to which each lock-up party, with limited exceptions, for a period of 90&nbsp;days after the date of this prospectus (such period, the "restricted period"), may not (and may not cause any of their
direct or indirect affiliates to), without the prior written consent of J.P. Morgan Securities&nbsp;LLC and BofA Securities,&nbsp;Inc., (1)&nbsp;offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of
our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-72</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=76,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=688392,FOLIO='S-72',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_73"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>such
other securities which may be deemed to be beneficially owned by such lock-up parties in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a
stock option or warrant (collectively with the common stock, the "lock-up securities")), (2)&nbsp;enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part,
any of the economic consequences of ownership of the lock-up securities, whether any such transaction described in clause&nbsp;(1) or (2)&nbsp;above is to be settled by delivery of lock-up
securities, in cash or otherwise, (3)&nbsp;make any demand for, or exercise any right with respect to, the registration of any lock-up securities, or (4)&nbsp;publicly disclose the intention to do
any of the foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other
transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other
derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (by any
person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such
transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or otherwise. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
restrictions described in the immediately preceding paragraph and contained in the lock-up agreements between the underwriters and the lock-up parties do not apply, subject in
certain cases to various conditions, to certain transactions, including (a)&nbsp;transfers of lock-up securities: (i)&nbsp;as bona fide gifts, or for bona fide estate planning purposes,
(ii)&nbsp;by will or intestacy, (iii)&nbsp;to any trust for the direct or indirect benefit of the lock-up party or any immediate family member or if the lock-up party is a trust, to a trustor or
beneficiary of the trust or to the estate of a beneficiary of such trust, (iv)&nbsp;to a partnership, limited liability company or other entity of which the lock-up party and its immediate family
members are the legal and beneficial owner of all of the outstanding equity securities or similar interests, (v)&nbsp;to a nominee or custodian of a person or entity to whom a disposition or
transfer would be permissible under clauses&nbsp;(i) through (iv), (vi)&nbsp;if the lock-up party is a corporation, partnership, limited liability company, trust or other business entity,
(A)&nbsp;to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule&nbsp;405 promulgated under the Securities Act) of
the lock-up party, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the lock-up party or its affiliates (including, for the
avoidance of doubt, where the lock-up party is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership) or (B)&nbsp;as part of a
distribution to members or stockholders of the lock-up party; (vii)&nbsp;by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation
agreement, (viii)&nbsp;to us from an employee upon death, disability or termination of employment of such employee, (ix)&nbsp;as part of a sale of lock-up securities acquired in open market
transactions after the completion of this offering, (x)&nbsp;to us in connection with the vesting, settlement or exercise of restricted stock units, options, warrants or other rights to purchase
shares of our common stock (including "net" or "cashless" exercise), including for the payment of exercise price and tax and remittance payments, (xi)&nbsp;pursuant to a bona fide third-party tender
offer, merger, consolidation or other similar transaction approved by our board of directors and made to all stockholders involving a change in control, provided that if such transaction is not
completed, all such lock-up securities would remain subject to the restrictions in the immediately preceding paragraph; or (xii)&nbsp;pursuant to a trading plan pursuant to Rule&nbsp;10b5-1 under
the Exchange Act that was in effect as of, and only shares scheduled for sale thereunder on, the date of this prospectus supplement; (b)&nbsp;exercise of the options, settlement of RSUs or other
equity awards, or the exercise of warrants outstanding as of the date granted pursuant to plans described in in this prospectus, provided that any lock-up securities received upon such exercise,
vesting or settlement would be subject to restrictions similar to those in the immediately preceding paragraph; (c)&nbsp;the conversion of outstanding preferred stock, warrants to acquire preferred
stock, or convertible </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-73</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=77,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=841980,FOLIO='S-73',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_74"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>securities
into shares of our common stock or warrants to acquire shares of our common stock, provided that any common stock or warrant received upon such conversion would be subject to restrictions
similar to those in the immediately preceding paragraph; and (d)&nbsp;the establishment by lock-up parties of trading plans under Rule&nbsp;10b5-1 under the Exchange Act, provided that such plan
does not provide for the transfer of lock-up securities during the restricted period. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;J.P.
Morgan Securities&nbsp;LLC and BofA Securities,&nbsp;Inc., in their sole discretion, may release the securities subject to any of the lock-up agreements with the underwriters
described above, in whole or in part at any time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to this offering, there has been no public market for our Mandatory Convertible Preferred Stock. We intend to apply to list the Mandatory Convertible Preferred Stock on NYSE under
the symbol "BSX PR A." Our common stock is listed on the NYSE under the symbol "BSX." </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
order to facilitate the offering of the Mandatory Convertible Preferred Stock, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of
the Mandatory Convertible Preferred Stock. Specifically, the underwriters may sell more shares than they are obligated to purchase under the underwriting agreement, creating a short position. A short
sale is covered if the short position is no greater than the number of shares available for purchase by the underwriters under the option. The underwriters can close out a covered short sale by
exercising the option or purchasing shares in the open market. In determining the source of shares to close out a covered short sale, the underwriters will consider, among other things, the open
market price of shares compared to the price available under the option. The underwriters may also sell shares in excess of the option, creating a naked short position. The underwriters must close out
any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price
of the Mandatory Convertible Preferred Stock in the open market after pricing that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering,
the underwriters may bid for, and purchase, shares of the Mandatory Convertible Preferred Stock in the open market to stabilize the price of the Mandatory Convertible Preferred Stock. These activities
may raise or maintain the market price of the Mandatory Convertible Preferred Stock above independent market levels or prevent or retard a decline in the market price of the Mandatory Convertible
Preferred Stock. The underwriters are not required to engage in these activities and may end any of these activities at any time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction
where action for that
purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in
connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and
regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the
distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such
an offer or a solicitation is unlawful. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters have performed commercial banking, investment banking and advisory services for us from time to time for which they have received customary fees and expenses. The
underwriters and their affiliates may, from time to time, engage in transactions with and perform services for us in the ordinary course of their business. Affiliates of the underwriters, including
J.P. Morgan Securities&nbsp;LLC and BofA Securities,&nbsp;Inc., are lenders under certain of our credit facilities. Affiliates of certain underwriters will receive at least 5% of the net proceeds
from this offering and the Concurrent </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-74</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=78,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=892249,FOLIO='S-74',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_75"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Offering
in connection with the repayment of borrowings under our April 2021 Term Loan. In addition, certain of the underwriters (or their affiliates) may hold our outstanding borrowings under our
credit agreements and/or debt securities, and to the extent such debt is repaid, repurchased or redeemed with the proceeds of this offering, such underwriters would receive a portion of the proceeds
of this offering in respect of such borrowings or securities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities
may involve securities and/or instruments of ours or our affiliates. If any of the underwriters or their affiliates have a lending relationship with us, certain of those underwriters or their
affiliates routinely hedge, and certain of those underwriters or their affiliates may hedge, their credit exposure to us consistent with their customary risk management policies. The underwriters and
their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to
clients that they acquire, long and/or short positions in such securities and instruments </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conflicts of Interest  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliates of certain underwriters will receive at least 5% of the net proceeds of this offering and the Concurrent Offering in connection with
the repayment of borrowings under our April 2021 Term Loan. See "Use of Proceeds." Accordingly, this offering is being made in compliance with the requirements of FINRA Rule&nbsp;5121. Because such
underwriters are not primarily responsible for managing this offering, pursuant to FINRA Rule&nbsp;5121, the appointment of a qualified independent underwriter is not necessary. Any underwriter with
a conflict of interest, as defined under FINRA Rule&nbsp;5121, will not confirm sales of the Mandatory Convertible Preferred Stock to any account over which they exercise discretionary authority
without the prior written approval of the customer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selling Restrictions  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares are offered for sale in the United States and certain jurisdictions outside the United States where such offer and sale is permitted. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Canada  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument&nbsp;45-106 </FONT><FONT SIZE=2><I>Prospectus Exemptions</I></FONT><FONT SIZE=2> or subsection&nbsp;73.3(1) of the </FONT><FONT SIZE=2><I>Securities
Act</I></FONT><FONT SIZE=2> (Ontario), and are permitted clients, as defined in National Instrument&nbsp;31-103 </FONT><FONT SIZE=2><I>Registration Requirements, Exemptions and Ongoing Registrant
Obligations</I></FONT><FONT SIZE=2>. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable
securities laws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement or the accompanying
prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the
securities legislation of the purchaser's province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province or territory for
particulars of these rights or consult with a legal advisor. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to section&nbsp;3A.3 of National Instrument&nbsp;33-105 </FONT><FONT SIZE=2><I>Underwriting Conflicts</I></FONT><FONT SIZE=2> ("NI&nbsp;33-105"), the Agents are not
required to comply with the disclosure requirements of NI&nbsp;33-105 regarding underwriter conflicts of interest in connection with this offering. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-75</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=79,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=828062,FOLIO='S-75',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_76"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


European Economic Area and the United Kingdom  </I></B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


PRIIPs Regulation/Prohibition of sales to EEA and UK retail investors  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to
any retail investor in the European Economic Area ("EEA") or in the United Kingdom ("UK"). For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as
defined in point (11)&nbsp;of Article&nbsp;4(1) of Directive 2014/65/EU (as amended, "MiFID II"); (ii)&nbsp;a customer within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance
Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10)&nbsp;of Article&nbsp;4(1) of MiFID II; or (iii)&nbsp;not a qualified investor as
defined in Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation"). Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation")
for offering or selling the shares or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore offering or selling the shares or otherwise making
them available to any retail investor in the EEA or in the UK may be unlawful under the PRIIPs Regulation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
prospectus supplement has been prepared on the basis that any offer of shares in any Member State of the EEA or in the UK will be made pursuant to an exemption under the Prospectus
Regulation from the requirement to publish a prospectus for offers of shares. This prospectus supplement is not a prospectus for the purposes of the Prospectus Regulation. Neither the Company nor the
underwriters have authorized, nor do they authorize, the making of any offer of shares through any financial intermediary, other than offers made by the underwriters, which constitute the final
placement of the shares contemplated in this prospectus supplement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
person located in a Member State of the EEA or in the UK to whom any offer of shares is made or who receives any communication in respect of an offer of shares, or who initially
acquires any shares, or to whom the shares are otherwise made available, will be deemed to have represented, warranted, acknowledged and agreed to and with each underwriter and the Company that it and
any person on whose behalf it acquires shares is: (1)&nbsp;a "qualified investor" within the meaning of Article&nbsp;2(e) of the Prospectus regulation; and (2)&nbsp;not a "retail investor" (as
defined above). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;References
in this section to Regulations or Directives include, in relation to the UK, those Regulations or Directives as they form part of UK domestic law by virtue of the European
Union (Withdrawal) Act 2018, as amended, or have been implemented in UK domestic law, as appropriate. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


United Kingdom  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus supplement is for distribution only to and is directed only at (i)&nbsp;persons having professional experience in matters
relating to investments falling within Article&nbsp;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"),
(ii)&nbsp;persons falling within Article&nbsp;49(2)(a) to (d)&nbsp;("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order, (iii)&nbsp;persons outside
of the United Kingdom, or (iv)&nbsp;persons to whom an invitation or inducement to engage in investment activity (within the meaning of section&nbsp;21 of the Financial Services and Markets Act
2000 (as amended, the "FSMA")) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to
as "relevant persons"). This prospectus supplement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment
activity to which this prospectus supplement relates is available only to relevant persons and will be engaged in only with relevant persons. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-76</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=80,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=790907,FOLIO='S-76',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_77"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Hong Kong  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may not be offered or sold in Hong Kong by means of any document other than (i)&nbsp;to "professional investors" as defined in the
Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (the "SFO") and any rules made thereunder or (ii)&nbsp;in other circumstances which do not result in the document being a
"prospectus" as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) and which do not constitute an offer to the public within the meaning of
that Ordinance; and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purposes of issue (in each case whether in Hong Kong
or elsewhere) which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong or otherwise is or contains an invitation to the public (except if permitted
to do so under the laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" as defined in
the SFO and any rules made thereunder. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Japan  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as
amended) (the "FIEL"), and, accordingly, will not be offered or sold directly or indirectly, in Japan or to, or for the account or benefit of, any Japanese Person or to others for
re-offering or resale, directly or indirectly, in Japan or to, or for the account or benefit of, a Japanese Person, except pursuant to an exemption from the registration requirements of, and otherwise
in compliance with, the FIEL and other applicable laws, regulations and ministerial guidelines promulgates by the relevant Japanese governmental or regulatory authorities in effect at the relevant
time. For the purpose of this paragraph "Japanese Person" means any person resident in Japan, including any corporation or other entity incorporated or organized under the laws of Japan. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Singapore  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus supplement and the accompanying prospectus have not been and will not be registered as a prospectus with the Monetary Authority
of Singapore under the Securities and Futures Act, Chapter&nbsp;289 of Singapore (the "SFA"). Accordingly, each underwriter has not offered or sold any shares or caused such shares to be made the
subject of an invitation for subscription or purchase and will not offer or sell such shares or cause such shares to be made the subject of an invitation for subscription or purchase, and has not
circulated or distributed, nor will it circulate or distribute, this prospectus supplement, the accompanying prospectus or any other document or material
in connection with the offer or sale, or invitation for subscription or purchase, of such shares, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional
investor under Section&nbsp;274 of the SFA, (ii)&nbsp;to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the
conditions, specified in Section&nbsp;275, of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where
the shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: (a)&nbsp;a corporation (which is not an accredited investor (as defined
in Section&nbsp;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor;
or (b)&nbsp;a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,
securities (as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferred within six months
after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: (1)&nbsp;to an institutional investor under Section&nbsp;274 of
the SFA or to a relevant person (as defined in Section&nbsp;275(2) of the SFA), or to any person arising from an offer referred to in Section&nbsp;275(1A), or Section&nbsp;276(4)(i)(B) of the
SFA; (2)&nbsp;where no </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-77</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=81,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=484437,FOLIO='S-77',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_78"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>consideration
is or will be given for the transfer; (3)&nbsp;where the transfer is by operation of law; (4)&nbsp;as specified in Section&nbsp;276(7) of the SFA; or (5)&nbsp;as specified in
Regulation&nbsp;37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations&nbsp;2018 of Singapore. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Singapore
SFA Product Classification&#151;In connection with Section&nbsp;309B of the SFA and the Securities and Futures (Capital Markets Products) Regulations&nbsp;2018 (the
"CMP Regulations&nbsp;2018"), the Company has determined, and hereby notifies all relevant persons (as defined in the CMP Regulations&nbsp;2018), that the shares are "prescribed capital markets
products" (as defined in the CMP Regulations&nbsp;2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16:
Notice on Recommendations on Investment Products). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Switzerland  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act ("FinSA")
and no application has been or will
be made to admit the shares to trading on any trading venue (exchange or multilateral trading facility) in Switzerland. Neither this prospectus supplement nor any other offering or marketing material
relating to the shares constitutes a prospectus pursuant to the FinSA, and neither this prospectus supplement nor any other offering or marketing material relating to the shares may be publicly
distributed or otherwise made publicly available in Switzerland. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Taiwan  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and
regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of
Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise
intermediate the offering and sale of the shares in Taiwan. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Republic of Korea  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees
and regulations thereunder (the "FSCMA"), and the shares have been and will be offered in Korea as a private placement under the FSCMA. None of the shares may be offered, sold or delivered directly or
indirectly, or offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea,
including the FSCMA and the Foreign Exchange Transaction Law of Korea and the decrees and regulations thereunder (the "FETL"). Furthermore, the purchaser of the shares shall comply with
all applicable regulatory requirements (including but not limited to requirements under the FETL) in connection with the purchase of the shares. By the purchase of the shares, the relevant holder
thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased the shares pursuant to the applicable laws and regulations of Korea. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-78</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=82,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=771017,FOLIO='S-78',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_79"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="leg"></A>LEGAL MATTERS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain legal matters in connection with the offering of the Mandatory Convertible Preferred Stock will be passed upon for us by
Shearman&nbsp;&amp; Sterling&nbsp;LLP, New York, New York. Certain legal matters in connection with the offering of the Mandatory Convertible Preferred Stock will be passed upon for the underwriters
by Simpson Thacher&nbsp;&amp; Bartlett&nbsp;LLP, New York, New York. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="exp"></A>EXPERTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Boston Scientific Corporation appearing in Boston Scientific Corporation's
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">Annual Report (Form&nbsp;10-K) for the year ended December&nbsp;31, 2019</A>
(including the schedule appearing therein), and the effectiveness of Boston Scientific Corporation's internal control over financial reporting as of December&nbsp;31, 2019 have been audited by
Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated
financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-79</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=83,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=193530,FOLIO='S-79',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<A NAME="page_cq13305_1_80"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="where"></A>WHERE YOU CAN FIND MORE INFORMATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the informational requirements of the Exchange Act, and, in accordance therewith, we file annual, quarterly and current
reports, proxy statements and other information with the SEC. Our SEC filings are available on the SEC's website at </FONT><FONT SIZE=2><I>http://www.sec.gov</I></FONT><FONT SIZE=2>. You can also
find information about us by visiting our website at </FONT><FONT SIZE=2><I>www.bostonscientific.com</I></FONT><FONT SIZE=2>. We have included our website address as an inactive textual reference
only. Information on, or accessible through, our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Incorporation by Reference  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are "incorporating by reference" specific documents that we file with the SEC, which means that we can disclose important information to you
by referring you to those documents that are considered part of this prospectus supplement and the accompanying prospectus. Information that we file subsequently with the SEC will automatically update
and supersede this information. We incorporate by reference the documents listed below, and any documents that we file with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act,
after the date of this prospectus supplement until the offering of our Mandatory Convertible Preferred Stock under this prospectus supplement and prospectus is terminated or completed (excluding any
portions of such documents that have been "furnished" but not "filed" for purposes of the Exchange Act):</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>  <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">our Annual Report on Form&nbsp;10-K
for the fiscal year ended December&nbsp;31, 2019, filed on February&nbsp;25, 2020;</A></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>  <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">our Quarterly Report on
Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2020, filed on May&nbsp;6, 2020;</A></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our Current Reports on Form&nbsp;8-K filed on
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000007/a8-kfebruary2020.htm">February&nbsp;5, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000156/ss167320_8k.htm">February&nbsp;27, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000017/a8-kapril2020.htm">April&nbsp;2, 2020</A> (Item&nbsp;5.02 only),
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000110465920045409/tm2015475-1_8k.htm">April&nbsp;10, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_8k.htm">April&nbsp;21, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000024/a8-kmay2020.htm">May&nbsp;12, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000110465920061823/tm2019839d1_8k.htm">May&nbsp;15, 2020</A> and
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_8k.htm">May&nbsp;18, 2020</A>; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> portions of our <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000104746920001770/a2241016zdef14a.htm">Proxy Statement on
Schedule&nbsp;14A, filed on March&nbsp;25, 2020</A>, that are incorporated by reference into Part&nbsp;III of our
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">2019 Form&nbsp;10-K.</A> </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
may also request a copy of these filings (other than certain exhibits), at no cost, by writing or telephoning our investor relations department at the following address: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Boston
Scientific Corporation<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752-1234<BR>
Attention: Investor Relations<BR>
Telephone: (508)&nbsp;683-5565<BR>
Email: BSXInvestorRelations@bsci.com </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
supplement and the accompanying prospectus to the extent that a statement contained herein or therein, in any other subsequently filed document that also is or is deemed to be incorporated by
reference herein, modifies or supersedes such statement. Any statement so modified or superseded
shall not be deemed, except as so modified and superseded, to constitute a part of this prospectus supplement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
statement made in this prospectus supplement and the accompanying prospectus concerning the contents of any contract, agreement or other document is only a summary of the actual
contract, agreement or other document. If we have filed or incorporated by reference any contract, agreement or other document as an exhibit to the registration statement, you should read the exhibit
for a more complete understanding of the document or matter involved. Each statement regarding a contract, agreement or other document is qualified by reference to the actual document. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-80</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=84,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=853474,FOLIO='S-80',FILE='DISK104:[20ZCM5.20ZCM13305]CQ13305A.;12',USER='JTAYLORA',CD='20-MAY-2020;13:03' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>PROSPECTUS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g364601.jpg" ALT="LOGO" WIDTH="253" HEIGHT="111">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="bc13301_common_stock_preferred_stock"> </A>
<A NAME="toc_bc13301_1"> </A>
<BR>  </B></FONT><FONT SIZE=4><B>Common Stock  <BR>    Preferred Stock  <BR>  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
securities covered by this prospectus may be sold from time to time by Boston Scientific Corporation (the "Company") in one or more offerings, including an indeterminate number of
common stock, par value $0.01 per share, of the Company that may be issued upon conversion, exchange or settlement of, or as dividends on, preferred stock, par value $0.01 per share, of the Company
offered or sold hereunder. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
we offer securities, we will provide you with a prospectus supplement describing the specific terms of the specific issue of securities, including the offering price of the
securities. You should carefully read this prospectus and the prospectus supplement relating to the specific issue of securities, as well as the documents incorporated by reference herein or therein,
before you decide to invest in any of these securities. This prospectus may not be used to offer or sell any securities unless accompanied by a prospectus supplement. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "BSX." On May&nbsp;19, 2020, the closing price of our common stock on the NYSE was $35.43 per share. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=3><B>Investing in our securities involves risks. See "Forward-Looking Statements" on page&nbsp;3 and the risks described in the "Risk Factors" on
page&nbsp;4 of this prospectus, the "Risk Factors" section of our periodic reports that we file with the Securities and Exchange Commission and any applicable prospectus supplement before investing
in any of our securities.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or
adequacy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may offer and sell securities to or through underwriters, dealers or agents as designated from time to time, or directly to one or more other purchasers or through a combination of
such methods. See "Plan of Distribution." If any underwriters, dealers or agents are involved in the sale of any of the securities, their names, and any applicable purchase price, fee, commission or
discount arrangements between or among them, will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>The
date of this prospectus is May&nbsp;20, 2020. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=85,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=309627,FOLIO='blank',FILE='DISK126:[20ZCM1.20ZCM13301]BC13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:08' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="BG13301A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> Table of Contents  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG13301_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_about_this_prospectus"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ABOUT THIS PROSPECTUS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_about_this_prospectus"><FONT SIZE=2>1</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_where_you_can_find_more_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_where_you_can_find_more_information"><FONT SIZE=2>2</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_forward-looking_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FORWARD-LOOKING STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_forward-looking_statements"><FONT SIZE=2>3</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_risk_factors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RISK FACTORS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_risk_factors"><FONT SIZE=2>4</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_boston_scientific_corporation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BOSTON SCIENTIFIC CORPORATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_boston_scientific_corporation"><FONT SIZE=2>5</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_use_of_proceeds"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>USE OF PROCEEDS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_use_of_proceeds"><FONT SIZE=2>5</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#da13301_description_of_capital_stock"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#da13301_description_of_capital_stock"><FONT SIZE=2>6</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_plan_of_distribution"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PLAN OF DISTRIBUTION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_plan_of_distribution"><FONT SIZE=2>10</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_legal_matters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LEGAL MATTERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_legal_matters"><FONT SIZE=2>12</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#dc13301_experts"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPERTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#dc13301_experts"><FONT SIZE=2>12</FONT></A></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=86,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=523602,FOLIO='blank',FILE='DISK126:[20ZCM1.20ZCM13301]BG13301A.;4',USER='JTAYLORA',CD='20-MAY-2020;08:46' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_da13301_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_about_this_prospectus"> </A>
<A NAME="toc_da13301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  ABOUT THIS PROSPECTUS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the "SEC") using the "shelf"
registration process. Under this shelf process, we may sell the securities described in this prospectus in one or more offerings. This prospectus provides you with a general description of the
securities we may offer. Each time we sell securities, we will provide a prospectus supplement, which may be in the form of a term sheet, or other offering material that will contain specific
information about the terms of that offering and the specific terms of the securities. The prospectus supplement may also add to, update or change information contained in this prospectus and,
accordingly, to the extent inconsistent, information in this prospectus is superseded by the information in the prospectus supplement. You should read both this prospectus and any accompanying
prospectus supplement together with additional information described under the heading "Where You Can Find More Information" before making an investment decision. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
prospectus supplement will describe: the terms of the securities offered, any initial public offering price, the price paid to us for the securities, the net proceeds to us, the
manner of distribution and any underwriting compensation and the other specific material terms related to the offering of the securities. For more detail about the terms of the securities, you should
read the exhibits filed with or incorporated by reference in our registration statement of which this prospectus forms&nbsp;a part. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All
of the summaries are qualified in their entirety by the actual documents. Copies of the documents referred to herein have been filed, or will be filed or incorporated by reference as exhibits to the
registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under "Where You Can Find More Information." </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
we are a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities Act of 1933, as amended (the "Securities Act"), we may offer additional securities by filing
an automatically effective post-effective amendment to this registration statement with the SEC at the time of the offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not authorized any person to provide you with any information or to make any representation other than as contained in this prospectus or in any prospectus supplement and the
information incorporated by reference herein and therein. We do not take any responsibility for, and can provide no assurance as to the reliability of, any information that others may provide you. The
information appearing or incorporated by reference in this prospectus and any accompanying prospectus supplement is accurate only as of the date of this prospectus or any accompanying prospectus
supplement or the date of the document in which incorporated information appears. Our business, financial condition, results of operations and prospects may have changed since those dates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated or unless the context otherwise requires, all references in this prospectus to "Boston Scientific," the "Company," "we," "us," and "our" refer to Boston
Scientific Corporation and our consolidated subsidiaries. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=87,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=819685,FOLIO='1',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_where_you_can_find_more_information"> </A>
<A NAME="toc_da13301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  WHERE YOU CAN FIND MORE INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, in accordance
therewith, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available on the SEC's website at </FONT> <FONT SIZE=2><I>http://www.sec.gov</I></FONT><FONT SIZE=2>. You can also find
information about us by visiting our website at </FONT> <FONT SIZE=2><I>www.bostonscientific.com</I></FONT><FONT SIZE=2>. We have included our website address as an inactive textual reference only. Information on, or accessible through, our website
is not incorporated by reference into this registration statement or prospectus or any accompanying prospectus supplement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Incorporation by Reference  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus is part of a registration statement on Form&nbsp;S-3 that we filed with the SEC. We are "incorporating by reference" specific
documents that we file with the SEC, which means that we can disclose important information to you by referring you to those documents that are considered part of this prospectus. Information that we
file subsequently with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below, and any documents that we file with the SEC under
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date of this prospectus until the offering of all of the securities covered by a particular prospectus supplement has been
terminated or completed (excluding any portions of such documents that have been "furnished" but not "filed" for purposes of the Exchange Act):</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>  <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">our Annual Report on Form&nbsp;10-K
for the fiscal year ended December&nbsp;31, 2019, filed on February&nbsp;25, 2020 ("2019 Form&nbsp;10-K");</A></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>  <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000022/q12020form10-q.htm">our Quarterly Report on
Form&nbsp;10-Q for the fiscal quarter ended March&nbsp;31, 2020, filed on May&nbsp;6, 2020 ("Q1 2020 Form&nbsp;10-Q");</A></FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our Current Reports on Form&nbsp;8-K filed on
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000007/a8-kfebruary2020.htm">February&nbsp;5, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000156/ss167320_8k.htm">February&nbsp;27, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000017/a8-kapril2020.htm">April&nbsp;2, 2020</A> (Item&nbsp;5.02 only),
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000110465920045409/tm2015475-1_8k.htm">April&nbsp;10, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_8k.htm">April&nbsp;21, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000024/a8-kmay2020.htm">May&nbsp;12, 2020</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000110465920061823/tm2019839d1_8k.htm">May&nbsp;15, 2020</A> and
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_8k.htm">May&nbsp;18, 2020</A>; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>  <A HREF="http://www.sec.gov/Archives/edgar/data/885725/000104746920001770/a2241016zdef14a.htm">portions of our Proxy Statement on
Schedule&nbsp;14A, filed on March&nbsp;25, 2020, that are incorporated by reference into Part&nbsp;III of our 2019 Form&nbsp;10-K.</A> </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
may also request a copy of these filings (other than certain exhibits), at no cost, by writing or telephoning our investor relations department at the following address: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Boston
Scientific Corporation<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752-1234<BR>
Attention: Investor Relations<BR>
Telephone: (508)&nbsp;683-5565<BR>
Email: BSXInvestorRelations@bsci.com </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained herein, in any other subsequently filed document that also is or is deemed to be incorporated by reference herein or in any accompanying prospectus supplement,
modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified and superseded, to constitute a part of this prospectus. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
statement made in this prospectus concerning the contents of any contract, agreement or other document is only a summary of the actual contract, agreement or other document. If we
have filed or incorporated by reference any contract, agreement or other document as an exhibit to the registration statement, you should read the exhibit for a more complete understanding of the
document or matter involved. Each statement regarding a contract, agreement or other document is qualified by reference to the actual document. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=88,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=532189,FOLIO='2',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_forward-looking_statements"> </A>
<A NAME="toc_da13301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus, any accompanying prospectus supplement and the documents incorporated by reference herein or therein contain or incorporate by
reference statements that may constitute "forward-looking statements" within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. Forward-looking
statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend," "aiming" and similar words. These forward-looking statements are based on our
beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be
incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. As a
result, investors are cautioned not to place undue reliance on any of our forward-looking statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
forward-looking statements in this prospectus, any accompanying prospectus supplement and the documents incorporated by reference herein or therein are based on certain risks and
uncertainties, including the risk factors described in Part&nbsp;I, Item&nbsp;1A. under the heading "Risk Factors" in our 2019 Form&nbsp;10-K and in Part&nbsp;II, Item&nbsp;1A. under the
heading "Risk Factors" in our Q1 2020 Form&nbsp;10-Q and in connection with forward-looking statements throughout our 2019 Form&nbsp;10-K and Q1 2020 Form&nbsp;10-Q, as well as in any other
document we may file with the SEC that is incorporated by reference herein, and the specific risk factors discussed in this prospectus and in any accompanying prospectus supplement which could cause
actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the
future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the forward-looking statements. Risks and
uncertainties that may cause such differences include, among other things: future economic, political, competitive, reimbursement and regulatory conditions, new product introductions and the market
acceptance of those products, markets for our products, expected pricing environment, expected procedural volumes, the closing and integration of acquisitions, clinical trial results, demographic
trends, intellectual property rights, litigation, financial market conditions, the execution and effect of our restructuring program, the execution and effect of our business strategy, including our
cost-savings and growth initiatives and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those
that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic. All of these factors are difficult or impossible to predict accurately and many of them are
beyond our control. We caution investors to consider carefully these factors. We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change
in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the
forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this prospectus. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
further discussion of these risks and uncertainties and other risk factors, see Part&nbsp;I, Item&nbsp;1A. in our 2019 Form&nbsp;10-K, under the heading "Risk Factors,"
Part&nbsp;II, Item&nbsp;1A. under the heading "Risk Factors" in our Q1 2020 Form&nbsp;10-Q and under the heading "Risk Factors" herein and in any accompanying prospectus supplement and in any
other document we may file with the SEC that is incorporated by reference herein and therein. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=89,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=267513,FOLIO='3',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_risk_factors"> </A>
<A NAME="toc_da13301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
business is subject to significant risks. You should carefully consider the risks and uncertainties set forth in Part&nbsp;I, Item&nbsp;1A. under the heading "Risk Factors"
included in our 2019 Form&nbsp;10-K and Part&nbsp;II, Item&nbsp;1A. under the heading "Risk Factors" in our Q1 2020 Form&nbsp;10-Q, which are incorporated by reference in this prospectus.
Additional risk factors that you should carefully consider also may be included in a prospectus supplement relating to an offering of our securities as well as the other documents filed with the SEC
that are incorporated by reference herein or therein. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
risks and uncertainties described in any accompanying prospectus supplement as well as the documents incorporated by reference herein or therein are not the only ones facing us.
Additional risks and uncertainties that we do not presently know about or that we currently believe are not material may also adversely affect our business. If any of the risks and uncertainties
described in this prospectus, any accompanying prospectus supplement or the documents incorporated by reference herein or therein actually occur, our business, financial condition, results of
operations and prospects could be adversely affected in a material way. The occurrence of any of these risks may cause you to lose all or part of your investment in the offered securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=90,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=1006311,FOLIO='4',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_boston_scientific_corporation"> </A>
<A NAME="toc_da13301_5"> </A>
<BR></FONT><FONT SIZE=2><B>  BOSTON SCIENTIFIC CORPORATION    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Company  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of
interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for
nearly 40&nbsp;years, we advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
history began in the late 1960s when our co-founder, John Abele, acquired an equity interest in Medi-tech,&nbsp;Inc., a research and development company focused on developing
alternatives to surgery. In 1969, Medi-tech introduced a family of steerable catheters used in some of the world's first less-invasive procedures. In 1979, John Abele joined with Pete Nicholas to form
Boston Scientific Corporation, which indirectly acquired Medi-tech. This acquisition began a period of active and focused new product development, innovation, market development and organizational
growth. Since then, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions,
and improve patients' quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
net sales have increased substantially since our formation. Our growth has been fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth
opportunities in the medical device industry and to build depth of portfolio within our core businesses. These strategic acquisitions have helped us to add promising new technologies to our pipeline
and to offer one of the broadest product portfolios in the world for use in less-invasive procedures in our core areas of Medical Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular. We believe
that the depth and breadth of our product portfolio has also enabled us to compete more effectively in the current healthcare environment that seeks to improve outcomes and lower costs. Our strategy
of category leadership also enables us to compete in a changing healthcare landscape and position our products with providers and payers, while also expanding internationally and managing the
complexities of the global healthcare market. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
principal executive offices are located at 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234. Our telephone number is (508)&nbsp;683-4000. Our website is located at
www.bostonscientific.com. We have included our website address as an inactive textual reference only. Information contained on, or accessible through, our website is not incorporated in this
prospectus, or any accompanying prospectus supplement or any document incorporated by reference herein or therein. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_use_of_proceeds"> </A>
<A NAME="toc_da13301_6"> </A>
<BR></FONT><FONT SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise indicated in a prospectus supplement, we intend to use the net proceeds from the sale of our securities for general corporate
purposes, which may include, without limitation, repurchases or redemptions of our outstanding debt securities or other reductions of our outstanding borrowings, repurchases of our outstanding equity
securities, working capital, business acquisitions, investments or other strategic alliances, payment of contingent consideration, investments in or loans to subsidiaries, capital expenditures or for
such other purposes as may be specified in the applicable prospectus supplement relating to such offering. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=91,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=696422,FOLIO='5',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da13301_description_of_capital_stock"> </A>
<A NAME="toc_da13301_7"> </A>
<BR></FONT><FONT SIZE=2><B>  DESCRIPTION OF CAPITAL STOCK    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following description summarizes the general terms and provisions of our common stock and preferred stock, certain provisions of the
Delaware General Corporation Law ("DGCL"), and provisions of our Third Restated Certificate of Incorporation ("Charter") and Amended and Restated By-Laws ("by-laws"). We have filed
copies of our Charter and by-laws as exhibits to the registration statement of which this prospectus forms&nbsp;a part. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
this section, "we," "us," or "our" refers to Boston Scientific Corporation, excluding its subsidiaries, unless otherwise expressly stated or the context otherwise requires. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Description of Common Stock  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following description of the terms of the common stock sets forth certain general provisions of the common stock as contained in our Charter
and by-laws and is qualified in its entirety by reference to Delaware law and our Charter and by-laws in their entirety. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently authorized to issue up to 2,000,000,000 shares of common stock, par value $0.01 per share. As of March&nbsp;31, 2020, there
were 1,646,877,242 shares of our common stock outstanding. All outstanding shares of our common stock are fully paid and nonassessable. Our common stock is listed on the NYSE under the symbol "BSX." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of our common stock have no preemptive, subscription, redemption or conversion rights and the common stock is not subject to redemption. The rights, preferences and privileges of
holders of common stock are subject to, and may be adversely affected by, the rights of holders of any series of preferred stock, whether currently outstanding or designated and issued in the future. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividends  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the preferences of holders of preferred stock, if any, holders of common stock are entitled to dividends and other distributions
when, as and if declared by our board of directors out of funds legally available therefor and shall share equally on a per share basis in all such dividends and other distributions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Rights  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided by law or by the designation of the preferences, limitations and relative rights of any series of preferred stock,
the voting power with respect to us is held by holders of our common stock. Each holder of common stock is entitled to one vote for each share held. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidation and Dissolution  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided by the certificate of designation and limitations and relative rights of any series of preferred stock, in the
event of any of our liquidation, dissolution, or winding up, whether voluntary or involuntary, after payment of all our liabilities and obligations and after payment has been made to holders of each
series of preferred stock of the full amount to which they are entitled, holders of shares of common stock will be entitled to share, ratably according to the number of shares of common stock held by
them, in all remaining assets available for distribution to holders of the common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=92,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=399791,FOLIO='6',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Description of Preferred Stock  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently authorized to issue up to 50,000,000 shares of preferred stock, par value $0.01 per share. As of March&nbsp;31, 2020, there
were no shares of our preferred stock outstanding. Pursuant to the provisions of our Charter, our board of directors is authorized, without stockholder approval and subject to limitations set forth in
our Charter and prescribed by Delaware law, to issue preferred stock in one or more series by resolution adopted by the Board. By filing a certificate of designation pursuant to Delaware law setting
forth such resolution or resolutions and providing for the issuance of such series, our board of directors is authorized to establish from time to time the number of shares to be included in each
series and to fix the designation, powers, preferences and relative, participating, optional or other rights, if any, of the shares of each series and any of its qualifications, limitations or
restrictions, in each case without further vote or action by our stockholder. Without limiting the generality of the foregoing, the resolutions providing for issuance of any series of preferred stock
may provide that such series shall be superior to, rank equally with or be junior to any other series of preferred stock to the extent permitted by law and the terms of any other series of preferred
stock. Shares of preferred stock may be convertible into shares of our common stock and any dividends payable on shares of preferred stock may be payable in cash or shares of our common stock at our
election. The issuance of preferred stock could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price
of our common stock and the voting and other rights of the holders of our common stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Certain Provisions of Delaware Law, the Charter and the By-laws  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business Combinations with Interested Stockholders.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the provisions of the DGCL. Section&nbsp;203 of the DGCL
prohibits a publicly
held Delaware corporation from engaging in a "business combination" with an "interested stockholder" for a period of three years after the date of the transaction in which the person became an
interested stockholder, unless the business combination is approved in a prescribed manner. A "business combination" includes mergers, consolidations, assets sales, and other transactions resulting in
a financial benefit to the interested stockholder. Subject to certain exceptions, an "interested stockholder" is a person who, together with affiliates owns, or within three years did own, 15% or more
of the corporation's voting stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liability of Directors and Officers.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As permitted by the DGCL, our Charter provides that our directors
will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except in certain circumstances involving wrongful acts, such as the breach of
a director's duty of loyalty, acts or omissions which involve intentional misconduct or a knowing violation of law or for any transaction from which the director derives an improper personal benefit.
Our directors are also subject to liability under Section&nbsp;174 of the DGCL, which makes directors personally liable for unlawful dividends or unlawful stock repurchases or redemptions if the
unlawful conduct is willful or results from negligence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
our Charter and by-laws (and in accordance with Section&nbsp;145 of the DGCL), we will indemnify to the fullest extent permitted by the DGCL any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or proceeding. These include civil, criminal, administrative, investigative or other proceedings by reason of the
fact that the person is or was one of our directors, officers or employees, or is or was serving in that capacity or as an agent at our request for another entity. Our indemnity covers expenses,
judgments, fines and amounts paid or to be paid in settlement actually and reasonably incurred in connection with the defense or settlement of an action, suit or proceeding if the person acted in good
faith and in a manner the person reasonably believed to be in or not opposed to our best interest and, with respect to any criminal action or proceeding, had no reasonable cause to believe that their
conduct was unlawful. We will indemnify a person in a derivative action under the same conditions, except that no indemnification is permitted without judicial approval if the person is adjudged to be
liable to us in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=93,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=524762,FOLIO='7',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>performance
of his or her duty. Derivative actions are actions by us or in our right to procure a judgment in our favor. Our agents may be similarly indemnified at the discretion of our board of
directors. In addition, we have entered into indemnification agreements with each of our directors and executive officers. These agreements provide rights of indemnification substantially similar to
and, in certain respects, broader than those provided by the Charter and by-laws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Election of Directors; Removal; Vacancies.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our Charter and by-laws provide that the directors shall be elected at each annual meeting
or at any
special meeting the notice of which specified the election of directors as an item of business for such meeting. Our by-laws provide that each nominee for director shall be elected to the board of
directors by the affirmative vote of the majority of votes cast, in person or by proxy, by the holders of shares entitled to vote at a meeting at which a quorum is present; provided, however, that if
the number of nominees exceeds the number of directors to be elected at any such meeting, the directors shall be elected by a plurality of the votes cast, in person or by proxy. Our Charter provides
that vacancies on the board of directors may only be filled by a majority of the board of directors then in office and further provides that directors may only be removed by the affirmative vote of
holders of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors. The provisions of our Charter and by-laws that govern
the number, election, and terms of the board of directors may not be amended without the
affirmative vote of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Meetings of Stockholders.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our Charter provides that stockholder action can only be taken at an annual or special meeting of stockholders
and that the
business permitted to be conducted at any special meeting of stockholders is limited to the business brought before the meeting by the Chairman of the board of directors or our President or at the
request of a majority of the members of the board of directors. Our Charter and by-laws provide that special meetings of stockholders can be called only by the Chairman of the board of directors, the
Chief Executive Officer (or if there is no Chief Executive Officer, the President), or pursuant to a resolution approved by a majority of the total number of directors which we would have if there
were no vacancies on the board of directors. Stockholders are not permitted to call a special meeting or to require that the board of directors call a special meeting of stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance Notice Requirements for Stockholder Proposals and Director Nominees.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our by-laws provide that stockholders seeking to make
nominations of
candidates for election as directors, or to bring other business before an annual or special meeting of the stockholders, must provide timely notice of their intent in writing. To be timely, a
stockholder's notice must be delivered to and received at our principal executive offices not less than 120&nbsp;days prior to the anniversary date that our proxy statement was released to
shareholders in connection with the previous year's annual meeting. However, in the event that the date of the annual meeting is more than 30&nbsp;days before or after the first anniversary date of
the preceding year's annual meeting, or in the event of a special meeting of stockholders called for the purpose of electing directors, then the deadline is a reasonable time before the we begin to
print and mail our proxy materials. Our by-laws also specify certain requirements as to the form and content of a stockholder's notice. These provisions may restrict the ability of our stockholders to
bring business before our annual meeting of stockholders or to make nominations for directors at our annual meeting or any special meeting of stockholders. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proxy Access.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our by-laws permit an eligible stockholder or group of stockholders to include up to a specified number of director
nominees in our
proxy materials for an annual meeting of stockholders. To qualify, the stockholders (or group of up to twenty stockholders) must have continuously owned for at least three years 3% or more of our
outstanding shares of common stock. The maximum number of stockholder nominees permitted under the proxy access provisions of our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=94,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=104294,FOLIO='8',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<A NAME="page_da13301_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>by-laws
is the greater of (i)&nbsp;two or (ii)&nbsp;20% of the total number of our directors in office as of the last day on which notice of a nomination may be delivered. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice
of a nomination under our proxy access by-law provisions must generally be submitted to our principal executive offices not less than 120&nbsp;days nor more than 150&nbsp;days
prior to the first anniversary of the date that we first mailed our proxy statement to stockholders for the immediately preceding annual meeting of stockholders. The notice must contain certain
information specified in our by-laws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock Repurchases; Change of Control.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our Charter prohibits us, with certain exceptions, from purchasing any shares of our stock from
any person,
entity or group that beneficially owns 5% or more of our voting stock at an above-market price, unless a majority of our disinterested stockholders approve the transaction. In addition, our Charter
empowers the board of directors, when considering a tender offer or merger or acquisition proposal, to take into account factors in addition to potential economic benefits to stockholders and to
consider constituencies other than stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment of Charter and By-Laws.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The DGCL provides generally that the vote of a majority of shares entitled to vote is required to act
on most
matters and to amend a corporation's certificate of incorporation. Our Charter and by-laws contain provisions requiring the affirmative vote of the holders of at least 80% of the voting stock, voting
together as a single class, to amend certain provisions of the Charter and our by-laws, including certain of the foregoing provisions. Such a supermajority vote would be in addition to any separate
class vote that might in the future be required with respect to shares of preferred stock then outstanding. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The foregoing and other provisions of Delaware law and the Charter and our by-laws could make it more difficult to
acquire us by means
of a tender offer, a proxy contest or otherwise. These provisions may have the effect of delaying, deferring or preventing a change in control of our company, may discourage bids for the common stock
at a premium over the market price of the common stock and may adversely affect the market price of the common stock. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent and Registrar  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The transfer agent and registrar for our common stock is Computershare Inc. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=95,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=467891,FOLIO='9',FILE='DISK126:[20ZCM1.20ZCM13301]DA13301A.;7',USER='DSLOAN',CD='20-MAY-2020;09:41' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dc13301_1_10"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dc13301_plan_of_distribution"> </A>
<A NAME="toc_dc13301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PLAN OF DISTRIBUTION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may sell our securities in any one or more of the following ways: (i)&nbsp;through agents; (ii)&nbsp;to or through underwriters;
(iii)&nbsp;through dealers; (iv)&nbsp;directly by us to a limited number of purchasers or to a single purchaser; or (v)&nbsp;through a combination of any of these methods of sale. The applicable
prospectus supplement will contain the terms of the transaction, name or names of any underwriters, dealers, agents and the respective amounts of securities underwritten or purchased by them, the
initial public offering price of the securities, and the applicable agent's commission, dealer's purchase price or underwriter's discount. Any dealers and agents, in addition to any underwriter,
participating in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities Act, and compensation received by them on resale of the securities may be
deemed to be underwriting discounts. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
initial offering price, dealer purchase price, discount or commission, and concessions allowed or reallowed or paid to dealers may be changed from time to time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Offers
to purchase securities may be solicited directly by us or by agents designated by us from time to time. Any such agent may be deemed to be an underwriter, as that term is defined
in the Securities Act, of the securities so offered and sold. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
underwriters are utilized in the sale of any securities in respect of which this prospectus is being delivered, such securities will be acquired by the underwriters for their own
account and may be resold from time to time in one or more transactions, including negotiated transactions, at fixed public offering prices or at varying prices determined by the underwriters at the
time of sale. Securities may be offered to the public either through underwriting syndicates represented by managing underwriters or directly by one or more underwriters. If any underwriter or
underwriters are utilized in the sale of securities, unless otherwise indicated in the applicable prospectus supplement, the obligations of the underwriters are subject to certain conditions precedent
and that the underwriters will be obligated to purchase all such securities if any are purchased. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a dealer is utilized in the sale of the securities in respect of which this prospectus is delivered, we will sell such securities as principal. The dealer may then resell such
securities to the public at varying prices to be determined by such dealer at the time of resale. Any such dealer may be deemed to be an underwriter, as such term is defined in the Securities Act, of
the securities so offered and sold. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Offers
to purchase securities may be solicited directly by us and the sale thereof may be made by us directly to institutional investors or others, who may be deemed to be underwriters
within the meaning of the Securities Act with respect to any resale thereof. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
so indicated in the applicable prospectus supplement, we may authorize agents and underwriters to solicit offers by certain institutions to purchase securities from us at the public
offering price set forth in the applicable prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on the date or dates stated in the applicable prospectus
supplement. Such delayed delivery contracts will be subject only to those conditions set forth in the applicable prospectus supplement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
may also be offered and sold, if so indicated in the applicable prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or
repayment pursuant to their terms, or otherwise, by one or more firms, which we refer to herein as the "remarketing firms," acting as principals for their own accounts or as our agents, as applicable.
Any remarketing firm will be identified and the terms of its agreement, if any, with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed
to be underwriters, as that term is defined in the Securities Act, in connection with the securities remarketed thereby. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=96,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=28816,FOLIO='10',FILE='DISK126:[20ZCM1.20ZCM13301]DC13301A.;5',USER='JTAYLORA',CD='20-MAY-2020;08:46' -->
<A NAME="page_dc13301_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agents,
underwriters and dealers may be entitled under relevant agreements with us to indemnification by us against certain liabilities, including liabilities under the Securities Act,
or to contribution with respect to payments which such agents, underwriters and dealers may be required to make in respect thereof. The terms and conditions of any indemnification or contribution will
be described in the applicable prospectus supplement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable
prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short
sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use
securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions may be deemed to be an underwriter and will
be identified in the applicable prospectus supplement (or a post-effective amendment). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may elect to list any series of securities on an exchange, but, unless otherwise specified in the applicable prospectus supplement, we shall not be obligated to do so. No assurance
can be given as to the liquidity of the trading market for any of the securities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agents,
underwriters and dealers may engage in transactions with, or perform services for, us and our respective subsidiaries in the ordinary course of business. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
underwriter may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation&nbsp;M under the Exchange Act.
Overallotment involves sales in excess of the offering size which creates a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do
not exceed a specified maximum. Short covering transactions involve purchases of the securities in the open market after the distribution is completed to cover short positions. Penalty bids permit the
underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a covering transaction to cover short positions. Those activities may
cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
place and time of delivery for securities will be set forth in the prospectus supplement for such securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=97,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=594954,FOLIO='11',FILE='DISK126:[20ZCM1.20ZCM13301]DC13301A.;5',USER='JTAYLORA',CD='20-MAY-2020;08:46' -->
<A NAME="page_dc13301_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg13301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dc13301_legal_matters"> </A>
<A NAME="toc_dc13301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  LEGAL MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the securities offered hereby will be passed upon for us by Shearman&nbsp;&amp; Sterling&nbsp;LLP, New York, New York. Certain
legal matters with respect to the offered securities will be passed upon for any underwriters, dealers or agents by counsel identified in the related prospectus supplement </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dc13301_experts"> </A>
<A NAME="toc_dc13301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  EXPERTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Boston Scientific Corporation appearing in Boston Scientific Corporation's
<A HREF="http://www.sec.gov/Archives/edgar/data/885725/000088572520000012/a2019form10-k.htm">Annual Report (Form&nbsp;10-K) for the year ended December&nbsp;31, 2019</A>
(including the schedule appearing therein), and the effectiveness of Boston Scientific Corporation's internal control over financial reporting as of December&nbsp;31, 2019 have been audited by
Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated
financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=98,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=152737,FOLIO='12',FILE='DISK126:[20ZCM1.20ZCM13301]DC13301A.;5',USER='JTAYLORA',CD='20-MAY-2020;08:46' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg13305a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g771996.jpg" ALT="LOGO" WIDTH="315" HEIGHT="138">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=99,EFW="2241681",CP="BOSTON SCIENTIFIC CORPORATION",DN="1",CHK=597599,FOLIO='blank',FILE='DISK104:[20ZCM5.20ZCM13305]HO13305A.;6',USER='JTAYLORA',CD='20-MAY-2020;10:39' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g364601.jpg
<DESCRIPTION>G364601.JPG
<TEXT>
begin 644 g364601.jpg
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M>&UA/FO2<Q&6!VXS%8@:G(+?DX^@SF'<WFG7?V&G5Y_3C)S.ET%J^#G[MJ0
M-WR9-&E8@@D&K1FXF" 2"Y'D _\ Z_.M._#C::Z]F3*UCZR73HC!JMY\>LQ5
MU+GS_7A?)\_C-_7S21D0'Q"R6*#A>"1*&''9(SHL'$\L06IN ,A9E.M?=$9K
MB%(B08_U)4E:5)8:<5C.,1ZF=F<G#-<G-OF>CM*U_55<V 8U48V38]C5>O46
M+L8#(?B%:8FV&B,$'+L,65&DQ_P^#.E.2'8TA$7+ZF'<(K0]L>:OF?H;R ^/
M70.E]HU69SKJ+K&D[@WMT(;,QJOJHB9KHJP":P)#6:QY$CI=,J3IHD=/768^
MS6II_->2!F3&!<@@Y=<#XCV^_IO'/S]RPQYMNG;I_4L99EQ9J:&D[,JK]]65
M(RA[?:]*IX0CR16=;Y%R^3GG6VS*::*YXYH_L)[6;159JRA2Q$U4M5J$"81"
M2P_K\MZ^CU'[3O5W+_0!,G7]$]&Z*W0= "XY@Z%U3MFB;"+!A,B2F P3*CJF
M=*RQX]Z=G$-J9+::CN2LXCH<4[GY/6&](=V<@\BN"HO1O06M]6&#S69 *K&S
M*IUX/1_F4C$@%0Z_&,7,RPMQ"V6GAP*0T\^G+#2UN_L>J1.;T::AAG@VOM8
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M3;O6-SPMOEJ!/< VZRZ6@M)EWO6($["PW-KF=CL,BZD6-C)$,B-K,TWF"_\
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MF C&C,20=_Q;B;N=@Y2::93SM7[V+1#1)M::U9[6NYJM$LU:-2U_:?@L2P]
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M*4_1<RZI*D+^7U+^..OK^;_..A\F[&'"G1YGQS=?/JQQU36FI#CPY[&=].F
M?+FI=)G.D26H6I]CA2N%^:<_/\8^,8N'S=.EL6_MXHWSZ+1=DSLU+VFKSE&W
MK>HDS_<U?"KX0S!/GIBZ^HM6UC1:AKFC"(M?IU#K(2FU4+":;9B":]6!L<*&
M@1VFD-MH:BP(3#:4H0G&584K.,94KU4R\IO@R[F[P\CF=PB]PTJ9S;;D4,?
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M%IW2G<Z<=)RI0D ^-,O%\[V0@I5YD.S@^:L0&_.2WH;K3O+QE;6>'Z\N&W-
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M>*7B-]!W#C>6GOJ_3<PXC*%*PM/OT&=M^/[BC>X36U:V]R[I._UW3P"35=6
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M.-CCPLK$B3!FP\7;T,70WP0_J\[Z5M3Z=5?:^D5.?,GZN?1ZUJ(U(>YCG3U
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M7S,M]^25=S$RL@^\Z[+RZMQ6<Z2!\(\45EFV1J]R/S6$B7N'%'W.$+TEKJ#
MM ^#8AMNACSD&-7FX9&!&M8839F(4AE<9JP#!YE#6"$-B0CO+\IY&7HY-L>9
M2<^5OY;<V=9Y=U%Y."JVKB]M($<>O7I.CH6WYX5J=>EUD(3 8Q:.#TKX[9WW
M(U-N;<=CI73EF>CJ0I+3XA_[-6:$1'*F2U)S$((S_:[$!;077U+O'G$URU:
MT$\=Y?\ %/325??F-L2&@%YO^^#E;:.QH[S:\L&(M6&'8@J>UAM^$P<(_1<2
MN1^6EN[0UXG>2+JQ.AX+V-UK^'^Z#36G:XS]&RS;J7WJX/UYB*]%PW*F'DJ&
MDXM84\M:XL]$1N.I&/E3BP5&UUK^%>B>T(=(J,39)JMC*:7V!&K@ABZ%*B%G
MRR@BKD;0W$2:FUX62G32 X-(FN#X4V7)E1X[;[[BU>TZ_HB+V]M%%,JJ-E2:
MHQ1)&P4U\4FZOTF*6=/QJ@[:,1<&G*Q'./O&6 2YN1C15YT@W&3*<6[D'/\
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MG&$I2G&,)QC&,8QC&,>O?K$VK2]JWJQ>MJ4K1R "]*,7=B% 4%F8DA0 //\
C0 _K\U$II&4Y( J2FDT4>2%1%"J 222   /))_\ V2?S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g814919.jpg
<DESCRIPTION>G814919.JPG
<TEXT>
begin 644 g814919.jpg
M_]C_X  02D9)1@ ! 0$ K "L  #__@ ^35),3%]'4D%02$E#4SI;0D]35$].
M7U-#245.5$E&24-=0D]35$].7U-#25]035,U-#%57TQ/1T\N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M+:?'Z8Y;4ZO"![@T:&*?<I*/#3@R[ZFR^W'S+$PEAKU&R5!^6S9867(5DD"
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M>7=@->0$NDNN5R'$)E5QKLG))4UU'\2GC&..''/&,?;&^Y'&/YL8U?;,8_\
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M)E#@ #L!!,OE+:$%:0P.AMO'IZXY^)>_W)^*?^=?8/\ 1^QT\G8<_BVM2?\
M//=']*EFZE-S7U@_QFX?>#3T1O,YO96RX-VR-IB_/E'^V=B&PXP_H']2.1_H
M/Z_K'0>;0HE]Q[]4J52:P<=285YK)E 'ZL2?,52'K$NR*?*!B?[%^_W/<B-^
MXQ<;]AUFIUN_:!TO=J[K:$)A=>0-MUA2[%#T2'5'A!9BJ?&2\,6'6H[(D1%"
MY"AV0Q_CQD>S[>&PQTMT=^RR,,-W1./R!AAA4)/W0WA P[(Z<-MZHV(EM'I9
M0C'H0G&,(3G'A.,8\8QXQU?Z-_P0G_)W_P#^+G5 OLO_ ,:-Q_\ ^4MU_P!%
M6Q>F/I"Y;?\ 7'WPE]JPY*>&F25->UBU$_)Y<QY* R(5DYG^XV0B)8?]CF2_
M?SO[(KH5R_ZR8I"5L9OB+#6L -@JO8(*@R$8(H4']%P4S #_ %'J/U\O-;1X
M\:#W>1"&[FTEJ7;)E<8,%@"ME:[J5X(A!I-T1Z2'B7K+$R2X]B0>!#=-:%RT
MV4X*,M]*U,MY31)J>O* 1WE ]5D4BHD:QSW )ZDJUT_7(=ZC*IS&TIJ.9JBJ
MFZ&N"56VH]EH%N#4#F,2&V@9(V&4I1CZ#'^]3_V?_''5!BF_QZ(7_P"2>R?T
MOSW7'^.]^].?]HHF[;E%/@&DVHF;+O55;(VCEE=?GX(9)S)R:A$O*9+ON9GY
MW]LU:T6>&-BNCVV.350>STK]C@@ZXP#3\?)@^,0/B<S'41'741\N6JX"<&?:
MRK'#;BSY]O.?/\ 6K?/GT^?/_P K_KYZI/[LI]2H?>-F:K1ZM6Z;6*_SGU;&
M0-=JL'%UZ#A(U%^UTXB/B8F(%# C@6UO.J0(&PR.C+B\I;QZL^?H+J_O&?\
MBL_^3J@5R7_CJ[A_T]-8?Z]ZVZ)_QRUM70T>?KOZ>A=6' ],P7;NV;("?Y5(
M?(0<TQ@O&9'N([ZF8[ZGXS]NT:52GQ<ZM.K6(N35!(J]=*2(?4V?$B6 S(]Q
M$]3/7<1/_7RU]W7N<A_!KB^=;:7].>W#L><SKO5#4DVV4-$S1@!TC,W8J->2
MIF3$I<((](M /X4(=-DP81R%A$DH5'7V&.,4+?Z7?^?&\6'MI[RV=L6R0-0O
M.PO1:IZ(@ZJ\.!8;-'R4JLMUFQ6>UYE8XB42R.7'0E?#AX=0,444.1QC\3,]
M)>YPW8SG.(C*]\/IQA;OI5*)_@P:\K1_>/4@%Q>&EX_LV$N/(Q_8LJ\R6]A_
M&,=MG47C&,>;CN?.?'ZYSG:MG^^?Y_\ ']_'CJ)9GJXO_C=1W,J?Q]7G/*)H
M;=]7];3,FH_:6O*%XS# IDW%2]R!F!<;GBWS H&#0M'M?;MC-O=NH\:QOR<Z
MJS]H"\].:9W3478%8@=!@+9,3*X6H@D2'OXHOXCJ=5!Z0T -':P8D)J6VN5*
M";R&CGV[#JHBFQ34B!!P5IC642L!)7MZ2><:6J3$&6'5C7 V7IA@(@"6CMP7
MG<VR.$/'.Z\@!YAK:LY0&7K 580W@)^< %E9,&J6B<$(98?:E[74!8*Q2*GF
MVWB2I)PUUMI92FD.L^.P4WEHEEI]K.4JRV\VAUO*D*PI*LMN)4C.4JQA2<Y3
MG*58QG'C.,9Z_7'CQ]OMC]/OC./TSX_3/W_Z_P!_Z_IGK)M#F:+_  # X3_!
MH58P]C0U9WRML?:L!?AHE2568J!I5Y@D2\%6#2]E*LZ$J=+C;>ZG'65>5:G(
M_P"28:=*A6I1E"@%I45:5S%EC1.9L-B1;ZR-4&H;+5^PEPL0\]'1T=43Y9_A
MUR7??^X?N+_-7L7_ %,G.NM=>A*Q<=-QDA#2X0\C%2P)D9)1Y;27A3H\\9T0
MT,EE7E+HY0KSK#S:L>EQIQ:,_;.>GZK819KO*)(4O2TACKN86P3F([_7<Q'4
M=_KOXT]<M2U43$2Q9A$S_P 1)#,1,]?OKN?W\HT]F?N0,<')<F@;R&GP>,.Y
M"XJ03=LQ$R_%ZXV*)'"0[MH&RR$XS,UV;CQ1(B[!PV39>+?B(F9&#?P'+"D7
M=J1?Z1LNM1EQU[;JW>*G,CH*BK)4YJ.L,)(#N)PI+@LE%$%"N8\9\+QAS"VU
MX4AU*'$J3C7 -(:>C-7Q>E ]84-&H86%%KL7K-ZJPQE&"@PL9^)%,U@T,B)P
M$QG.5-M*%5X7G+GJRYG*\I+*]H'MVR<D=*B\<XVJ/R;SI!XNO+]M76T.4\\K
MU+6N HMY@(1'C/GT)9 :;;PMS#:$^M?JUSGG,.!_8F]=Y$_+WN'Z5ILQ9/,7
MG\CJ:BUQ"Z]NS3LW>.GGZ)($ M%7MW:[R 3]8NESVT+C&!RGB>97RE7<O?II
M")4%QEO)?2,_[M0FPFMK#:J0V2),-17:N"*/.0\%+YEW0N?U$TGJFV<?-42C
M&S^7&[821UGK;45%3BVVZ(,N@;L$1:I^(A_FNQ:(H"0>)@8J00V?89A0+(X?
MT=J7E8W>>V+P5SQ,X21VC]G @'W+9OYBMNY8AE]DT(:2O$*'7WZ2F1'2A)[%
M;IP$76RRV7GA"95B6, ?<#(8=6SF@N%'%+B\Z49H?1&O==3!R7FSK-%Q&3[B
M:R1Z?D#F72>?EK64,_E*<NBNS&1E^A/J9SA*<8:3JM:7*L^KQH.(<63?3GNU
M$;6SKZ7I3I[.A32Q&< TZC;",O/SQ<]B:@W=!S+3CL-N="I*YBGAVW[!;^XR
MJRVNDS.S\^G[64L^J\P9;,K%@%-NV[9+6#'S6JK!"Q2")[,RHS\>J[+=GGNL
MUB$WYB2@-1%JNM&CMC.AOI@K+IV^,9&J-^&)0A]!(=:F8^K?GX,-9,A62HR:
MP4SEIH59=T\_<FIHNCN;,D-FZ_#UVS'*EW+T_<JXFGXBTL_(S(8LGU+,0X'E
MC.'4/ME+0XVI.6_5E2<9QNY="Z:Y"U-RC;MUG3=G55;JB&HFX0@DLV 8MI3'
MU&'*=1@^#E4LK6VU*PQ8,BTA64ME)QGQTCM;[-';4JTV!.Q_%JJ&O1AZ9,*+
MLMGV%;JNV:AW#S;KU0L]NE:P<EM6/V&9"*+8]/[*FEIZM'+^<\6^R"Q]GE4<
M@R.49^77R=-^+GYNIG;RJAM8FYU<ULAV3=:3VB_Q7IH\97*UC"H6<+@\:W.(
M1?S\+^*OXMNZR]37I6[E*WF&\5K8CNO1OKO5P%02OLZ;)*"\B[/R'7^+>RC>
M6?)39_.(*0G*YQ+UWK [0W'<^P'2M8@=JYQ9F[;N?D"_7Y0L,-BK8.A(2F4*
MQ3 K+Q$+%6"02D%!#Z,0W?B/+]1;M,<0ETZYU*UHCP-V8/56K+"3V <E%:R^
M-@S,2<9@7Y.!W\CY?]&'O9=PUE>6G,(ME'TZI2M3,H<G6*_(TB0@'ZJ?3S8:
M.)JYE8) 5%$5PJ ='5%/03T8I4<[$+$S'K 5D10^1\Y;Z7!K@3P?8QG#'#WC
M"QC/C"L,:(UDQA6$_9.%8:K2,*]./[GSY]/G/CQYSTQPK[!PN,<WSN8.R]**
M^$AE#&Q*;*K C/+*M9@S=T'2@CO&=IE^X]5,56KK7DM-1+ 2ISD7$]/9XY:P
M5W:<MTFA;T=*P+Q*;<7D7)_&J+A@C6$4!5KJ.Q)IK@H28XQ)AJ=V9[U2"NWI
MQ6I0]PJI-O&HMF=*JC%BAW;&.TSL*XD/*)@FS%RK3;;#[#KRG \);9>;6O*4
M.)SFNGM?44]VB^ZOK?;T_"3+/'8W;LO=:+;(N/>.#-U3?FIF(NU.%<QC#3]P
MUO&6J1%*KV76Y23BHJ'EP6'!IAK+=Q'7_%'C!JBT,W?6''71VN[F.&;',VVC
MZJI%6LS0$DVVU(A-SL)"A2:!#VF66S!TDX:);:;0\A:4)QCH6R=6ZXW%4I&A
M[5HU4V)39;",R%8N4%'6&%)<:PO#!*@),<AELP7*UJ$.92T8&XK+@S[3G[71
M>)]I4L'EW,=-.?>T>+<_5KHY+C66(JW!3L6;KB*C85-A,V,\+KEUFN"!>MU@
M#6@F+>EG1X3:T\'C]-EJK4V^*G09CZ"0:^O)T$U@B+*F0ID+M'66;07,RHEJ
M(29 FL\56-VZ@N%"&VA6-GT*<UV3&(EV[L!;()RLHC5,?(465+Y/2& AII*U
M%-G.C/!*;=:,;8=9=0B/K36S2></,6-WSK:3F5\1N*E5V!1:#=A3)2+K'('?
M6PE1\-=['71DN#AW'6VIJA$NUV(L9HST8?=+%)F5UU]N,R8G-1?9G[:,1.)G
M1N*]1(=0:W(?29:S;$FZHZ6TMMQM95.F+@;63FDK;QGXQ\64+G"EI4PI"U)Z
MDE@Z] 5F$CJU7(2)@*[#@,141 0L:'%0L7&"M88&C8V+ 9'!! '8QAE@05AH
M=IK'H0VE/VZI3[O$\A5^>-LW=.Y?K6**;6[GY^8&12N 2+OJKT=37C1O6:;&
MT1M,91362^PU=-EEE=M.Q*K;U]E2-D<NG6JN3:8C,M6[A7[-8Q;6\VV:='\2
MLFP 692 V6N8I(%8!0M!]9K\19LK75VX\\?@Z=?:5:S =ZR))@=;M=?GBA!O
MX-K2/\@D>)D3'6!_?=;8R\ZA+:7G&VU*PMQ&%,?V#=D:\A>"%2J<O>Z9%VF1
MW-MI@"MR-J@09\QZ2M(R8YH6&*D&9(EP]3B,!-L#.+*RM'L)<]:/5)VG@5P@
M;6MQOA[Q@:<<SG+CC6B-9-+7E2LK5E:VZTE2O*\Y7GU9SY5GU9^_WZRL'PFX
M<UF?AK77>*G'."M%=DP)J L<1I;7<?/0DQ%$-EQDK$RXM>:/CI&.*::)!-$(
M:($?;0\PXVXE*L7BY]A<6L?5U/ZV"GOB-'99MIUC'.\FN*+TA694&Q, OSN?
MV<+S+Q7^E3)=16T<4VU<TL<P*QE25J@O/.B)7/%:QBJ).!\JB2/JMV*R6(S)
M]2<1'<ICWD]D:]_K?'+&C_GNFXNF*?6Q_P I9M,#^9\D*OM(/2Q] ^H?5_>4
M#G!B6LAX<4+G!"4Y:SA68B/PX>PZ#17.8:[K=ZA44R*M'JCU6>SP=?2?@-.T
MOF9#S+GAX*P+@AC).6?6EC#S7NY1EUO"K*URX?<3]BVJ5O5^XS:!NUUG7F")
MJWVS4%"L%HEWQ@QXX9Z2GI6!*E#G6 !!0F7"2G%M"#L#(SAEI"$ZP]P(X/$)
M]!'#SC 2GTK3Z2-$:R?3Z7,>E:<8>K2\82M/V7C&/"\?96,XQTWB<_XQF?6.
M]]=OI[S9Y'HT=6UJ*'/B*;ZS,=S*]>L=B/R$DS)@0:QJ&>#O*5P0>)=Z/%MN
MYS+,Y8M^6'\14L4D4C*W_P"0IPWUBQSA3/J9 7I(@ &#Y+B(*8+N(4_Q)D4=
M,Z!XPW&*'7)5B.V_8!C)P'&"XMA=JUX2NO*<-'RX/AJ8^F%(CWO<RR6XE#;+
MBUNM)<9/L>;6UK5>V77I.RWRIP$?K&V[D(V&9,ST;%CTH9V]3=C8)LKII#&(
MD8B".$E1GR_;;)#?0Z.IWSZ>IBKAJ36%_P!=F:DNNOZ?9]8GPX=?)H,S7XPV
MI*AHUMAN,CFH-T?( PT5@0142D9EE46X(*['K&=&96A$:QV=^VY4;.-;8KBU
M3B9(,QB0&!L4]>[=6$E"O)?%6]3K3:I>K&M"O)]T4:1B3!1UY];3*58QG'M?
MG_&=#ZJI?7&ZG=I,QN1,V\_2R:F??"XDRT"FI<3<TLXJ;9_DK 183-P0\$LE
M#.C4?CN+;53F]GEV8>98'0R@SK52\^U5*NP1J!#D&BI;BP$1367K9^.1>1A[
M![$X9J@<KM'[/U53-J!7..IM;V779"S4P39Q<=KNR3-83(RD3&V5BN6<\*4Q
M!V%,?]6KT@IG#4G"G1T@CVTE8;11_P"SS8J_6^YEH><L,[#04*));DR7+S,J
M!%Q8J2M7[ 8&41('$#B,X??>:98]QY/O.NMMM86M:$YO1['XP<;MPR,1+[9T
M#I?9TK 0[=>@I/8&L*7<)"&@6B'"VH6*,GX8]^/B6RGG2&XT1;(;;[BW4,I6
MK.<Z$O@;PC<3E#G$'C*XC/CRV[HS6KC:O3G&4^I"ZXI.?3G&,I\XSXSC&<>,
MXQTYP;[%XMP_ Y[BQF;KHYWEMRC\6T#C&1*=FJ@EN(E%I,!&J,L(TT(8Q$]
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M@US1:9>>]AQIP:M1$T;[K21LN)YAP3WWMS9PF^=1\C"Z>3R$XT;A-UY?2Z+
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ME'[+2$8^W0E3G@+=R<KE&R]?*=?0T+C%W1"U73HYG(<TX0UB&B5E<;QL-AC
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g208995.jpg
<DESCRIPTION>G208995.JPG
<TEXT>
begin 644 g208995.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#%?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ )0$  0$1 /_$ !L  0 # 0$! 0
M           !!P@)"@(&_\0 ,Q   0,$ 0(""0,$ P      !@0%!P ! P@"
M"1$A,1(3%!=!45AA<8&8V!46&"A"D:'_V@ ( 0$  #\ ]ALT;SCX'/[)J=$,
M5GVR6R"X XRT5@4<N 4/,$115G=_Z$TG,OR)(1&-BPI@+'G&J:P<4;,A(?E>
M9"O<4 IP'4*Q]P9J,.KV+ "<(0F&I.T;(=F^Z[9T_L$:K+P*F*6?8LBCIBE
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M-U085J=_-647-'-A3X&?(Y+4ZA(,.W-0N3)4//%@Q*LBM/S3O,_6[[W[:*Z
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G#(HY:$8\WD2=8>/>-VRIT9.4D[,&(2PO: -L&6I_5([;\I2E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g353076.jpg
<DESCRIPTION>G353076.JPG
<TEXT>
begin 644 g353076.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#)?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ )0$" 0$1 /_$ !T  0 !!0$! 0
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MD\FD")M5*6:/*)&J1N"9@)>G(I,VFO2A M(:BU62\Y(I+3Y$9ZNL-K?*V.&
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E(*(RV-[B4PG19ACS4+0^JGLPM0U"Z%N&*MP7@?/'CCCCCG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g920114.jpg
<DESCRIPTION>G920114.JPG
<TEXT>
begin 644 g920114.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#-?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ (0#) 0$1 /_$ !P  0 " P$! 0
M           ("04&!PH" __$ $(0  $$ @(! 0$*" X#      4#! 8' @@
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MYM,1%?Q8Q,#S63/! -!)R];0V$S2QI,JFJZ0:88B857D?E,S/K]*N4\E&H(
M2<HML5WBR.#-LY72XC$]LZJFDE"Q,-'=BFI4^^Q','$HT\V[@T=1<9I*K=9E
MYA-J.CT1CS+K!'/K(E(#@P=@KVDCF[Q67034DJHIBFGDIGEUCACCWGEEGWUC
MCAAUU[66>?>7>/6..&/7>67N]]>YUUW^G\7*1-3-F=VO)+1<_P!Q-<[*HJC:
MAE$QMR*Z>U]-Z6-VF1FD=J*926O6=C; 2Y.T(8_$_*9,HP6R;0:N XE2 Q/
M>Z7E4T,.E\4X=WYY!MY*$NFP*WM'9[3W78G5WBTI;>,@$NZFFYH9(-@9"6F\
M"GVOS8X%O2O2A:.NIM7#O"-NH8U(S7!Q+QPQBU/Y,&")N=L7\H5HOZ/TC=DM
M5"BFV6UFJ=G[32.@2\YRK$77,.I&!QF0SI0C)9-%I$78DI7*IQ!(G6L6,1Y%
MTH[EGK3(_'QL9.ENK+]=;U@^SU"TWL56JC]2 W?6<*M2(?"S7IB71 3F/L9
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M*>V8+K[86LM@AD0Q$WS(F;>GL3-6VW"I15L&D4WK80RF,3L5 _.&D>G$!51
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MM77HJ)#G#$&SPC%>M8[9D:P69X-0_<"7<#D_?'31+/*ZK-3,Q\YFO.U<]'D
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B)$<UJ>_G"] _Z)JW_HWE]AK\HO4O_"?87_O?67DW..?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g330364.jpg
<DESCRIPTION>G330364.JPG
<TEXT>
begin 644 g330364.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#1?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ *@"] 0$1 /_$ !T  0 " @,! 0
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MPWFJ"96W,IA04Z@'4@0=+V=-OY)V8K#\]Q_U0%>K9MFC(IUW61A%$=)MDVG
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;-J@PVIS+K[T+/^FW_P :5_.M/FOY\Y<<<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g95360.jpg
<DESCRIPTION>G95360.JPG
<TEXT>
begin 644 g95360.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#5?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ *P"< 0$1 /_$ !X  0 !!0$! 0$
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MH%\)V=OIU^O.+*[CUUSO]./K^G&8#MG&OU>_IQG;;.-?7O.<^\^5^\_B2_\
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(T<KZJ2<\_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g125798.jpg
<DESCRIPTION>G125798.JPG
<TEXT>
begin 644 g125798.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$P-#I;,C!:0TTU+C(P6D--
M,3,S,#4N3U544%5473(P,C,S7S5?0D]35$].,#9?2U]%44XN15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ )0#/ 0$1 /_$ !X   (" @,! 0
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MP[SYZ >\@[F/DWJIM23 *)N@*]MXL":[!R^>@QJ"KP'G1P>LTTC@I>Z@\3&
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M+'&SLG$VTM*%8HVQJN30D3HJCE31GWF X:9,^=7K<QMPD0ZW&B LYIR <O\
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M:^V,[9SMGWSG.<GZ<G)7\"&7]>>BO[M^C].3DK^!#+^O/17]V_6./'1R/GY
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M='.FJRZ,5'N9!5%+93.J>JJJ;;9-/93;&FN^VNV^?HXSZ\ZW,KKISM[QD/\
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I!R7N\A0)9D39)(2TKF0BH5^ENE%R#I1-^JU4QH]PLKI]=LUWH]'K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g771996.jpg
<DESCRIPTION>G771996.JPG
<TEXT>
begin 644 g771996.jpg
M_]C_X  02D9)1@ ! 0$ V #8  #__@ ^35),3%]'4D%02$E#4SI;0D]35$].
M7U-#245.5$E&24-=0D]35$].7U-#25]035,U-#%57TQ/1T\N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M%PU:7.:3;IRLJG'/XYECY!^3L']@<UV5CF]@^DQN_DVGXDOTI%SN+[J1B87
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MR3-SQS3^.+)5&/N^-<0D8DZ LI+-3.!,\1\IH"RY04,0$S//;&V@WP3OB]J
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M3CV4B@10JI$7[1N]1(H4.Q5").DEDR'+]1B%*8/MY]I$R)E*0A2D*0H$(4H
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M]VN9/&^-DJ?)V1#&S7Y@W#EFHJJN8=I\$!"ZH@W%,Q6PXFGZB>MLX(H+^PF
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MXS8EDWUBDU',<BNZ*962]&@T(84$$0=H#?#2,   V]UE[   '_'GC7Y!\/\
MVCXE[T2L<8^RKOM6*?DZBT_(M3<XHRT_<5B\UJ'ME?6?L(^"%@^5AYUF^CSO
M&)EUCLG1FXKM#J'4;J)J#XN.A_Q#M)/_ '0M9?\ \&8U_P#YSE5_$G;BE>>9
MZVO'(*$4XOFA5#D1F51"K]W2M2HQLQ%AV\VM%JTB!^M1Q7^DQ$[M!7<GC+9<
M[\3:AMINYB/_ ')9(:%DHM-KAF8O7U]9B;3[>TWF?Z^932ZW]]Q+D'?!S?\
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M;#%/G;.4*_%V[?._=Q&+I8[9=3ML/<KF/">3=K^#\4R>6YY=?B*&=5VA<SE
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M0LJ[9!S)Q%*J=^>L?H_#OEBJ.8F.EK,I-3DPU8*MTI9T:.6D =#'L?3_ &R
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M7:W)EC7J\7((H2"3=9F95FX3,L4Z1BA7MBB&A,J=:S;B?R.BA,SFM> ,#5[
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M[ '<0*4 #[   #X  !3WUOVZTCIA!P22@%"Q[.ZNP"I#?$JR4EEN&3\HP?\
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M/.1[B+DV:@E$!\#EDZ71-V^( ?N'Q .=YPXA/ZVAJ.5T'FKF;H%-<9HJ,/Q
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M:MGYS3BI@P2!,9[C:IVLUD?RWFC.>98];^EX)[B%:FR:&2CJUK1X93"K6]+
MAIL*YAWFDW$TN XP-AM\=8L%H9A36;UFGK>\6@CLWH?3L^7C'>:*3D;(6N6P
MF*HM>MTS,V'U81"8^ACQ;S7E%M-;L$;)UBWU XG<':P\LQ\#!9TX%!0S9==H
MKV58U:R\KC[.]'S-M[E'-Q\SXW?XVC9*:H>)Z4TQLQEH2S0LM-5BOT.M0\7(
MSLD6PHKN7=A%\7M#1S9(J: N 4FYPYVCE&W""N;=H)ED?CA&[.?G-.I#$W5Z
MBZ>DRH7155JW$F^H!H:MK$/%@S4YJWYSAYDM';@!!F9]I9J%MP"[-[KRK8K"
M86!J'-*_@7SE!8T5J.8O%ACFL D^G3@^8TDQ_HUD)U9KOC['-=KT57+B#MM6
M+]$3U5=.WE=O,#*0B!6L%:XA9XMZ1RT:JLSHJ+LWC-TQ=NFRODJII/LY!C4H
M2:ZENS%GH=7G8.0<0+JBX*C;5986$D4GHUFP9084?Z:N64LU0)%2\DD[2F7;
M%1P8'I'2I'"5E7#G>O,>0Q1P9'0MC=?;U34T<W*TZ#TGYB77DJZ"3-<YIJ:T
M^<V?"UR?$'VF?@#Z<[<>R9LO:BY 66571'91QY.UTU?TLLQ95D,MA!'M Z-2
M:M8N3Q']Y?VB=(:GUV1W1@MT%+;/DM$#@&1P&WI)6<4:LJQ$E;U+<K83O3(C
M,DER.%!9%;IK@P,V#QG3%;XASM_J?6]P*'1*%:+7/5%A1<TXSS.V>5]G%/7,
ME)8TE'4FR@GB<LBL@G%RIW1D7RZ!2O4DRE%L<IA$>2PX<@#W]@+F7H#>)1S%
M !;+/%!>R8%K$N 8XD<TM [&):))6]IF\S:9_7B3?)SR+O*76I9?2*4[PO8D
M0P4U:5+>\Q>+5F]1TB8I-8\5CQ$?OS G9+0VN9LRS4MC,<Y8R3K7LA3X,:@C
MEW%!J\Z<6FD'?&?FIV0*A;(N7JUTA4'!SG8%DV8.6@F(F99R@U8(L_6TG56R
MOJ#F''6TF>;CMS6<QPS.L2T+D*FXZH]?@JRE'2#*1C("#QC!5YN@ZF7$@$B]
MG'"R\R@\CHA6.=LU(]-0TR>'.\\HW+(*9UW*7"A4-$#D31OIHB79JVN!'8NM
M;637 S7Y1+K.B".TWBHXK>]9Y1B9D-';A>U2-6)=H56&JILW*&5RE9SZFA Y
M2!GTN4JUR6B(FUIM6LQ5-4^G;G?%=36Q=AGJ0;.T3$31%2-J52EJ?@_(UAH]
M?\LB+2 K>1KI1WUJ08Q2(&1B!744/'H@@D@!2( 4]GM8AEJ[6Z_7W$U,61>#
MA(F'6L-A70=3\\M&1[=BK,S;ELW:-W$O*'0,_DUT&K9%9ZX742;HIF*F7O.'
M.6OR'4W9I;3NF4M2$-<X,O+198.:*04[K2":S#YB>D6L9TIR3>U[^WN2]K=$
M,E',]H3H<=9I051D=>9"(0YF:"7"TP82PZ^?$#7H*D5BM?'K6L1%/;[56#V\
MQY4,=V&Y6&E1]3S!C++P/JVSB7KJ4>XRG#3\; O4IA%=N2+D7P(&>+(%*\2]
M.F9L<IO%W^K:?4K&6V5-@*[>'5GJ]GH=I9WW%65,?R_T<R5BJ^1HB+&TTNP
M@Z(U<^'LVD(]\U>14LS $7K4RB35PVE%PY^%=[82KF54?.M&.RVWFR&:4LJP
M_4%';UM6L6O#(U@C,,LD'<5)%-/CN2MOT?*SF9=LPH(TZ 0 <^3VM!Q*R2R]
M9K-O6LAL4EQW'%+UO:+Q;WK68JXDNF_9LMR%/8[=;@YOVCQA1Y6*L4?ANPUG
M%6-*#:+%!.$',+(Y-1QC5825R$VCETO5IP\P_2C%WPE<NTEP Z*LF++JE 63
M;W%NW"UPL#2:Q5AR[X=AZ&W91 U=Y'7F7;RLA-N79T!EV\BW]&S:MVS19-@9
M!JEYB7B+R5_#DUCEW(&;5FSU CHEHYXUDD<_.1"KKA^#4J'/0462"1\7BC;
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?3FC/ACZ-2FM:]R%JM%[DO<EK22TVDX<.'*'JUZ__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
